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Summary 
Resumen 
SUMMARY 
Sorting nexin 27 (SNX27) belongs to the SNX family of proteins that control intracellular protein 
trafficking.  SNX27 bears a PX (Phox homology) domain that regulates its endosomal 
localization, a unique PDZ (PSD-95, Dlg1, ZO-1) domain and an atypical FERM (4.1, ezrin, 
radixin, moesin) domain, which bind short peptide sequence motifs in the cargo protein 
cytoplasmic domains.  SNX27 recycles PDZ-interacting receptors at the neuronal synapse, and 
its low expression is associated with impaired synaptic function and neurological diseases.  
T lymphocyte antigen recognition leads to the formation of a highly organized structure termed 
immune synapse (IS), by analogy with the nervous synapse.  SNX27-positive endosomes 
polarize to the IS, but the role of SNX27 during T cell activation remains unknown. 
In this study we investigated SNX27 dynamics and functions during IS formation.  We 
characterized a previously unidentified FERM domain lipid-binding site that enhances SNX27 
endosomal localization, and showed that a fraction of SNX27 accumulates at the IS in a PDZ 
ligand-dependent manner.  We used proteomics to identify the SNX27 interactome in IS-forming 
T cells; a comparative interactome analysis of SNX27 WT and a mutant deficient for PDZ ligand 
recognition identified various cargoes linked to signaling and cytoskeletal regulation.  We 
demonstrated that SNX27 controls the signaling and trafficking of some of these cargoes 
including the lipid kinase diacylglycerol kinase ! (DGK!) and the epithelial cell-cell junction 
protein zona occludens-2 (ZO-2).  Proteomic analyses also detected the retromer and the actin 
nucleator WASH complex, and we confirmed that SNX27 acts as a WASH adaptor for PDZ 
cargoes in T cells.  Analysis of Snx27−/− mice supported our studies in human T cell lines, 
underscoring a putative role for SNX27 in sustaining the function of the metabolic regulator 
mTOR (mammalian target of rapamycin) in activated T cells.  This study broadens our 
knowledge of the SNX27 function in integrating sorting events with endosomal lipid signaling in 
T lymphocytes, and suggests conservation in the pathways that delimit polarized structures in 
nervous and epithelial systems during IS formation. 
For their migration and invasion, cancer cells also need to form highly organized structures. 
Cells assemble invadopodia to coordinate the signaling and trafficking that promote increased 
secretion and matrix degradation.  The SNX27 partner WASH, assisted by the exocyst complex, 
controls integrin and metalloproteinase recycling at invadopodia. The role of SNX27 in invasive 
cell polarized recycling has nonetheless not been explored.  We showed SNX27 localization to 
invadopodia in a cancer cell line, and addressed the effects of its downmodulation on invasive 
migration.  We identified the phosphatidylinositol (4,5)-bisphosphate-synthesizing enzyme 
phosphatidylinositol 4-phosphate 5-kinase " (PIP5K "), a known modulator of exocyst function, 
as a SNX27 partner.  Our results support a SNX27 function as an endosomal hub that assists 
lipid modulation in the recycling compartment, and suggest that the frequent amplification of 
SNX27 in human cancers promotes oncogenic traits in tumor cells. 
RESUMEN 
Sorting nexin 27 (SNX27) pertenece a la familia de SNX, moléculas que controlan el tráfico 
intracelular de proteínas; su dominio PX (Phox homology) permite su localización endosomal, 
mientras que sus dominios PDZ (PSD-95, Dlg1, ZO-1), y FERM (4.1, ezrin, radixin, moesin) 
atípico unen secuencias peptídicas cortas en los dominios citoplasmáticos de las proteínas 
cargo.  En la sinapsis nerviosa, SNX27 recicla receptores unidos a su PDZ, y su baja expresión 
está asociada a una disfunción sináptica y a enfermedades neurológicas.  Por analogía con 
dicha sinapsis, se llama sinapsis inmune (SI) a la estructura formada por los linfocitos T tras el 
reconocimiento antigénico.  Los endosomas positivos para SNX27 polarizan a la SI, sin 
embargo, se desconoce el papel de esta proteína en la activación de las células T. 
En este estudio investigamos las dinámicas y funciones de SNX27 durante la formación de 
la SI.  Caracterizamos un sitio de unión a lípidos en el dominio FERM de SNX27 que promueve 
su localización endosomal, y demostramos que la acumulación de SNX27 en la SI es 
dependiente de su unión a ligandos de PDZ.  Usando una aproximación proteómica 
identificamos las proteínas asociadas a SNX27 en la SI; comparamos el interactoma de la 
proteína WT con el de una mutante incapaz de unir ligandos de PDZ, y detectamos varios 
cargos que regulan la señalización y el citoesqueleto.  Además, demostramos que SNX27 
controla la señalización y el tráfico de algunos de ellos como la diacilglicerol quinasa ! (DGK!) y 
la proteína de las uniones intercelulares epiteliales zona occludens-2 (ZO-2).  Nuestro análisis 
proteómico también detectó el retrómero y el complejo WASH, y confirmamos que, en 
células T, SNX27 dirige sus cargos de PDZ hacia el transporte mediado por WASH.  Los datos 
obtenidos en ratones Snx27−/− apoyaron los obtenidos en la línea celular T humana Jurkat y 
pusieron de manifiesto el papel de SNX27 en la activación del regulador metabólico mTOR 
(mammalian target of rapamycin) en células T activadas.  Este estudio amplia el conocimiento 
sobre la función de SNX27 en la integración del tráfico y la señalización lipídica endosomal en 
linfocitos T.  Además, sugiere que los mecanismos que delimitan las estructuras polarizadas en 
los sistemas nervioso y epitelial están conservados en células T durante la formación de la SI. 
Las células tumorales forman estructuras altamente organizadas para migrar e invadir 
tejidos; en los invadopodios se coordina la señalización y el tráfico facilitando la secreción así 
como la degradación de las matrices extracelulares.  WASH, ayudado por el complejo del 
exocisto, recicla integrinas y metaloproteasas en estas estructuras.  Sin embargo, no se ha 
explorado la función de SNX27 en el reciclaje polarizado en células tumorales.  En este estudio 
usamos una línea celular de cáncer de mama para mostrar la localización de SNX27 a los 
invadopodios, y el efecto de su silenciamiento en la invasión celular.  Además, identificamos la 
asociación de SNX27 con la enzima lipídica reguladora del exocisto fosfatidilinositol 4-fosfato 5-
kinasa " (PIP5K ").  Nuestros datos apoyan la hipótesis de que SNX27 facilita la modulación de 
lípidos endosomal y sugieren que su amplificación promueve un fenotipo invasivo.
  
Index 
SUMMARY ........................................................................................................ 12!
RESUMEN ........................................................................................................ 14 !!
I. ABBREVIATIONS .......................................................................................... 24!
II. INTRODUCTION .......................................................................................... 30!
1. LIPID MODULATION IN ENDOSOMAL COMPARTMENTS ............................................. 30!
1.1. Lipids and membrane trafficking ................................................................................ 30!
1.1.1. Phosphoinositides ................................................................................................ 30!
1.1.2. Diacylglycerol and phosphatidic acid .................................................................... 31!
1.2. Endosomal lipid signaling ........................................................................................... 33!
2. CELL MODELS OF POLARIZED TRAFFICKING .............................................................. 36!
2.1. T cell activation and immune synapse formation ....................................................... 36!
2.1.1. Signaling at the immune synapse ......................................................................... 36!
2.1.2. Membrane and cytoskeletal remodeling ............................................................... 37!
2.1.3. Vesicle trafficking at the immune synapse ............................................................. 38!
2.2. Cell migration and invasion ........................................................................................ 39!
3. SNX27: A UNIQUE SORTING NEXIN ................................................................................ 42!
3.1. The sorting nexin family .............................................................................................. 42!
3.2. SNX27 is a core component of a multimeric protein complex ................................... 43!
3.3. SNX27 PDZ cargoes ................................................................................................... 44!
3.4. SNX27 in polarized cell models .................................................................................. 46!
III. OBJECTIVES ............................................................................................... 52!
IV. MATERIAL AND METHODS ....................................................................... 56!
1. REAGENTS ........................................................................................................................ 56!
2. CONSTRUCTS .................................................................................................................. 56!
2.1. Mutagenesis ............................................................................................................... 57!
2.2. Cloning ....................................................................................................................... 57!
2.2.1. pSUPER-derived shRNA plasmid ......................................................................... 57!
2.2.2. pLKO-derived shRNA plasmids ............................................................................ 57!
3. CELL CULTURE ................................................................................................................ 57!
3.1. Cell lines ..................................................................................................................... 57!
3.2. Mouse-derived primary T cell culture ......................................................................... 58!
3.3. Transient protein and shRNA expression ................................................................... 58!
3.4. Generation of viral particles and transduction ........................................................... 58!
3.5. Generation of stable shRNA-expressing cell lines ..................................................... 59!
4. ANALYSIS OF T CELL STIMULATION ............................................................................. 59!
4.1. T cell/APC conjugate formation ................................................................................. 59!
  
4.2. Anti-CD3 or anti-CD3/CD28 stimulation .................................................................... 59!
4.2.1. Stimulation with antibody solution ......................................................................... 59!
4.2.2. Stimulation with plate-bound anti-CD3 ................................................................. 60!
4.3. Proliferation assay ...................................................................................................... 60!
4.4. Dual luciferase reporter assay .................................................................................... 60!
5. PROTEIN STABILITY ASSAYS ......................................................................................... 60!
6. MIGRATION AND INVASION ASSAYS ............................................................................. 60!
6.1. Circular invasion assay ............................................................................................... 60!
6.2. Inverted invasion assay .............................................................................................. 61!
7. IMMUNOASSAYS ............................................................................................................. 61!
7.1. Western blot analysis ................................................................................................. 61!
7.2. Immunoprecipitation .................................................................................................. 62!
7.3. Flow cytometry analysis ............................................................................................. 62!
7.4. Immunofluorescence .................................................................................................. 63!
8. MICROSCOPY .................................................................................................................. 64!
8.1. Live cell imaging ......................................................................................................... 64!
8.2. Fluorescent recovery after photobleaching (FRAP) .................................................... 64!
8.3. Microscopy and image processing ............................................................................ 64!
9. PROTEOMICS ANALYSIS ................................................................................................. 65!
9.1. Protein identification ................................................................................................... 65!
9.2. LC-MS/MS analysis .................................................................................................... 65!
9.3. Data analysis .............................................................................................................. 66!
9.4. Functional interpretation ............................................................................................. 66!
10. STATISTICAL ANALYSIS ................................................................................................ 66!
V. RESULTS ...................................................................................................... 70!
1. SNX27 DYNAMICS AND FUNCTION AT THE IMMUNE SYNAPSE ................................. 70!
1.1. FERM domain contribution to SNX27 localization to the IS ....................................... 70!
1.1.1. NPxY/NxxY binding contribution to SNX27 localization ......................................... 70!
1.1.2. Lipid binding contribution to SNX27 localization ................................................... 70!
1.2. PDZ domain contribution to SNX27 localization at the IS .......................................... 78!
1.3. Analysis of the SNX27 interactome during IS formation ............................................ 79!
1.3.1. PDZ-independent SNX27 interactions during IS formation .................................... 79!
1.3.2.  SNX27 role in WASH-mediated transport in T cells .............................................. 84!
1.3.3. Identification of SNX27 PDZ cargoes during IS formation ..................................... 85!
1.3.4. Characterization of the ZO-2/SNX27 interaction during IS formation ..................... 87!
2. SNX27 REGULATION OF LIPID SIGNALING ................................................................... 92!
2.1. Analysis of the SNX27/DGK! PDZ-dependent interaction ......................................... 92!
2.2. SNX27 contribution to DGK! stability ........................................................................ 93!
2.3. Analysis of DAG signaling in SNX27-silenced activated T cells ................................. 95!
2.4. Analysis of TCR signaling in SNX27-silenced T cells ................................................. 97!
2.5. Analysis of DGK! function in SNX27-silenced T cells ................................................ 98!
3. EFFECT OF SNX27 DEFICIENCY ON PRIMARY T CELL FUNCTION .............................. 100!
3.1. T cell development analysis ..................................................................................... 100!
3.2. T cell activation analysis ........................................................................................... 104!
3.2.1. Induction of T cell activation markers .................................................................. 104!
3.2.2. Induction of T cell growth and proliferation ......................................................... 105!
3.2.3. mTOR activation in T cells .................................................................................. 110!
3.2.4. Analysis of surface levels of putative SNX27 cargoes .......................................... 111!
4. SNX27 ROLE DURING INVASION .................................................................................. 114!
VI. DISCUSSION ............................................................................................. 124!
1. ROLE OF SNX27 IN T CELLS ......................................................................................... 124!
1.1. SNX27 at the immune synapse ................................................................................ 124!
1.1.1. FERM domain lipid binding contributes to SNX27 localization ............................. 124!
1.1.2. PDZ ligand binding mediates SNX27 accumulation at the immune synapse ....... 125!
1.1.3. SNX27 controls ZO-2 dynamic redistribution at the immune synapse ................. 127!
1.2. SNX27 as an adaptor for WASH-mediated trafficking ............................................. 128!
1.3. SNX27 modulates lipid and metabolic signaling pathways ..................................... 130!
1.3.1. DGK!/SNX27 association regulates DAG signaling in T cells .............................. 130!
1.3.2. SNX27 silencing or depletion in T cells affects mTOR activation ......................... 133!
2. ROLE OF SNX27 IN CANCER CELL INVASION ............................................................. 135!
3. SNX27: A HUB FOR ENDOSOMAL SIGNALING AND PROTEIN TRANSPORT IN 
POLARIZED CELLS ............................................................................................................ 137!
VII. CONCLUSIONS ....................................................................................... 142!
VII. CONCLUSIONES ..................................................................................... 144!
VIII. REFERENCES ......................................................................................... 148!
IX. APPENDIX ................................................................................................. 173!
1. SNX27 data from cBioPortal for Cancer Genomics 49, 113 ............................................. 173!
2. Analysis of SNX27 PtdInsP-binding capacity 118 ........................................................... 174!
3. Links to videos and supplemental tables ...................................................................... 175!
4. Published articles ........................................................................................................... 176!
 
!!!!!!!!!!!!!!!!!! !!! !
Abbreviations 
  ! 24 
I. ABBREVIATIONS 
5-HT4(a)R!5-hydroxytryptamine 4a receptor 
ABC ATP-binding cassette 
ACOT8 acyl CoA thioesterase 8 
AD Alzheimer disease 
AMPAR #-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid 
AP-1 activator protein 1 
APC Allophycocyanin (flow cytometry) 
APC antigen-presenting cell 
APPL adaptor protein containing PH 
domain, PTB domain and leucine 
zipper motif 
AR  adrenergic receptor 
Arf ADP-ribosylation factor 
AU Arbitrary units 
A$ $-amyloid 
BAR Bin, amphiphysin, Rvs 
BARS brefeldin-A ADP-ribosylated substrate 
BIM Bisindolylmaleimide 
CASP cytohesin-associated scaffolding 
protein 
CENPJ centromere associated protein J 
CHX cycloheximide 
CIA circular invasion assay 
CIN85 85 kDa Cbl-interacting protein 
CMAC 7-amino-4-chloromethylcoumarin 
ConA concanavalin A 
COPI coat protein complex I 
CRIK citron Rho-interacting kinase 
CTL cytotoxic T cells 
Cx connexin 
DAG diacylglycerol 
DGK diacylglycerol kinase 
DN double negative 
Dok1 docking protein 1 
DOX doxycycline 
DP double positive 
 
DS Down syndrome 
ECM extracellular matrix 
EEA1 early endosomal antigen 1 
ER endoplasmic reticulum 
ERC endocytic recycling compartment 
ERK extracellular signal-regulated kinase 
ERM ezrin/radixin/moesin 
ESCRT endosomal sorting complex 
required for transport 
FERM 4.1/ezrin/radixin/moesin 
FRAP fluorescence recovery after 
photobleaching 
FSC forward scatter 
FYVE Fab1p, YOTB, Vac1, EEA1 
FZD Frizzled 
GEF guanine nucleotide exchange factor 
GIRK G protein gated inward rectifying 
potassium channels 
GIT G protein-coupled receptor kinase-
interacting protein 
GJ gap junction 
GLUT1 glucose transporter 1 
GMFI geometric mean fluorescence 
intensity 
GO gene ontology 
GPCR G protein-coupled receptor 
GTPase small guanosine triphosphatases 
HBSS Hankʼs balanced salt solution 
HPV human papillomavirus 
Hrs hepatocyte growth factor-regulated 
tyrosine kinase substrate 
IFT intraflagellar transport system 
IL interleukin 
IS immune synapse 
ITC isothermal titration calorimetry 
Kidins220 kinase D-interacting substrate of 
220 kDa 
  
25 
LAT transmembrane adaptor linker for 
activation of T cells 
Lck  lymphocyte-specific protein tyrosine 
kinase 
LFA-1 lymphocyte function-associated 
antigen 1 
LN lymph nodes 
MAGUK membrane-associated guanylate 
kinase 
MAPK mitogen-activated protein kinase 
MARCKS myristoylated alanine-rich C-
kinase substrate 
MCT1 monocarboxylate transporter 1 
MEK MAPK/ERK kinase 
MFI mean fluorescence intensity 
MHC major histocompatibility complex 
MICAL-L1microtubule-associated mono-
oxygenase, calponin, and LIM 
domain containing-like 1 
MMP matrix metalloproteinases 
MRP4 multidrug resistance-associated 
protein 4 
MT microtubule 
MT1-MMP transmembrane type 1 MMP 
MTM myotubularin 
MTOC microtubule-organizing center 
mTOR mammalian target of rapamycin 
mTORC1 mTOR complex 1 
MVB multivesicular bodies 
NF-%B nuclear factor %B 
NFAT nuclear factor of activated T cells 
NHE3 Na+/H+ exchanger 3 
NK natural killer 
NLS nuclear localization signal 
NMDAR N-methyl-D-aspartate receptors 
NSF N-ethylmaleimide-sensitive factor 
PA phosphatidic acid 
PAK p21-activated kinase 
PDK1  phosphoinositide-dependent kinase 1 
PDZ PSD-95, Dlg1, ZO-1 
PDZ-bm PDZ-binding motif 
PE phycoerythrin 
PFA paraformaldehyde 
PH pleckstrin homology 
PHLPP PH domain and leucine rich repeat 
protein phosphatase 
PIK PtdIns kinase 
PIPase PtdIns phosphatase 
PIPK PtdInsP kinase 
PIX p21-activated kinase-interactive 
exchange factor 
PKC protein kinase C 
PKD protein kinase D 
PLC phospholipase C 
PLD phospholipase D 
PM plasma membrane 
PMA phorbol 12 myristate 13-acetate 
PS1 preselinin 1 
PSD-95 postsynaptic density protein 95 
PtdIns phosphatidylinositol    
PtdInsP phosphatidylinositol phosphate 
PTEN phosphatase and tensin homolog 
PTHR parathyroid hormone receptor 
PX phox homology 
RA Ras association 
Rab Ras-related in brain 
RasGRPRas guanyl nucleotide-releasing 
protein 
RCP Rab-coupling protein 
Rhod rhodamine 
RLU relative luciferase units 
RPMI Roswell Park Memorial Institute 
Rps6 ribosomal protein S6 
RT room temperature 
S6K Ribosomal protein S6 kinase 
SEE Staphylococcus enterotoxin E 
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SEM standard error of the mean 
SH Src homology 
SH3KBP1SH3-domain kinase binding protein 1 
SHIP SH2-containing Ins 5ʼ-phosphatase 
SHKBP1 SH3KBP1 binding protein 1 
SMAC supramolecular activation clusters 
SNARE soluble NSF attachment protein 
receptor 
SNX sorting nexin 
SOS son of sevenless 
SP simple positive 
SSTR5 somatostatin receptor subtype 5 
TCR T cell receptor 
Tf/TfR transferrin/ transferrin receptor 
TGF$ transforming growth factor 
TGN trans-Golgi network 
TIRF total internal reflection fluorescence 
Tks5 Tyr kinase substrate with five SH3 
domains 
VAMP7 vesicle-associated membrane 7 
VPS vacuolar protein sorting-associated 
protein 
WASH WASP and SCAR homologue 
WASP Wiskott-Aldrich syndrome protein 
XPR1 xenotropic and polytropic murine 
leukemia virus receptor 
ZO zona occludens ! !
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II. INTRODUCTION 
1. LIPID MODULATION IN ENDOSOMAL COMPARTMENTS 
1.1. Lipids and membrane trafficking 
Intracellular membrane traffic comprises a network of pathways that distribute proteins and 
other macromolecules among different cell organelles, mostly by vesicular transport.  A vast 
number of complex mechanisms regulate intracellular trafficking, which indicates the importance 
of this process for correct cell function.  The cargo selection systems are coupled to the 
machinery for vesicle budding, scission, coating and fusion, and all are tightly regulated to 
ensure rapid, accurate delivery of cargo molecules.  Rab (Ras-related in brain) GTPases (small 
guanosine triphosphatases) and lipids are important for the orchestration of cytoskeletal and 
membrane remodeling.  Rab proteins are well-known molecular switches that regulate traffic 
between organelles, and lipids control physical properties of membranes directly and through 
the recruitment of curvature-generating or -sensing proteins, as well as by regulating 
cytoskeleton-associated molecules (reviewed in 8, 151).  Each intracellular organelle can be 
identified by the presence of a specific subset of lipids and Rab GTPases (reviewed in 75, 79). 
1.1.1. Phosphoinositides 
Phosphoinositides are derived from the phosphorylation of phosphatidylinositol (PtdIns), and 
consist of a glycerol moiety with two fatty acid chains that allow insertion into lipid membranes, 
and an inositol headgroup that can be phosphorylated at D-3, D-4 and/or D-5 positions (Fig I1A, 
bottom).  Although the exact subcellular distribution of the phosphoinositide species is not 
completely understood, the use of fluorescently tagged biosensors in cell imaging studies has 
contributed substantially to tracking their location in distinct subcellular compartments or 
domains within compartments (reviewed in 75, 79) (Fig I1B). 
PtdIns 4,5-bisphosphate (PtdIns(4,5)P2), and PtdIns 3,4,5-triphosphate (PtdIns(3,4,5)P3) are 
enriched at the plasma membrane (PM) and the endocytic recycling compartment (ERC), where 
they participate in nearly all events that involve membrane remodeling.  PtdIns(4,5)P2 promotes 
the recruitment and regulation of endocytic proteins such as the clathrin adaptors AP-2 and 
$-arrestin, the membrane fission regulator dynamin, or cytoskeleton-associated proteins 
involved in internalization and exocytosis including the Arp2/3 activator N-WASP (neural 
Wiskott-Aldrich syndrome protein) (reviewed in 79). 
Following endocytosis, PtdIns(4,5)P2 and PtdIns(3,4,5)P3 must be removed to allow the 
dissociation of endocytic factors.  This function is carried out by PtdIns5-phosphatases 
(PI5Pase) such as synaptojanin or SHIP (SH2-containing Ins 5ʼ-phosphatase), which generates 
the PtdIns(3,4)P2 present in the early endocytic pathway (reviewed in 224).  Sequential 
dephosphorylation by PtdIns4-phosphatases (PI4Pase) generates PtdIns 3-phosphate 
(PtdIns3P), the phosphoinositide that characterizes the early endosomes!294; the majority of this 
lipid is nonetheless produced by the class III PtdIns 3-kinase (PI3K) termed VPS34 (vacuolar 
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protein sorting-associated protein 34)!285 (Fig I1A,B).  PtdIns3P-binding domains such as FYVE 
[Fab1, YOTB, Vac1, EEA1 (early endosomal antigen 1)] and PX (phox homology) are found in a 
variety of endosomal proteins that regulate membrane tethering and fusion, microdomain 
formation, cytoskeleton interaction and cargo transport; these include EEA1, Hrs [hepatocyte 
growth factor-regulated tyrosine kinase substrate, which is a component of ESCRT (endosomal 
sorting complex required for transport)], and the sorting nexins (SNX) (reviewed in 65, 66).  PtdIns3P 
effectors are also important for autophagosome formation and maturation (reviewed in 68). 
PtdIns3P can be dephosphorylated at the endosomal surface by members of the 
myotubularin (MTM) family (reviewed in 273), degraded within the lumen of multivesicular bodies 
(MVB), or phosphorylated to PtdIns(3,5)P2 by the PIKfyve kinase (reviewed in 223).  
PtdIns(3,5)P2 localizes to late endocytic compartments and to MVB, where it triggers vesicle 
budding and controls their size as well as protein sorting (reviewed in 295) (Fig I1A,B). 
PtdIns 4-phosphate (PtdIns4P) is generated in the secretory compartments, where it binds to 
proteins that control vesicle budding and membrane dynamics, and regulates vesicle-mediated 
export (reviewed in 127); in the trans-Golgi network (TGN), PtdIns4P production by 
PtdIns 4-kinase (PI4K) facilitates cargo release from the retromer, which mediates protein 
transport from the endocytic compartment 185, 242 (Fig I1A,B). 
1.1.2. Diacylglycerol and phosphatidic acid 
Diacylglycerol (DAG) and phosphatidic acid (PA) are also important membrane constituents 
(Fig I1C).  Both lipid species are major biosynthetic precursors of phospholipids and 
intermediates of the PtdIns cycle, but are also immediately implicated in membrane trafficking.  
Both are conical-shaped lipids and thus directly assist the negative membrane curvature 
necessary for vesicle fission and fusion; additionally, these lipids regulate intracellular transport 
indirectly by recruiting and/or activating proteins (reviewed in 44).  On the one hand, PA 
generation collaborates with membrane-binding proteins such as BARS (brefeldin-A ADP-
ribosylated substrate) that bend membranes to promote vesicle fission 352.  PA also binds and/or 
activates proteins involved in membrane traffic control.  These include Arf (ADP-ribosylation 
factor) family members, PIP5K (PtdIns4P 5-kinase), and NSF (N-ethylmaleimide-sensitive 
factor) 176, 205.  On the other hand, DAG controls the secretory pathway mainly by regulating the 
Ser/Thr kinase PKD (protein kinase D, also termed protein kinase C µ).  PKD activation 
promotes vesicle formation and fission at the TGN 18, 191 as well as MVB maturation, which 
involves intraluminal exosome nanovesicle biogenesis and secretion 4, 215.  DAG is also needed 
at the cis-Golgi for the biogenesis of COPI (coat protein complex I)-coated vesicles 11, 99.  In 
addition, DAG participates in exocytosis through regulation of the membrane fusion steps that 
involve SNARE (soluble NSF attachment protein receptors) complex assembly.  In neurons, 
direct DAG binding or DAG-dependent activation of PKC (protein kinase C) activates several 
components of the Munc family of proteins, and thus enhances vesicle priming and 
neurotransmitter release 17, 25, 265, 347" 
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Ordered lipid segregation in endosomal membranes drives directional vesicle and cargo 
trafficking from donor to acceptor membranes, facilitated by modification of physical membrane 
properties and recruitment of the budding and fusion machinery.  Phospholipids can rapidly 
diffuse within, but not between, membranes, so their spatiotemporal restriction is mainly 
regulated by their interconversion through lipid kinases and phosphatases.  The correct 
activation of lipid modifying enzymes is essential for membrane trafficking and their deregulation 
has been linked to a number of human diseases (reviewed in 28, 174, 333). 
Our group studies the DAG kinases (DGK), which phosphorylate DAG and transform it to PA  
(Fig I1C).  DGK are potential drug targets for cancer, epilepsy, autoimmunity, cardiac 
hypertrophy, hypertension and type II diabetes.  Ten mammalian DGK isoforms have been 
identified and classified into five different subtypes on the basis of their regulatory domains 
(reviewed in 221, 277).  Of all the DGK family components, the DGK# isoform accounts for most 
descriptions of these enzymes in the control of membrane and protein trafficking.  PA 
generation by DGK# facilitates the biogenesis of tubular recycling endosomes and the recycling 
of class I MHC (major histocompatibility complex) molecules through MICAL-L1 interaction  
(microtubule-associated mono-oxygenase, calponin, and LIM domain containing-like 1) 348; 
Fig  I1 . Phosphol ip id  d istr ibut ion in  intracel lu lar  membrane organe l les 
(A) Phosphatidylinositol (PtdIns) is phosphorylated at distinct sites to generate phosphoinositide 
species (B) that segregate to the subcellular organelles  (PM, plasma membrane; ERC, endocytic 
recycling compartment; MVB, multivesicular bodies).  Lipid kinase (enzyme names in grey) and 
phosphatase activity (enzyme names in blue) maintain intracellular lipid distribution (see text for 
details). (A, bottom) Structure of PtdIns, diacylglycerol (DAG) and phosphatidic acid (PA). DAG and PA 
are interconverted by DAG kinase (DGK) and PA phosphatase (PAP) activity. 
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DGK# also regulates membrane tethering of the Rab11 effector RCP (Rab-coupling protein) and 
thus controls integrin recycling 263.  As a negative DAG modulator, DGK# in T lymphocytes limits 
MVB maturation and exosome secretion in part by controlling the DAG effector PKD 215.  The $, 
&, and " isoforms of DGK were identified as potential regulators of endocytosis and recycling in a 
large kinome screening 252.  In epithelial cells, DGK& suppresses endoplasmic reticulum (ER) 
traffic to Golgi 233.  The DGK! isoform controls transferrin receptor (TfR) trafficking 271 and was 
identified as a Golgi architecture regulator in an RNAi screening, DGK! knockdown resulted in 
dramatic Golgi fragmentation 57.  
1.2. Endosomal lipid signaling 
Endocytosis was originally considered a mechanism for signal attenuation through 
internalization of unstimulated or ligand-associated cell surface receptors and their subsequent 
recycling or degradation.  The endosomes are now also recognized as platforms that sustain 
cell signaling.  The endocytosed ligand-associated receptors remain active throughout the 
endocytic pathway, where they converge with activated molecules from other routes to allow 
signal crosstalk.  Receptor access to new substrates and scaffolds located exclusively in 
endosomal compartments constitutes endosome-specific signaling (reviewed by 286, 303; for an 
extensive review, see 296). 
There is a growing list of pathways that involve protein localization to endosomes for the 
control of signal transduction.  Several components of major signal transduction cascades are 
located at the endosomes, including those regulated by lipids such as the Akt, the PKC and the 
Fig  I2 . S igna l crosstalk  in endocyt ic compartments 
(A) The APPL adaptors in pre-early endosomes, as well as PI3P-binding protein adaptors in early 
endosomes act as scaffolds for endosomal signaling and allow signal crosstalk (see text for details). 
(B) In response to serum, amino acid or mechanical stimulation, mTOR translocates to lysosomes.  
Phosphatidic acid (PA) generated by phospholipase D (PLD), and possibly by diacylglycerol kinase 
(DGK), activates mTOR at this compartment. 
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ERK (extracellular signal-regulated kinase) MAPK (mitogen-activated protein kinase) pathways 
(reviewed in 82, 303) (Fig I2A).  The spatiotemporal restriction of lipids is thus important for 
modulating local signaling.  A subset of PtdIns3P-negative pre‑early endosomes contains the 
APPL1/2 proteins (adaptor protein containing PH domain, PTB domain and leucine zipper motif 
1 and 2), which are adaptors that interact with receptor and signaling molecules.  They 
modulate signaling of pathways such as the Akt pathway 283, 343.  Although the APPL 
endosomes constitute a stable cargo-sorting compartment 167, a fraction of these vesicles serve 
as intermediates en route to the early endosomes.  PtdIns3P generation by VPS34/PI3K 
promotes the switch from APPL1-dependent signaling to that controlled by PtdIns3P-binding 
scaffold proteins such as Hrs and EEA1 367.  Hrs mediates crosstalk between the TGF-$ 
(transforming growth factor $) and MAPK pathways!226, and EEA1 controls that between MAPK 
and Akt pathways 236 (reviewed in 247) (Fig I2A).  
The mTOR (mammalian target of rapamycin) Ser/Thr kinase acts as a signaling hub to 
control cell growth; it receives signals from growth factors and nutrients, and regulates the 
balance between protein synthesis and autophagy.  Signal-mediated PI3K (class I)-dependent 
PtdIns(3,4,5)P3 generation at the PM activates the classical mTOR complex 1 (mTORC1) 
pathway and inhibits autophagy, whereas pharmacological inhibition of mTORC1 by rapamycin 
treatment induces autophagy (reviewed in 171).  The lipid second messenger PA binds directly to 
the domain in mTOR that is targeted by rapamycin, and activates mTOR in response to serum 
and mechanical stimulation 93, 357 (Fig I3).  During amino acid stimulation, mTORC1 localizes to 
lysosomes 104, 279(reviewed by 26) and is activated in a VPS34/PI3K (class III)-dependent 
manner 38.  PA is generated in endosomal membranes by phospholipase D (PLD1), which 
bears a PI3P-binding PX domain 305, 356 (Fig I2B); studies nonetheless show that PLD1 inhibition 
prevents autophagosome formation 69.  The alternative source of PA, DGK, specifically the 
DGK! isoform, activates PA-mTOR signaling in response to mechanical or serum stimuli and 
limits mTORC1 sensitivity to rapamycin treatment 12, 325, 358.  The Drosophila and Caenorhabditis 
elegans DGK! homologs rdgA and dgk-5 also control TOR function 190.  
Fig I3.  mTOR regula tes prote in  
synthes is  and autophagy 
The mTOR Ser/Thr kinase controls cell growth. 
Extracellular stimuli trigger PI3K-dependent 
PtdIns(3,4,5)P3 generation at the plasma 
membrane and activation of the classical mTOR 
complex 1 (mTORC1) pathway leading to 
protein synthesis and autophagy inhibition.  
Production of phosphatdic acid (PA) also 
activates the mTOR pathway through its binding 
to the same domain in mTOR that is targeted by 
the pharmacological inhibitor rapamycin. 
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DGK also modulate cell signaling through DAG consumption (reviewed in 221).  Several 
DAG-responsive proteins localize in endomembranes, including components of the classical 
and the novel PKC subfamilies and the Ras guanine nucleotide exchange factor (GEF) termed 
RasGRP1 (Ras guanyl nucleotide-releasing protein 1).  The classical PKC# and PKC$II and the 
novel PKC& isoform localize to the ERC and control signaling of endocytosed receptors 5, 13, 23, 
153, 261.  In smooth muscle cells, PKC# specifically regulates EEA1-dependent Akt signaling 236.  
In cytotoxic T cells, PKC& additionally localizes to secretory lysosomes and transduces signals 
necessary for polarized granule secretion 206.  DAG is present in bacteria-containing and 
rapamycin-induced autophagosomes and, although PKC& localization to autophagosomes has 
not been studied, DAG-mediated activation of PKC& induces autophagy 289.  RasGRP1, which is 
expressed in lymphocytes, keratinocytes and in some cells of the brain, is located at DAG-
enriched membranes such as those of the ER and Golgi compartments.  Stimulus-dependent 
DAG generation at the PM leads to RasGRP1 and PKC translocation to this site (reviewed 
in 164).  The control of RasGRP and PKC dynamics and activation by DGK has been previously 
examined in the context of the PM 119, 120, 183.  Further studies are nonetheless required to 
determine whether DGK modulates DAG/PKC/RasGRP signaling in endomembranes.  !  
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2. CELL MODELS OF POLARIZED TRAFFICKING 
The correct function of the intracellular trafficking routes is of particular importance in polarized 
cells, which rely on formation of an active membrane traffic zone to carry out their specialized 
functions efficiently.  In addition to the classical examples of neuron polarity and epithelial cell 
apicobasal polarity, other models of cell-cell or cell-extracellular matrix (ECM) contacts show a 
notable degree of polarization (reviewed in 84, 175,!345). 
2.1. T cell activation and immune synapse formation 
T lymphocytes are cells specialized in pathogen recognition through the T cell receptor (TCR), 
which recognizes antigen-derived peptides bound to MHC proteins on the surface of antigen-
presenting cells (APC).  TCR stimulation triggers formation of a highly organized structure 
termed the immune synapse (IS) by analogy with chemical synapses in the nervous system 84. 
2.1.1. Signaling at the immune synapse 
After antigen recognition, the IS acts as a signaling platform; the TCR activates Src family 
kinases and recruits the adaptor molecules that lead to the activation of additional signaling 
molecules, including phospholipase C-"1 (PLC- "1) 50.  PLC-"1 hydrolyzes PtdIns(4,5)P2 in the 
PM to generate inositol 1,4,5-triphosphate (Ins(1,4,5)P3) and DAG; soluble Ins(1,4,5)P3 
production leads to triggering of the 
Ca2+/calcineurin/NFAT (nuclear factor of 
activated T cells) signaling pathway 131.  
DAG generated at the PM stabilizes and 
activates various targets including 
components of the PKC family, regulators 
of the GTPases of the Ras and Rac 
families 44 such as RasGRP1 86, which 
promotes Ras/ERK activation and AP-1 
(activator protein 1)-dependent 
transcription.  Although antigen-stimulated 
generation of Ca2+ and DAG drives a 
transcriptional program for the expression 
of activation-induced genes 159, 
costimulatory molecules such as CD28 
are needed to trigger the full T cell 
activation program; CD28 binding of 
APC-presented B7 ligands activates 
signaling molecules such as PI3K or 
PKC', a PKC isoform that requires DAG 
generation for full competence.  These in 
turn trigger the activation of the nuclear 
Fig I4.  TCR-mediated signal transduction 
Antigen-induced stimulation of the TCR triggers 
PLC"-mediated hydrolysis of PtdIns(4,5)P2 (PIP2), 
which leads to Ins(1,4,5)P3 (IP3) and DAG 
generation.  These two mediators stimulate the 
Ca2+-NFAT and Ras-ERK-AP-1 pathways, resulting 
in target gene transcription. Costimulatory receptors 
such as CD28 promote activation of the 
PKC'-NF-%B pathway. 
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factor %B (NF-%B) family of transcription factors 173, 269, which contribute to the immune response 
by allowing transition to a metabolically active state that permits cell proliferation and effector 
functions (reviewed in 108) (Fig I4). DAG-regulated pathways are thus necessary for T cell 
function, and must be tightly controlled.  DGK# and DGK! are the two main DGK isoforms 
expressed in T cells, and both contribute to terminate DAG signaling downstream TCR 
activation by limiting the DAG-mediated recruitment of RasGRP1 to the PM.  They are not fully 
redundant, with studies suggesting a dominant role for DGK! in suppressing the Ras/ERK 
signaling pathway after antigen recognition.  DGK! indeed additionally controls the activation 
and the transient translocation to the IS of PKC#, another DAG effector that participates in 
Ras-ERK activation (119, 120, reviewed in 220). 
2.1.2. Membrane and cytoskeletal remodeling 
During IS formation, T cell signal transduction is facilitated through the reorganization of 
signaling molecules in supramolecular activation clusters (SMAC) 227, which are designated 
according to their location at the T cell-APC contact area.  Clustered TCR and associated 
signaling proteins localize to the central zone (cSMAC) and are surrounded by cell-cell adhesion 
proteins that form a peripheral ring (pSMAC).  The outermost region is termed distal SMAC 
(dSMAC) and was established as the site of proteins with large ectodomains, such as CD43 and 
CD45 (reviewed in 85) (Fig I5A).  Later studies nonetheless describe the dSMAC as a 
lamellipodium-like area of active membrane movement where new TCR microclusters form after 
antigen engagement and show centripetal movement towards the pSMAC and cSMAC 166, 331.  
This relocation is an actin-dependent process reminiscent of retrograde actin flow during cell 
spreading and migration.  Cytoskeletal rearrangement is indeed essential for mature IS 
formation; in addition to the centripetal flow of F-actin at the dSMAC, actin filaments are also 
found at the pSMAC, where they anchor to integrins to prevent filament movement and to 
Fig I5.  Immune synapse structure and polarization of intracellular organelles  
(A) The immune synapse forms at the T cell-antigen presenting cell (APC) contact area, where 
signaling and adhesion molecules are reorganized in central, peripheral and distal supramolecular 
activation clusters (c-, p-, and dSMAC, respectively).  (B) The T cell also reorients intracellular 
organelles towards the APC. These include the microtubule-organizing center (MTOC) and the 
recycling and secretory compartments. 
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sustain the adhesion ring (reviewed in 85).  Another type of F-actin organization structure termed 
actin foci were recently characterized in T cells as necessary scaffolds for Ca2+ and distal TCR 
signaling 177. 
Cytoskeletal remodeling is necessary not only for redistribution of signaling receptors and 
molecules in the vicinity of the T cell-APC contact area, but also for polarization of intracellular 
organelles; the microtubule-organizing center (MTOC), the Golgi apparatus, and the endosomal 
compartments are reoriented towards the contact site 7, 71, 106, 178, 245 (Fig I5B).  T cell reshaping 
during IS formation thus involves rapid changes in polarity and architecture of both the 
microtubule (MT) and actin cytoskeletons.  Many scaffolds and signals involved in the control of 
T cell polarization have been elucidated and include some of the classical epithelial polarity 
proteins 175, 201.  Lipid signaling has a notable role in the coordination of cytoskeletal structure 
and polarity.  Phospholipids such as PtdIns(4,5)P2 or PtdIns(3,4,5)P3 modulate T cell rigidity at 
the IS 314 and control actin architecture 181, respectively.  DAG drives MTOC polarization, and 
DGK inhibition destabilizes synaptic DAG accumulation and impairs MTOC recruitment to the 
IS 262.  The activation and localization of these lipid modulatory enzymes are thought to sustain 
the membrane lipid gradient that drives T cell reorientation via a mechanism analogous to 
direction-sensing during migration of leukocytes and Dictyostelium (262, reviewed in 148). 
Many lipid species are essential for T cell polarization and signal transduction.  Similarly to 
epithelial cells, the reorganization of glycosphingolipids with cholesterol to form the membrane 
microdomains termed lipid rafts also participates in signaling and intracellular transport in 
T cells 3.  Although the participation of lipid rafts in PM micro- and nanodomain functions was 
debated, the role of membrane compartmentalization in the control of immune cell 
spatiotemporal responses and specialized functions continues to be studied 83, 188, 292.  Recent 
studies indicate that redirection of vesicular traffic to the T cell-APC contact area after TCR 
engagement assists in the formation of membrane signaling nanoterritories 302. 
2.1.3. Vesicle trafficking at the immune synapse 
Increasing evidence supports the relevance of the intracellular transport pathway for T cell 
activation.  Vesicle fusion and continuous protein recycling cooperate to regulate signal intensity 
and duration (302 reviewed in 245), and endosomal transport of TCR to the IS is a major source of 
TCR replenishment after its exhaustion and endocytosis-mediated downregulation 71.  Other 
receptors and membrane-associated TCR signaling mediators are also partitioned between the 
PM and endocytic compartments during IS formation.  These include the TfR 20, Lck 
(lymphocyte-specific protein tyrosine kinase) 87, and LAT (transmembrane adaptor linker for 
activation of T cells) 32, among others (see also review in 245).  The IS is thus used as a model to 
study the role and dynamics of different molecules in activation-induced polarized recycling.  
Although first applied to T and B cells of the adaptive immune system, the concept of the IS has 
expanded to cells of the innate immune system such as natural killer (NK) cells or 
phagocytes!21, 73.  The IS is not only considered a polarized model for recycling, but also for 
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secretion.  APC-targeted exocytosis of cytokines by helper T cells and of cytotoxic granules by 
cytotoxic T cells (CTL) or NK cells, as well as T cell-APC information transfer through exosomes 
and microvesicles!are crucial for their effector functions 7, 58, 128, 225. 
While the prominent role of vesicle trafficking during IS formation is widely accepted, its 
regulatory mechanisms remain to be fully understood.  Receptor-triggered signals elicit and 
sustain rapid endosomal polarization to the IS, which correlates with that of the MTOC, and is in 
fact MT polymerization-dependent in some cell types 71.  Although MT polymerization is needed 
for secretion by cytolytic cells 311, cytokine release by CD4 T cells requires local actin 
remodeling 53, 149, 310.  In addition to these cytoskeletal components, the endosomal machinery 
also participates in regulation of IS-directed trafficking.  Most research efforts focus on 
determining the molecular mechanisms that drive TCR endosomal dynamics; the growing list of 
TCR trafficking regulators includes several members of the Rab GTPase family such as Rab4, 
Rab11 and Rab35, the endosomal actin nucleation-promoting factor WASH (WASP and SCAR 
homologue), some of the vesicle fusion mediators including SNARE, the UNC-119 adaptor, and 
even the intraflagellar transport system (IFT) ciliary protein IFT20 (reviewed in 245).  Further 
studies are needed to fully understand the complex network of pathways that facilitate trafficking 
not only of the TCR, but also of other proteins that contribute to T cell activation. 
2.2. Cell migration and invasion 
To carry out their physiological functions in response to pathogens or in inflammation, immune 
cells develop plasticity that allows the transition from a migratory to a static mode of action.  
Cytoskeletal rearrangement and membrane remodeling in these cells allow turnover of 
substrate adhesions and formation of transient, organized structures such as the IS or the 
podosome, a site of protease-dependent focal degradation linked to extravasation 43.  During 
migration and invasion, cancer cells exploit these mechanisms shared with untransformed cells 
to attain aggressive behavior. 
In migrating cells, polarity is established by reorganization of cytoskeletal and membrane 
proteins 156, 332.  Signaling, polarity and adhesion protein traffic is directed to the cell leading 
edge, where large clusters of transmembrane receptors, integrins and cytosolic proteins 
connect the ECM with the actin cytoskeleton.  These structures, termed focal adhesions, 
assemble continuously at the leading edge and disassemble at the trailing edge, making integrin 
trafficking particularly necessary for sustained migration (Fig I6A) 46, 48, 103, 266, 327.  Several 
components of the vesicular trafficking machinery are associated to the control of integrin traffic 
to the cell front, including Rab4, Rab11 and Rab25 46, 48, some Rab GTPase-interacting proteins 
such as the Rab11 effector RCP 47, and the exocyst complex, which mediates docking of post-
Golgi and endocytic recycling vesicles at the PM! 192.  In this model of polarized trafficking, lipid 
modulation also coordinates cytoskeleton and membrane remodeling.  PtdIns(4,5)P2 production 
by PIP5K" facilitates exocyst complex assembly and promotes integrin trafficking in directionally 
migrating cells 322.  PA generation by DGK# regulates tethering of RCP to pseudopods in 
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migrating cancer cells and thus controls integrin recycling and tumor invasiveness 263.  Lipid 
rafts are also involved in adhesion protein internalization and recycling, as well as in regulation 
of focal adhesion disassembly 339, 340. 
In tumors, some migrating cells with an invasive phenotype form invadopodia, PM 
protrusions that promote attachment to and degradation of the ECM and assist tumor 
aggressiveness (Fig I6B).  During invadopodium formation, membranes and proteins reorganize 
into a bullʼs eye-structure, and metalloproteinases (MMP) are rapidly recycled and secreted at 
this site.  Extracellular microenvironmental stimuli trigger intracellular signaling pathways, 
leading to localized F-actin remodeling and recruitment of several proteins including the actin 
regulators cortactin, cofilin and the Arp2/3 activator N-WASP, and adaptors such as Tks5 (Tyr 
kinase substrate with five SH3 domains).  The actin core is surrounded by a ring containing 
integrins, paxillin and vinculin, among other adhesion proteins.  These structures are not 
considered mature until functional accumulation of the transmembrane type 1 MMP (MT1-MMP) 
is observed at the core of the invadopodia (reviewed in 232) (Fig I6C,D) 
Mechanisms of MT1-MMP localization to invadopodia are still being studied, but intracellular 
trafficking is known to be major regulator of invadopodia maturation.  Similarly to integrins, cell 
surface levels of MT1-MMP are regulated by clathrin- and caveola-mediated endocytosis and 
subsequent transport to endosomal or lysosomal compartments for recycling or degradation, 
respectively.  MT1-MMP delivery to invadopodia is controlled by cortactin and several 
components of the exocytic machinery, including the SNARE protein vesicle-associated 
Fig I6.  Polarized trafficking during migration and invadopodium formation 
Polarized intracellular trafficking of signaling and adhesion molecules allows (A) adhesion site turnover 
during migration as well as (B) extracellular matrix (ECM) degradation during invasion.  Invadopodium 
structures have a central core with functional molecules such as matrix metalloproteinases (MMP), 
surrounded by an integrin-enriched adhesive ring. (C) Front view; (D) top view. 
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membrane protein 7 (VAMP7) and the exocyst complex (reviewed in 257).  A recent report 
showed that this complex acts in concert with the WASH complex to target a sizable fraction of 
MT1-MMP stored in late endocytic compartments to the PM 228.  Actin polymerization is thus not 
only essential for N-WASP-dependent invadopodium formation, but also mediates vesicle 
exocytosis through WASH actin nucleation-promoting activity 228.  Cytoskeletal MT are also 
important for MMP transport to invadopodia, as they participate in a trafficking route analogous 
to that of proteins sorted to the apical domain of polarized cells 41.  MT disruption impairs matrix 
degradation and invadopodium elongation into basement membranes, which suggests impaired 
cargo delivery to the protruding tip 41, 168, 284. 
With cytoskeleton remodeling, the modulation of membrane lipid composition in the 
invadopodium facilitates changes in membrane morphology and protein recruitment.  
PtdIns(4,5)P2 patches are observed near invadopodia, where they activate actin-related 
proteins such as vinculin, talin, ezrin/radixin/moesin (ERM) proteins and N-WASP as well as 
other invadopodium components involved in endocytosis including dynamin-2.  Local 
PtdIns(4,5)P2 generation is associated with PIP5K accumulation, whereas class I PI3K uses 
PtdIns(4,5)P2 as a substrate for PtdIns(3,4,5)P3 production and regulates invadopodium 
formation, probably through PDK1 (phosphoinositide-dependent kinase 1) and Akt activation.  
PtdIns(3,4,5)P3 is enriched in a ring around the invadopodium core, consistent with its 
conversion in the core to phosphatidylinositol-3,4-bisphosphate (PtdIns(3,4)P2) by SHIP2 and 
synaptojanin phosphatases.  This SHIP2-dependent PtdIns(3,4)P2 generation is needed for 
recruitment of the key invadopodium scaffold protein Tks5 through its PX domain 291, 350, 351.  
Lipid raft enrichment in membranes is also reported in invadopodia; several components 
involved in actin polymerization and membrane trafficking such as N-WASP, dynamin-2, and 
Arf6 localize to these rafts, which are also sites for caveolin-1-dependent trafficking of 
invadopodium components, including MT1-MMP (reviewed in 350). 
Invadopodium formation promotes the ECM remodeling necessary for cancer cell invasion 
and metastasis, the main cause of mortality in cancer patients.  The abnormal arrangement of a 
similar structure termed podosome in specialized cells like osteoclasts, macrophages or smooth 
muscle cells is associated to developmental, vascular and immune diseases 36, 165, 232.  Further 
study is needed of the mechanisms that coordinate the cell-matrix and/or cell-cell contact 
signaling, cytoskeletal rearrangement, and polarized trafficking that are necessary for cell 
migration and invasion, for the development of therapeutic strategies.!!  
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3. SNX27: A UNIQUE SORTING NEXIN 
3.1. The sorting nexin family 
The SNX are molecules that regulate intracellular protein trafficking and endosomal signaling.  
All members of the SNX family have a PX domain that binds to PtdIns3P-enriched endosomal 
membranes.  SNX are classified in subfamilies based on the presence of other structural 
domains: SNX-PX, SNX-BAR (Bin, amphiphysin, Rvs), SNX-FERM (4.1/ezrin/radixin/moesin), 
SNX-PXA-RGS-PXC and SNX-MIT (reviewed in 319).  Given their relevance in our studies, the 
SNX-BAR and SNX-FERM proteins will be detailed below. 
The SNX-BAR have a BAR domain that forms a rigid curved structure with a membrane-
binding surface that interacts preferentially with membranes of positive curvature, such as those 
of small vesicles or narrow-diameter membrane tubules.  SNX-BAR acts as a scaffold for the 
remodeling of vesicular membranes to promote tubulation, and are best known for cooperation 
with the retromer in intracellular protein trafficking.  The retromer, a heterotrimeric protein 
complex composed of VPS35, VPS29 and VPS26, regulates protein export from the endocytic 
compartment.  In yeast, the retromer interacts strongly with the SNX-BAR subcomplex, whereas 
the association with the SNX-BAR mammalian homologue (SNX1 or SNX2 in complex with 
SNX5 or SNX6) appears to be less robust.  Compared to yeast, the mammalian retromer binds 
a large number of additional proteins, and the SNX-BAR subcomplex therefore cannot be 
considered an integral retromer component.  Members of the SNX-PX subfamily such as SNX3, 
as well as SNX27 of the SNX-FERM subfamily, are also important to retromer function 
(reviewed in 112). 
The SNX-FERM proteins have a C-terminal atypical FERM or ʻFERM-likeʼ domain, so termed 
by analogy with the canonical FERM domain; both the classical and the atypical FERM have F1, 
F2 and F3 subdomains, although their sequence similarity is low and the atypical SNX FERM 
domain has a notably smaller F2 module 117.  FERM domains generally mediate interactions of 
membranes or cytoskeletal elements with cytoplasmic proteins.  SNX FERM domains are 
known to regulate endosomal cargo interactions and to act as scaffolds for signaling complexes; 
the F3 module binds cargoes bearing a NPxY/NxxY (Asn-Pro-Xaa-Tyr/Asn-Xaa-Xaa-Tyr) 
sequence 116, and the F1 contains a Ras-association (RA) domain, suggesting a role in Ras-
mediated endosomal signal transduction!117. 
The SNX-FERM subfamily has three components, SNX17, SNX27 and SNX31. SNX17 and 
SNX31 are similar, whereas SNX27 has a PDZ domain (PSD-95, Dlg1, ZO-1) in addition to the 
PX and FERM-like domains.  In peptide array experiments, the FERM domains of SNX27, 
SNX17 and SNX31 share the ability to bind NPxY/NxxY sequences from a large variety of 
proteins, although SNX27 shows a preference for sequences phosphorylated at Y0 116.  In vivo 
studies nonetheless demonstrated a role only for SNX17 and SNX31 in preventing lysosomal 
degradation of transmembrane proteins with NPxY/NxxY sequences 246, 309, 326.  Studies of the 
FERM-RA domain showed H-Ras binding to all SNX-FERM proteins in vitro 117, but only linked 
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functionally the SNX27 RA domain to a specific Ras protein; it binds K-Ras 196 and regulates 
expression of GIRK potassium channels (G protein-coupled inwardly-rectifying potassium 
channels) 14.  SNX17, SNX27 and SNX31 FERM domains thus share similar cargo- and Ras-
binding capacity in vitro, although cell biology studies reveal distinct binding properties for 
SNX27, suggesting evolutionary divergence of its FERM domain. 
3.2. SNX27 is a core component of a multimeric protein complex 
SNX27 is unique in the SNX family in that it has an N-terminal PDZ domain that binds proteins 
bearing a C-terminal class 1 PDZ-binding motif (PDZ-bm), a [Ser/Thr]-x-( (( = any hydrophobic 
residue) consensus motif 64.  The importance of the SNX27 PDZ lies in that it also mediates 
direct SNX interaction with the retromer complex, which increases SNX27 cargo binding affinity 
111.  The retromer was originally characterized for its role in endosome-to-TGN transport and 
transcytosis in polarized cells; SNX27 association to the retromer thus broadens its functions to 
direct endosome-to-PM recycling (reviewed in 112) (Fig I7A). 
SNX27 directly binds the VPS26 retromer subunit, to which is also indirectly recruited via 
association with the SNX-BAR 308 and the WASH complex 308, 321, which induces actin 
polymerization at the endosomes and maintains endosomal and lysosomal network 
integrity 124, 125.  While an intact FERM-like domain is necessary to bind retromer SNX-BAR, the 
F3 FERM module interacts independently with the WASH complex through one of its core 
Fig I7. SNX27 localization and interactions in the intracellular trafficking pathway 
(A) Intracellular transport routes.  SNX27 participates mainly in endosome-to-plasma membrane 
protein recycling (expanded in C).  (B) SNX27 protein structure.  SNX27 domain interaction with 
different proteins and PtdIns3P (PI3P) lipid are detailed.  Modified from 308. 
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components, FAM21 185, 308.  FAM21 bridges SNX27 and the retromer subunit VPS35 via their 
respective interactions with the FAM21 globular or tail regions 137,! 160, 185 (Fig I7B). Its protein 
domains thus facilitate the interactions that situate SNX27 as a core component of a 
multiprotein complex that directs endosome-to-PM protein recycling.  The current model 
suggests that direct SNX27 association with the retromer and FAM21 prevents cargo transport 
to the lysosomes or to Golgi, respectively 185, 308.  SNX27 cargoes are then transported from 
early endosomes through SNX-BAR-decorated tubules, and coupled to F-actin-mediated 
endosomal trafficking as a result of SNX27/WASH interaction (Fig I7C).  Recent findings 
identified additional accessory proteins that participate in SNX27-retromer-mediated protein 
recycling such as VARP (also known as ANKRD27) 144, 217, which controls the fusogenic state of 
VAMP7 and thus regulates late endosome-lysosome fusion 282. 
3.3. SNX27 PDZ cargoes 
The specific combination of the PDZ-PX-FERM structural domains, the singularity of FERM 
domain association to the WASH complex, and the differential binding to NPxY/NxxY and Ras 
compared to other SNX-FERM proteins all make SNX27 unique among SNX proteins and in 
need of further study. 
SNX27 is known primarily for its PDZ-mediated contribution to the trafficking of type 1 
PDZ-bm-bearing transmembrane proteins (see Table I1).  These include G protein-coupled 
receptors (GPCR) such as $2AR ($2-adrenergic receptor) 180, 321, $1AR 234, PTHR (parathyroid 
hormone receptor) 51, 216, and SSTR5 (somatostatin receptor subtype 5)! 22, ion channels and 
antiporters such as GIRK 15, 202, 231 and NHE3 (Na+/H+ exchanger 3) 300.  Others include proteins 
involved in neuron plasticity such as AMPAR (#-amino-3-hydroxy-5-methyl-4-isoxazolepropionic 
acid) 150, 196, NMDAR (N-methyl-D-aspartate) 40, 342 and 5-HT4(a)R (5-hydroxytryptamine 4a 
receptors) 162, as well as the metabolic transporters GLUT1 (glucose transporter 1) and MCT1 
(monocarboxylate transporter 1) 308. 
The majority of these proteins use SNX27 as an adaptor for retromer-mediated transport 
from endosomes to the cell surface; SNX27-silenced or KO cells thus show decreased surface 
abundance and increased degradation of these cargoes.  Several studies have nonetheless 
shown that SNX27 promotes internalization and lysosomal delivery of PDZ-bm-bearing cargoes 
such as Fzd7 (Frizzled 7) 313, 5-HT4(a)R 162, GIRK 202, GluN2C (also termed NR2C) 40 and MRP4 
(multidrug resistance-associated protein 4) 139.  Although some of these reports were based 
exclusively on experimental SNX27 overexpression 162, 202, 313, others showed that knockdown or 
KO of SNX27 indeed increases surface levels of cargo proteins 40, 139. 
The SNX27 PDZ domain also binds non-transmembrane PDZ-bm-bearing cargoes involved 
in cytoskeleton rearrangement, including the tight junction protein ZO-2 (zona occludens-2) 366 
and the Rho GEF $-PIX (p21-activated kinase-interactive exchange factor) 328 as well as in 
vesicle formation, such as CASP (cytohesin-associated scaffolding protein)!209"  Also noteworthy  
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Cargo 
C-terminal 
sequence 
SNX27 effect on cargo References 
AMPAR  SNX27 knockdown (KD) decreases surface and 
total levels 
150  
  GluA1 PLGATGL SNX27 KO leads to hydrocephalus and impaired 
long-term potentiation (LTP) 
196 
  GluA2 GIESVKI   
  GluA3 GTESVKI   
    
ATP7A EDDDTAL SNX27 KD decreases surface abundance and 
increases degradation 
308 
CASP EEEESRF SNX27 colocalizes at the endosomes 209  
CD97 LRASESGI SNX27 KD decreases surface abundance and 
increases degradation 
308 
DGK! EDQETAV SNX27 KD increases Ras/ERK signaling 271!270 
FZD 7 SKGETAV SNX27 overexpression (OE) enhances 
endocytosis, promotes degradation and results in 
enhanced Wnt signaling 
313 
GIRK/ 
Kir 3.3 
PESESKV SNX27 OE reduces surface expression, increases 
degradation and results in smaller potassium 
currents  
15 202 
  SNX27 KO in dopamine neurons reduces GIRK 
currents and enhances cocaine response 
231 
GLUT1 LGADSQV SNX27 KD decreases surface abundance and 
increases degradation 
308 
MCT1 PKEEESPV SNX27 KD decreases surface abundance and 
increases degradation 
308 
MRP4 TIFETAL SNX27 KD increases plasma membrane 
expression 
139 
NHE3 LPESTHM SNX27 KD decreases its activity and reduces 
surface expression 
300 
NMDAR    
  GluN1 PSVSTVV SNX27 knockdown (KD) decreases cell surface 
and total levels, SNX27 KO in mice results in 
synaptic dysfunction and cognitive deficits 
150 342 
  GluN2C/ 
  NR2C 
ISSLESEV SNX27 KO in neurons increases expression, and 
impairs endocytosis 
40 
PS1 AFHQFYI SNX27 KO increases "-secretase A$ generation 341 
PTHR EEWETVM SNX27 KD and KO reduces cell surface levels, 
promotes lysosomal localization and augments 
PTHR signaling 
KO mice show reduced bone mineralization and 
skeletal defects 
51!216 
SSTR5 LMQTSKL SNX27 KD delays postendocytic recycling and 
enhances degradation 
22  
ZO-2 RYRDTEL SNX27 KD decreases mobility at cell-cell contact 
regions and results in increased junctional 
permeability to large solutes 
366 
$-PIX AWDETNL SNX27 OE promotes endosomal localization, 
SNX27 KD decreases cell motility 
328 
$1AR GFASESKV SNX27 KD enhances lysosomal delivery 234 
$2AR CSTNDSLL SNX27 KD decreases plasma membrane 
expression and reduces adrenergic signaling 
180 321 
5-HT4aR ESLESCF SNX27 OE promotes endosomal localization 162 
Table I1. Validated SXN27-PDZ cargoes The canonical type I consensus PDZ-binding motif 
is underlined; possible phosphorylation sites (pink) and positively charged amino acids (blue) 
are colored. 
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is the recent report of SNX27 PDZ domain interaction with the human papillomavirus 16 
(HPV-16) L2 protein 255.  Although this association depends on the PDZ-bm-binding region of 
SNX27 PDZ, the L2 protein does not bear a C-terminal PDZ-bm.  L2/SNX27 interaction is 
disrupted by deletion of a central part of L2, a previously unreported type of SNX27 PDZ 
interaction 255 that could be a mechanism for virus to perturb and exploit transport processes to 
complete their life cycle. 
3.4. SNX27 in polarized cell models 
SNX27 is ubiquitously expressed, but numerous SNX27 PDZ cargoes have prominent roles in 
neurons.  Defective cargo trafficking is linked to synaptic dysfunction and cognitive defects in 
Snx27 KO mice 196, 342, as well as to attenuation of neuropathic pain development after 
knockdown of spinal SNX27 expression in rats 189.  In humans, deleterious homozygous 
mutations in SNX27 are found in patients with myoclonic epilepsy 70; in Down syndrome (DS) 
brain, an extra copy of the chromosome 21-encoded miR-155 leads to low SNX27 levels and 
contributes to the synaptic and cognitive deficits of DS patients 342.  SNX27 PDZ binding to the 
"-secretase subunit PS1 (presenilin 1) is associated with Alzheimer disease (AD), in which 
SNX27 depletion results in enhanced "-secretase-dependent $-amyloid (A$) production 341.  
SNX27 overexpression in a Ts65Dn DS mouse model or AD transgenic mice rescues cognitive 
and synaptic impairments 342 and decreases A$ generation!341, respectively.  These fundamental 
discoveries thus identify a molecular mechanism for AD-like neurodegeneration in DS patients 
and illustrate the importance of neurological disorders associated with loss of SNX27 function. 
Our group originally identified SNX27 in a proteomic screen for PDZ domain-containing 
interactors of DGK! in T cells 271.  We and others showed that in APC-responsive T cells 270 and 
tumor-engaged NK cells 210 endosomal SNX27 undergoes rapid polarization to the IS.  In T 
cells, SNX27 is sorted into two pools at the IS, where it is found at the PM and on TfR-positive 
vesicles 270.  PX and PDZ domains contribute to SNX27 recruitment to the T cell synapse; the 
PX domain binds to PtdIns3P-enriched endosomal membranes, driving SNX27 localization to 
the ERC, and the PDZ domain is necessary for its accumulation at the T cell-APC contact 
area 270.  The SNX27 FERM domain as well as the dual role for SNX27 PDZ domain in the 
recognition of PDZ-bm-containing cargoes and VPS26 were later identified 111, 117, 308; 
determining their particular contribution to SNX27 IS localization was one of the objectives of the 
present study. 
Localization studies suggest an important function of SNX27 at the IS that correlates with 
DGK! translocation to the T cell-APC contact area.  Moreover, attenuation of SNX27 expression 
mirrors the effect of DGK! silencing on ERK activation during T cell activation, indicating that 
SNX27 interaction helps to regulate localized DGK!-dependent DAG signaling 270.  SNX27 IS 
accumulation, however, is independent of DGK! 270, which suggests the presence of other 
SNX27 PDZ cargoes at the IS.  Further studies were thus required to fully characterize the 
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contribution of SNX27/DGK! association to the control of DAG signaling and to identify 
additional SNX27 partners during T cell activation. 
Besides providing a better understanding of the IS, the study of SNX27 dynamics and 
function in the T cell model offers interesting possibilities to extrapolate some findings to other 
models of intense polarized trafficking.  As detailed above, from the neurological synapse to 
invadopodium formation, all are polarized cell-cell communication systems that share 
fundamental structures necessary for the correct rearrangement of actin, MT, adhesion 
molecules and lipids that facilitate vesicle trafficking.  In invasive tumor cells, the SNX27 partner 
WASH mediates integrin 360 and MT1-MMP recycling 228.  Moreover, data from several web-
based bioinformatics resources such as the cBioPortal for Cancer Genomics 49, 113 indicate that, 
in humans, SNX27 chromosome localization (1q21.3) is frequently amplified in different types of 
invasive cancer (see Appendix 1).  SNX27 role in tumor cell polarized recycling, however, has 
not yet been explored. 
 !!! !
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III. OBJECTIVES 
SNX27 PDZ and FERM domains facilitate the intracellular trafficking of protein cargoes, and its 
PX domain assist in SNX27 endosomal localization.  Using immune synapse (IS) formation as a 
model of polarized vesicle trafficking, our group identified SNX27 association with the PDZ-
binding diacylglycerol kinase ! (DGK!).  Later studies in neurons and epithelial cells identified 
additional interactors of SNX27, which is proving to be a critical hub for protein recycling in the 
nervous system.  The precise function of SNX27 is not fully understood in other polarized cell 
systems.  Our overall objective was to determine the role of SNX27 during T cell activation 
and cancer cell invasion, two situations when polarized intracellular trafficking is crucial for 
specialized cell function.  To achieve this aim, we proposed the following specific objectives: 
 
1. Determine the role of SNX27 during IS formation 
a. Assess the contribution of the SNX27 FERM and PDZ subdomains to SNX27 
dynamics at the IS 
b. Identify the SNX27 PDZ-dependent and -independent interactome during IS 
formation 
c. Study the function of SNX27 interaction with partners identified in T cells 
 
2. Assess the role of SNX27 during T cell activation 
a. Analyze the molecular details of SNX27/DGK! association 
b. Examine the contribution of SNX27 in the control of T cell signaling 
c. Characterize the effects of SNX27 deficiency on mouse T cell development and 
function 
 
3. Study the role of SNX27 during breast cancer cell invasion 
a. Examine SNX27 localization to invadopodia 
b. Analyze the effects of SNX27 silencing on invadopodium formation and invasion in 
breast cancer cells ! !
   !  
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IV. MATERIAL AND METHODS 
1. REAGENTS 
The reagents used in the present study are detailed in Table M1.  Remaining reagents were 
purchased as indicated. 
Supplier Reagents 
Roche Leupeptin, aprotinin  
Sigma 
Na3VO4, PMSF, $-glycerophosphate, NP-40, G418, poly-DL-lysine, methanol, 
paraformaldehyde (PFA), gelatin, cycloheximide (CHX), polybrene, BSA, 
doxycycline (Dox), phorbol 12-myristate 13-acetate (PMA), concanavalin A (ConA) 
Calbiochem Triton X-100, Tween 20, Gö6976, PD98059, MG-132 
Life Technologies Transferrin-rhodamine (Tf-Rhod), calcein-AM, BODIPY 630/650 succinimidyl ester, CMAC (7-amino-4-chloromethylcoumarin) 
Invitrogen LIVE/DEAD violet dead cell stain, Cell Trace Violet Cell Proliferation kit, AlexaFluor 647-phalloidin, rhodamine phalloidin 
Table M1. Reagents used in this study 
2. CONSTRUCTS 
The constructs used in the present study for protein or shRNA expression are detailed in 
Table M2, or were generated as indicated in sections 2.1 and 2.2. 
Plasmid  Supplier / Reference 
pEGFP-C2-mSNX27a (WT/)PDZ) E. Rincon 271 
pEGFP-C1-hSNX27 (WT/L67-77A/H114A) P. Cullen 111, 308 
pmCherry-mSNX27 B. Collins 118 
pEGFP-N-SNX17 B. Collins 116 
pDsRed2-AKT-PH M. Almena 118 
pmCherry-C2-2xFYVE F. Meunier 344  
pEGFP-C3-ZO-2 M. Sudol Addgene #27422 243  
pEGFP-ZO-1  A. Fanning Addgene # 30313 95 
pEGFP-C1-CD63 G. Griffiths 29 
mRFP-Lifeact R. Wedlich-Soldner 267  
pEFbos-GFP DGK! (WT/)ETAV) T. Santos 281 
pSUPER.basic Oligoengine (VEC-PBS-0001/0002) 
pSUPER-shRNA mouse DGK#(Ctrl) A. Ávila-Flores 271 
pSUPER-shRNA human DGK! A. Ávila-Flores 271 
PLKO-Tet-on-neo D.Wiederschain/Addgene#21916 346 
PLKO-shRNA mouse DGK#(Ctrl) P. Torres-Ayuso, A. Ávila-Flores 
MT1-MMP-mCherry P. Chavrier 278 
pDMyc-SNX27 (FL/NT) W. Hong 40 
pGEX4T1-GST-SNX27 FL W. Hong 40 
pcDNA-GFP-PIPK"i2-FLAG A. Huttenlocher 195 
pEGFP-C1-PIPK"i1 S. Mañes 179 
HA-PIP5KI$ S. Mañes 211 
Table M2. Constructs used in this study 
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2.1. Mutagenesis 
To generate the SNX27 FERM non-PtdInsP-binding mutant (pEGFP-C2-mSNX27a RRK/E) and 
SNX27 FERM non-NPxY-binding mutant (pEGFP-C2-mSNX27a W475A and pDMyc-SNX27 
W475A), the sequences 5ʼ-TCG AGG AGG AAG GGA-3ʼ, or 5ʼ-GCA GCG AGC GGA CAC-3ʼ 
were mutated to the sequences detailed in Table M3.  The presence of the mutations was 
confirmed by sequencing using SeqSNX27400 primer (5ʼ- TCA ACA TGC TAA GGA CCT 
GC-3ʼ). To generate the DGK! PDZ-bm mutants pEFbosGFP-DGK! D924A, E926A, DE/A, 
T927D and T927A, then pEFbosGFP-DGK! sequence 5ʼ-GAC CAG GAG ACA GCT-3ʼ was 
mutated to the sequence detailed in Table M3.  The presence of the mutations was confirmed 
by sequencing using SeqDGK!Ct primer (5ʼ-GAG ACC TGT CTA CAC CAG GCA-3ʼ). Site-directed 
mutagenesis was performed using the QuikChange mutagenesis kit (Agilent Technologies). 
Generated mutant Sequence (5’-3’) 
SNX27 RRK/E  TCG GAG GAG GAG GGA 
SNX27 W475A GCA GCG AGC GGA CAC 
DGK! D924A GCC CAG GAG ACA GCT 
DGK! E926A GAC CAG GCG ACA GCT 
DGK! DE/A GCC CAG GCG ACA GCT 
DGK! T927D  GAC CAG GAG GAT GCT 
DGK! T927A GAC CAG GAG GCA GCT 
Table M3. Oligonucleotides used for mutagenesis 
Nucleotides underlined encoded the modified amino acids 
2.2. Cloning 
2.2.1. pSUPER-derived shRNA plasmid 
For SNX27 silencing, double strand oligonucleotides encompassing the 5ʼ-CCA GGU AAU UGC 
AUU UGA A-3ʼ interfering sequence 180 and a hairpin structure were cloned between the BglII 
and HindIII restriction sites of the pSUPER vector for transient shRNA expression.  The 
presence of the inserts was confirmed by sequencing using the T7Seq primer (5ʼ-AAT ACG 
ACT CAC TAT AG-3ʼ). 
2.2.2. pLKO-derived shRNA plasmids 
For SNX27 silencing, double strand oligonucleotides encompassing the 5ʼ-CCA GGU AAU UGC 
AUU UGA A-3ʼ interfering sequence 180 and a hairpin structure were cloned between the AgeI 
and EcoRI restriction sites of the pLKO-Tet-on vector for transient shRNA expression.  The 
presence of the inserts was confirmed by sequencing using the pLKOSeq primer (5ʼ-GGC AGG 
GAT ATT CAC CAT TAT CGT TTC AGA -3ʼ). 
3. CELL CULTURE 
3.1. Cell lines 
Human leukemic Jurkat T cells and Raji human B lymphoma cells (American Type Culture 
Collection; ATCC) were maintained at subconfluence (<5 × 105 cells/ml) in RPMI-1640 medium 
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(BioWhittaker) supplemented with 10% FBS (Sigma or GBi Genycell Biotech) and 2 mM 
L-glutamine (Sigma or BioWhittaker) (37°C, 5% CO2).  Human epithelial HEK293T cells and 
breast cancer MDA-MB-231 cells (ATCC) were maintained at subconfluence in DMEM 
(BioWhittaker) supplemented as above (37°C, 5% CO2). 
3.2. Mouse-derived primary T cell culture 
Snx27+/− mice were kindly provided by Dr. Brett Collins (Institute for Molecular Bioscience, 
University of Queensland, Australia), originally from Dr. Wanjin Hong (Institute of Molecular and 
Cell Biology, Singapore) 40.  Mice were housed in specific pathogen-free conditions and handled 
in accordance with the Australian Code of Practice for the Care and Use of Animals for 
Scientific Purposes.  Experiments were approved by the Ethics Committee of the University of 
Queensland. 
Thymus, spleen, or peripheral lymph nodes were dissected and mechanically disaggregated 
in PBS.  Single-cell suspensions were obtained using a 40-µm cell strainer (BD Biosciences).  
Splenocytes were treated with red blood cell (RBC) lysis buffer (eBioscience) according to 
manufacturerʼs instructions.  Cells were prepared for flow cytometry as described in section 7.3, 
or stimulated as indicated in section 4.2 and maintained in RPMI-1640 medium supplemented 
with 10% heat-inactivated FBS, 2 mM L-glutamine, penicillin/streptomycin (all from Gibco) and 
50 mM $-mercaptoethanol (Sigma) (37°C, 5% CO2). 
3.3. Transient protein and shRNA expression 
Jurkat T cells in logarithmic growth phase were transfected (1.2 x 107 cells in 400 µl complete 
medium) with 20 µg plasmid DNA by electroporation using a Gene Pulser (BioRad; 270 V, 975 
mF) 271.  For transient protein expression in the MDA-MB-231 cell line, DNA plasmids were 
transfected using Lipofectamine 2000 or LTX (Life Technologies) or the Amaxa Nucleofector 
System (Lonza), both according to manufacturerʼs instructions.  For nucleofection, cells were 
transfected (1-2 x 106 cells in 100 µl solution V (Lonza)) with 2 µg plasmid DNA by 
electroporation using a Nucleofector Device (program X-013).  HEK293T cells were transfected 
using FuGENE (Roche) at a 3:1 v:w FuGENE:DNA ratio. 
For all cell types, assays were generally performed 24 or 48 h post-transfection.  For shRNA 
expression using pSUPER-derived plasmids, cells were assayed at 72-96 h post-transfection. 
3.4. Generation of viral particles and transduction 
Lentiviral particles were produced in human HEK293T cells by cotransfecting the lentiviral 
vector and the appropriate viral envelopes [pRSV-Rev, pMDL-g/pRRE, pVSV-G, all a kind gift 
from Dr John Stingl (Cambridge Research Institute, UK)].  DNA was used at a proportion of 2.5 
µg/106 packaging cells, which were cultured in 10 cm2 plates.  After 48 h transfection, cell 
medium containing the viral particles was collected and centrifuged (1500 × g, 5 min, 33oC).  
The remaining supernatant was filtered through a low-protein-binding 0.45 µm filter (Pall Life 
Sciences). 
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Viral supernatant and complete medium were added at a 1:1 ratio to target cells, in the 
presence of 6 µg/ml polybrene to increase viral transduction efficiency.  Cells were centrifuged 
in a 6-well plate (1500 × g, 90 min, 33oC) and incubated (3-4 h, 33°C).  The virus-containing 
medium was then replaced with fresh medium.  At 48 h post-infection, antibiotic (600 µg/ml 
G418) was added to growth medium to select efficiently transduced cells.  Cells were 
maintained in antibiotic-containing medium for a minimum of 7 days. 
3.5. Generation of stable shRNA-expressing cell lines 
For loss-of-function analysis in MDA-MB-231 cells, we use the pPLKO-Tet-on-neo system for 
inducible expression of shRNAs.  Cells were transduced with lentiviral particles containing 
shRNA-encoding plasmid pPLKO-Tet-on-neo against target sequences described in 
section 2.2.2.  shRNA expression of MDA-MB-231-derived pLKO-Tet-on-neo cell lines was 
induced by doxycycline (Dox) treatment (1 µg/mL every 48 h). Protein silencing was effective 
after 72-96 h of Dox treatment. 
4. ANALYSIS OF T CELL STIMULATION 
4.1. T cell/APC conjugate formation 
Raji B cells used as APC were pulsed with 1 µg/ml superantigen Staphylococcus enterotoxin E 
(SEE; Toxin Technology) at 107 cells/ml in medium containing 10 µM CMAC or 
1 µM BODIPY 630/650 (1 h, 37ºC).  For microscopy, CMAC-stained APC were washed and 
mixed 1:1 with Jurkat T cells for the times indicated.  Flow cytometry-based conjugation assays 
were performed and analyzed as described 297, with minor modifications.  Briefly, BODIPY-
stained APC (red) and Jurkat cells stained with 4 nM calcein-AM (1 h, 37ºC) (green) were 
washed, resuspended to 106 cells/ml in medium and mixed 1:1 (37ºC) for indicated times.  The 
relative proportion of red, green, and red/green events in each tube was determined by two-
color flow cytometric analysis using a Cytomics FC500 analyzer (Beckman Coulter).  The 
percentage of conjugation was calculated as the number of dual-labeled (red/green) events 
divided by the sum of the dual-labeled events and the unconjugated Jurkat cells (green events). 
4.2. Anti-CD3 or anti-CD3/CD28 stimulation 
The antibodies used for T cell stimulation are detailed in Table M4. 
Antibody (anti-) Supplier Reference 
Human CD3* (clone HIT3a; mouse) BD PharMingen 555336 
Human CD28 (clone CD28.2; mouse) BD PharMingen 555725 
Mouse CD3* (clone 145-2C11; hamster) BD PharMingen 553058 
Mouse CD28 (clone 37.51; hamster) BD PharMingen 553295 
Table M4. Antibodies used for T cell stimulation 
4.2.1. Stimulation with antibody solution 
Jurkat T cells were stimulated in complete medium (107 cells/ml) with soluble anti-CD3 
or -CD3/CD28 antibodies (1 µg/ml) (Table M4) for the indicated times.  Where indicated, cells 
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were pretreated for pharmacological inhibition with Gö6976 (100 nM) or PD98059 (50 µM) 
(37°C, 30 min) prior to stimulation. 
4.2.2. Stimulation with plate-bound anti-CD3 
Primary cells were stimulated in complete medium (2.5 × 106 cells/ml) with plate-bound 
anti-CD3 (plate coated with 2.5 µg/ml anti-CD3; 1 h, 37ºC) (Table M4); where indicated, medium 
was supplemented with anti-CD28 (1.25 µg/ml). 
4.3. Proliferation assay 
For staining, cells were incubated in pre-warmed Cell Trace Violet/PBS solution (5 µM; 
5 × 106 cells/ml, 30 min, 37ºC).  Unbound dye was quenched by adding 5 times the staining 
volume of complete culture medium (5 min, 37ºC).  Cells were then washed in complete 
medium, cultured for indicated times and processed for flow cytometry (see section 7.3).  The 
FlowJo Proliferation Platform (TreeStar) was used to track cell generations and calculate 
proliferation statistics. 
4.4. Dual luciferase reporter assay 
Jurkat cells were transfected with the indicated shRNA constructs as described in section 3.3. 
At 48 h post-transfection, cells were transfected with the indicated promoter construct 
(pGL2-AP-1 or pGL4-NF-%B plasmids with four or three transcription factor binding sites, 
respectively, were made in our laboratory by Raquel Arcos) and the 100 ng of Renilla luciferase 
vector pRL-TK (Promega) as internal control.  After 24 h, cells were washed, allowed to recover 
(6 h), and stimulated as described in section 4.2.1.  Cells were harvested and assayed for 
luciferase activity using the Dual-Luciferase Reporter Assay (Promega).  Relative luciferase 
units (RLU) were calculated relative to Renilla luciferase values and, where indicated, 
normalized to the RLU of unstimulated control cells. 
5. PROTEIN STABILITY ASSAYS 
Cells were treated with 10 µg/ml cycloheximide (CHX) for the indicated times.  Cells were 
processed as in section 7.1 to determine protein levels by quantitative western blot.  Protein 
levels were normalized to GAPDH or tubulin.  Results for each time point were also normalized 
to the untreated control, which was set to 1. 
6. MIGRATION AND INVASION ASSAYS 
6.1. Circular invasion assay 
The circular invasion assay (CIA) was performed as described 359.  Cells were plated onto 
35 mm micro-dishes using silicon inserts (both from Ibidi) to generate a cell-free space.  After 
incubation (overnight, 37°) and removal of the insert, 250 µl 4.5-5.5 mg/ml Matrigel (BD 
Bioscience) diluted in DMEM at a 1:1 ratio was overlaid onto the cell monolayer and allowed to 
polymerize (2 h, 37°C).  After addition of complete medium, cells were allowed to invade the 
Matrigel and imaged (24 h, 37°C).  Cells were then fixed in 4% PFA and prepared for 
immunofluorescence analysis as in section 7.4.  Time-lapse imaging was performed using a 
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phase-contrast microscope with a 20× objective, with image acquisition at 15 min intervals.  The 
area covered by cells was measured using ImageJ Freehand Selection.  The increase in cell-
covered area was calculated for each time point and normalized to control cells at the final time 
point.  Duplicates were analyzed for each sample and 3 time-lapse positions were measured for 
each replica in at least three independent experiments. 
6.2. Inverted invasion assay 
In a modification of traditional transwell-Matrigel inserts, inverted invasion assays were 
performed as described 143.  Briefly, 100 µl of 4.5-5.5 mg/ml Matrigel (BD Bioscience) were 
allowed to polymerize in transwell inserts (Corning) (1 h, 37°C).  Inserts were then inverted, and 
5 x 105 cells plated onto the outer side of the transfilter and allowed to adhere (3 h).  Inserts 
were then washed in serum-free DMEM to remove unattached cells, and placed in 500 µl 
serum-free medium.  To create a chemotactic gradient, 100 µl of 10% FBS-supplemented 
medium were added to the Matrigel-containing chamber.  At 72 to 96 h post-seeding, cells were 
stained with calcein-AM (4 µM) in serum-free DMEM (1 h, 37°C).  Cells that did not cross the 
transfilter were removed with a tissue and the invading cells were imaged on an FV1000 
confocal laser-scanning microscope (Olympus) using a 40× objective.  Serial optical sections 
were captured at 15-µm intervals.  The area covered by cells was measured in each section 
using the ImageJ plugin “Area Calculator” in 8-bit images (threshold 30-50/255).  Relative 
invasion was calculated as the area covered by cells that invaded 45 µm or more relative to total 
cell area of the Z-stack.  At least three independent experiments in duplicate were performed for 
each sample. 
7. IMMUNOASSAYS 
The buffer solutions used for immunoassays are detailed in Table M5. 
The antibodies used for immunoprecipitation, western blot and immunofluorescence are 
detailed in Table M6 and Table M7.  
Buffer Preparation 
P70 glycerol /1% NP-40 10 mM HEPES pH 7.5, 15 mM KCl, 1 mM EDTA, 1 mM EGTA, 10% glycerol, 1% NP-40 
RIPA 20 mM Tris-HCl pH 7.5, 300 mM NaCl, 2 mM EDTA, 1% Triton X-100, 
0.1% SDS, 0.5% sodium deoxycholate, 10% glycerol 
Sample buffer (5X) 312 mM Tris-HCl pH 6.8, 10% SDS, 25% $-mercaptoethanol, 50% glycerol, 
0.1 mg/ml bromophenol blue 
PBS staining buffer 1% FBS, 0.5% BSA, 0.01% sodium azide/PBS 
Table M5. Buffer solutions used in this study 
7.1. Western blot analysis !For western blot analysis, cells were washed in cold PBS and lysed (15 min, 4oC) in the 
indicated buffer solutions detailed in Table M5, containing protease and phosphatase inhibitors 
(20 µM leupeptin, 1.5 µM aprotinin, 1 mM PMSF, 1 mM Na3VO4, 40 mM $-glycerophosphate and 
2 mM NaF); clarified lysates were quantified with the Pierce 660 nm Protein Assay (Thermo 
Scientific).  An equivalent protein amount per sample was analyzed by SDS-PAGE.  Proteins 
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were transferred to nitrocellulose membrane (Bio-Rad) and incubated with indicated primary 
antibodies.  For HRP- or fluorescent-conjugated secondary antibodies, we used an ECL 
detection kit (Amersham Bioscience) or an Odyssey scanner (LI-COR), respectively.  
Densitometric analysis of proteins in western blots was performed using ImageJ. 
7.2. Immunoprecipitation 
For protein-protein interaction analysis by immunoprecipitation, cells were lysed as above.  
Lysates (500 µg - 1 mg) at a protein concentration of 1 µg/µl were incubated (1 h, 4oC) with the 
appropriate antibody, followed by incubation (30-60 min, 4oC) with 30-60 µl of 50% protein 
G-Sepharose slurry (GE Healthcare Life Sciences). Immunoprecipitates were washed three 
times in lysis buffer and eluted in sample buffer (Table M5).  Immunoprecipitated proteins were 
analyzed by western blot (section!7.1) for validation and by 1D-gel-MS for protein identification 
(section 9). 
7.3. Flow cytometry analysis 
Cells were collected in ice-cold PBS and cell surface proteins stained with saturating 
concentrations of the indicated fluorophore-conjugated primary antibodies (Table M8) in PBS 
staining buffer as indicated in Table M5 (30 min, 4ºC).  Cells were washed with the same buffer 
Antibody (anti-) Supplier  Reference 
Akt Cell Signaling 2910S 
DGK! Abcam ab105195 
Drebrin Abcam ab12350 
EEA1 BD Biosciences 610456 
FLAG-tag Cell Signaling 2368S 
GAPDH Santa Cruz sc25778 
GFP Roche 11814460001 
GFP (for IP) Invitrogen A11122 
GLUT1 (for WB) Abcam ab15309 
I%B-# Cell Signaling 9242S 
Kidins220 Kind gift from Dr Teresa Iglesias 154 
MMP-14 (clone LEM-2/15.8) Millipore MAB3328 
Myc-tag Cell Signaling 2276S 
p44/42 MAPK (ERK1/2) Cell Signaling 4696S 
P70 S6 kinase Cell Signaling 2708 
Phospho-(Ser) PKC substrate Cell Signaling 2261L 
Phospho-Akt (S473) Cell Signaling 4060 
Phospho-p44/42 MAPK (ERK1/2)(T202/Y204) Cell Signaling 4370 
Phospho-p70 S6 kinase (T389) Cell Signaling 9206L 
Phospho-PKD/PKCµ (S744/748) Cell Signaling 2054L 
Phospho-S6 ribosomal protein (S235/236) Cell Signaling 2211S 
PKC' BD Transduction 610090 
PKCµ/PKD Santa Cruz sc-935 
SNX27 Abcam ab77799 
Talin Sigma T3287 
Transferrin receptor Zymed 13-6800 
WASH1 (for IF) Atlas Antibodies HPA002689 
WASH1 (for WB) Roche 11814460001 
ZO-2 Zymed 71-1400 
#-tubulin Sigma 9026 
$-actin Sigma A2228 
$-PIX Millipore 07-1450-I 
Table M6. Primary antibodies used for western blot (WB), immunofluorescence (IF) and 
immunoprecipitation (IP) 
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and maintained at 4ºC for flow cytometry using Cytomics FC500 or Gallios cytometer (Beckman 
Coulter).  Live cells were gated using forward and side scatter parameters.  For fixed cells, 
LIVE/DEAD violet dead fixable cell stain (Invitrogen) was used.  For primary cells, each sample 
was acquired for a minimum of 100,000 events.  Data were analyzed using FlowJo software 
(TreeStar). 
Antibody (anti-) Supplier Reference 
Mouse IgG-AlexaFluor 680  Life Technologies A-21057 
Mouse IgG-Cy3 Jackson ImmunoResearch 115-166-071 
Mouse IgG-HRP Dako P0447 
Rabbit IgG light chain-specific-HRP Jackson ImmunoResearch 211-032-171 
Rabbit IgG-AlexaFluor 488 Life Technologies A-11034 
Rabbit IgG-Dylight 800 Thermo Scientific SA5-35571 
Rabbit IgG-HRP Dako P0448 
Table M7. Secondary antibodies used for western blot and immunofluorescence 
 
Antibody (anti-) Supplier Reference 
Human CD11a-FITC (clone 25.3) Immunotech 860  
Human CD3*-PC5  Beckman Coulter A07749 
Human CD69-PE  Beckman Coulter IM1943 
Human CD71-PE  Immunotech 2001 
Human GLUT1-PE (also used for mouse) R&D Systems FAB1418P 
Isotype control mouse IgG1-FITC  Beckman Coulter PNIM0639 
Isotype control mouse IgG1-PCy5  Beckman Coulter A07798 
Isotype control mouse IgG1-PE  BD PharMingen 556029 
Mouse B220-FITC  Beckman Coulter 732154 
Mouse CD11a-PE (clone 2D7) PharMingen 553121 
Mouse CD25-PE  PharMingen 553866 
Mouse CD3*-APC  eBioscience 17003183 
Mouse CD4-PECy5 BioLegend 100434 
Mouse CD44- FITC Beckman Coulter 731957 
Mouse CD69-FITC PharMingen 553236 
Mouse CD71-PE  PharMingen 553267 
Mouse CD8-PeCy7  BioLegend 100722 
Mouse TCR$-APC PharMingen 553174 
Mouse TCR"&–biotinylated PharMingen 553176 
Streptavidin- APC Cy7 BioLegend 405208 
Table M8. Antibodies used for flow cytometry 
7.4. Immunofluorescence 
MDA-MB-231 cells were plated on 0.1% gelatin- or 10 µg/ml fibronectin-coated coverslips for 
the indicated times.  Jurkat cells were plated on poly-DL-lysine-coated coverslips.  Where 
indicated, transfected cells were pre-stained with Tf-Rhod (20 µg/ml, 15-30 min, 37°C).  Jurkat T 
cells were washed and incubated with APC in complete medium for indicated times. 
Cells were fixed and permeabilized (cold methanol (4 min) or 2% PFA (10 min) + 0.05% 
Triton X-100 (10 min)) and blocked in 10% goat serum/PBS (30 min).  Cells were incubated with 
specific antibodies (3 h, RT), washed, and incubated with secondary antibodies (1 h, RT).  
Coverslips were washed and mounted on glass slides.  An FV1000 confocal laser-scanning 
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microscope (Olympus) was used for imaging. 
8. MICROSCOPY 
8.1. Live cell imaging 
For time-lapse experiments using MDA-MB-231 cells, an Andor spinning disc confocal system 
with Cairn Optsplit (for simultaneous GFP/RFP imaging) was used for imaging. Images were 
collected at 0.3-s intervals. 
For time-lapse experiments, live Jurkat cells were imaged as described, with minor 
modifications 119.  Images were collected every 15 s, before, during and after addition of 
SEE-pulsed or unpulsed stained APC.  Where indicated, transfected cells were pre-stained with 
Tf-Rhod (20 µg/ml, 15-30 min, 37°C).  Cells were imaged on an FV1000 confocal laser-scanning 
microscope (Olympus). 
8.2. Fluorescent recovery after photobleaching (FRAP) 
Transfected cells were collected in HBSS, transferred to poly-DL-lysine-coated 8-chambered 
glass coverslips (Ibidi) and allowed to attach for at least 5 min (37ºC). Live-cell microscopy was 
performed at 37°C with a Leica SP5 TCS confocal scanning unit equipped with a PL APO 
lambda blue 63×/1.2-NA water immersion objective with the 488-nm Ar laser line for EGFP, and 
a pinhole setting of 5 AU.  Within 30 min of T cell stimulation with APC, we bleached membrane 
areas of the T cell-APC contact site and on comparable areas of the PM of nonconjugated T 
cells.  Laser power for bleaching was maximal but was reduced to 30% for imaging.  At the 
optimal focal plane, the acquisition protocol was: 5 pre-bleach images, 5 bleach pulses and 
90 images at 0.65 s intervals (512 × 512).  Fluorescence recovery in the bleached region (5 µ2) 
was measured as mean signal intensity.  All recovery curves were generated from background-
subtracted images.  The fluorescence signal in the same region of interest was normalized 
using the mean prebleach signal as 1, and the intensity immediately following photobleach as 0.  
Curves were fitted by one-phase association exponential equations with GraphPad Prism.  
Statistical analyses were performed on the normalized data for each condition.  The immobile 
fractions and half-recovery times were determined from the fitted curves. 
8.3. Microscopy and image processing 
Time-lapse phase contrast imaging was performed using: 
- Nikon inverted fluorescence microscope TE 200 Wide Field fitted with a Nikon Plan-Fluor 
10×/0.3NA objective.  Imaging was performed using a CoolSnap HQ2 charge-coupled device 
camera (Photometrics) equipped with a Perfect Focus System device. 
- Leica inverted fluorescence microscope DMI6000B with a Leica HC PL 10×0.3NA objective 
lens and 1.6× magnification, and fitted with a monochrome digital camera Orca R2, 
12bit/16bit (Hamamatsu). 
Confocal images were collected using: 
- Fluoview FV1000 confocal laser-scanning microscope (Olympus) equipped with a uPlan-
SApochromat 60×/1.35NA oil objective lens.   
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- Leica SP5 TCS confocal scanning unit equipped with a PL APO lambda blue 63×/1.2-NA 
water immersion objective.   
- Zeiss Axiovert LSM 510-META inverted microscope equipped with a Zeiss PlanNeoFluar 
20×/0.5NA and Zeiss Plan-Apochromat 63×/1.4NA oil objective lens. 
Images were collected with Metamorph v.7.7.7 (Molecular Devices), FV10-ASW1.7 (Olympus), 
LAS AF v. 2.6.0. (Leica) or LaserSharp 2000v. 5.2  (Zeiss) acquisition software. 
Images and videos were processed using ImageJ and Adobe Photoshop.  We used ImageJ 
to quantify fluorescence signals or calculate areas of interest as described for each methods 
section, and to generate orthogonal and Z-projections. Pearsonʼs correlation and Mandersʼ 
overlap coefficients were calculated with ImageJ plugin JACoP (Just Another Co-localization 
Plugin) 30. To quantify fluorescence immune synapse signals, we measured mean fluorescence 
intensity (MFI) ratios at the IS vs. other regions of interest using an ImageJ plugin developed 
in-house (COS Sorzano, CNB/CSIC) 270.  Ratio values were represented in graphs as dot plots, 
with each dot representing an individual cell. 
9. PROTEOMICS ANALYSIS 
9.1. Protein identification 
We used standard procedures for protein identification.  Briefly, eluted protein samples were 
separated by SDS-PAGE.  Sixteen bands per sample were digested by automated in-gel 
digestion in a Proteineer DP (Bruker Daltonics); gel plugs were reduced (10 mM DTT) and 
alkylated (50 mM iodoacetamide), and digested with ~10 ng trypsin (Proteomics Grade Trypsin; 
Sigma-Aldrich) per gel plug (18 h).  Tryptic peptides were extracted with 50% ACN, 1% TFA and 
dried by speed vac.  Samples were pooled and analyzed by LC-MS/MS. 
9.2. LC-MS/MS analysis 
Tryptic peptides were analyzed by LC-MS/MS using a nano-HPLC system (Eksigent 
Technologies nanoLC Ultra 1D plus, AB SCIEX) coupled online to a TripleTOF 5600 mass 
spectrometer (AB SCIEX) with a nano-spray ionization source.  The analytical column was a 
nano-Acquity UPLC column (1.7 µm, BEH 130 C18; Waters).  The trap column was a nanoViper 
column Acclaim PepMap C18, 5 µm (Thermo Fisher Scientific).  The loading pump delivered 
0.1% formic acid in water at 2 µl/min; the nanopump provided a flow rate of 250 nl/min and was 
operated in gradient elution conditions with 0.1% formic acid in water as mobile phase A, and 
0.1% formic acid in ACN as mobile phase B.  Gradient elution was as follows: 98% A:2% B for 
1 min, a linear increase to 30% B in 110 min and to 40% B in 10 min, then to 90% B in 5 min; 
isocratic conditions of 90% B for 5 min and return to initial conditions in 2 min.  In general, 
one-third of the sample was processed by nanoLC-MS in a 5 µl injection volume. 
Settings for TripleTOF were: ionspray voltage floating (ISVF) = 2800 V, curtain gas 
(CUR) = 20, interface heater temperature (IHT) = 150, ion source gas 1 (GS1) = 30, 
declustering potential (DP) = 85 V.  Data were acquired in an information-dependent acquisition 
(IDA) mode with Analyst TF 1.7 software (AB SCIEX).  For IDA parameters, a MS survey scan 
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(250 ms) in the mass range of 350-1250 m/z was followed by 25 MS/MS scans (100 ms) in the 
mass range of 100-1500 m/z.  Switching criteria set to ions greater than m/z = 350 and smaller 
than m/z = 1250, with a charge state of 2-5, threshold >90 counts (cps) and dynamic exclusion 
of 20 s.  Collision energy (CE) was set as rolling CE using a parameter script.!
9.3. Data analysis 
MS and MS/MS data for each sample fraction were processed using Analyst TF 1.7 Software.  
Raw data were translated to mascot general file (mgf) format using the PeakView program v.1.2 
and a Uniprot database (2014-03-26) with human taxonomy restriction (NEWT 9606), 
containing 39,785 protein-coding genes and their reverse entries in an in-house Mascot Server 
v.2.5.1 (Matrix Science).  Search parameters were as follows: fixed modification of 
carbamidomethyl cysteine; variable modifications oxidation of methionines and acetylation of 
the peptide N termini; peptide mass tolerance ±25 ppm; fragment mass tolerance ±0.05 Da; 
maximum of two trypsin digestion missed-cleavages.  Accuracy of  ±10 ppm was typically found 
for MS and MS/MS spectra.  Criteria to accept individual spectra were based on Mascot ion 
score threshold (0.05) as the standard ion score threshold, and the identification certainty was 
established using false discovery rate criteria (FDR ≤1%) for peptide and protein matches using 
the Scaffold bioinformatic tool v.4.2.1 (Proteome Software).  This cutoff value for protein 
identification corresponded to a Mascot score of protein identification of 25.  A minimum of two 
peptides was required to identify a protein. The mass spectrometry proteomics data have been 
deposited in the ProteomeXchange Consortium via the PRIDE 336 partner repository with the 
dataset identifier PXD003628 and 10.6019/PXD003628. 
9.4. Functional interpretation 
To interpret the biological role of genes reported, Gene Ontology (GO) clustering analysis was 
performed by ClueGO (v.2.2.3), a Cytoscape plug-in (v.3.3.0).  The PDZ-independent SNX27 
interactome was clustered in molecular function GO categories with a 0.3 kappa score.  The 
color code indicates the p value for enriched GO terms, and node size, the number of mapped 
genes.  The CluePedia plug-in (v.1.2.3) was used to depict proteins associated with GO terms, 
and the STRING interaction database (v.10) to show reported interactions among transport-
related proteins. 
10. STATISTICAL ANALYSIS 
Studentʼs t-test was used to analyze differences between two conditions, using the paired two-
tailed t-test when comparing data sets from each pair of WT and Snx27−/− mouse littermates.  
Two-way ANOVA with the Bonferroni post-hoc test was used for multiple comparisons, both 
with GraphPad Prism 5 software.  Differences were considered not significant (ns) when 
p >0.05, significant (*) when p <0.05, very significant (**) when p <0.01 and extremely significant 
(***) when p <0.001. ! !
  
! !
Results 
!70 
V. RESULTS  
1. SNX27 DYNAMICS AND FUNCTION AT THE IMMUNE SYNAPSE 
Our group examined the dynamics of SNX27 localization to the IS in T lymphocytes, and 
showed that SNX27 PX and PDZ domains are involved in IS recruitment 270.  Recent structural 
studies have revealed molecular details of SNX27 FERM and PDZ domains 111, 117, 308.  We 
investigated their particular contribution to SNX27 IS localization. 
1.1. FERM domain contribution to SNX27 localization to the IS 
1.1.1. NPxY/NxxY binding contribution to SNX27 localization 
SNX-FERM proteins have an atypical FERM domain responsible for binding cargoes bearing 
the NPxY/NxxY motif for recycling 117.  In peptide array experiments, SNX27 bound 
preferentially to sequences phosphorylated at Y0 in a large variety of transmembrane proteins 
116; these include proteins stimulated after T cell activation.  To determine whether SNX27 
binding to NPxY/NxxY motif-containing cargoes participates in its localization to the IS, we 
tested the ability of the non-NPxY/NxxY-binding mutant SNX27 (GFP-SNX27 W475A; Fig R1A) 
to accumulate at the T cell-APC contact area.  Jurkat T cells were transfected with the 
GFP-tagged constructs (Fig R1A) and incubated with SEE-loaded Raji B cells as APC, to allow 
IS formation.  Videomicroscopy showed that, compared to the WT protein, GFP-SNX27 W475A 
did not show localization defects (Fig R1B, C), demonstrating that impaired NPxY/NPxxY motif 
binding does not prevent SNX27 localization to the IS. 
1.1.2. Lipid binding contribution to SNX27 localization 
FERM domains show PtdInsP-binding activities in some proteins (reviewed in 16).  In 
collaboration with our colleagues from Dr. Brett Collinsʼs group (Institute for Molecular 
Bioscience, University of Queensland, Australia), we examined SNX27 PtdIns-binding capacity, 
and identified a new PtdInsP-binding site with a clear preference for bi- and triphosphorylated 
PtdIns (see table in Appendix 2) 118.  Homology modeling identified the PtdInsP-binding site in 
the SNX27 FERM F3 subdomain.  Sequence alignment comparison of the F3 subdomain of 
SNX17, SNX27 and SNX31 indicated the positively charged amino acids that constitute a basic 
patch on the SNX27 F3 module, which were absent in SNX17 and SNX31.  The interaction was 
confirmed by biophysical, mutagenesis and modeling approaches (for more information see 118 
in Appendix 4.1). 
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T cell-APC encounter triggers signaling processes such as PI3K activation, which increases 
local concentrations of PtdIns(3,4,5)P3 (
63, 138, 181).  We thus hypothesized that the FERM 
PtdInsP-binding site plays a role in SNX27 recruitment to the IS, and therefore analyzed the 
localization of the SNX27 non-PtdInsP-binding mutant R435E/R436E/K437E (hereafter RRK/E) 
Fig R1.  FERM domain interactions with PtdInsP lipids and NPxY/NxxY-motif are 
not necessary for SNX27 recruitment to the immune synapse !(A) Scheme of proteins used (GFP not shown). SNX27 W475A is the non-NPxY/NxxY-binding mutant, 
and SNX27 RRK/E is the non-PtdInsP-binding mutant.  (B, C) For videomicroscopy, Jurkat T cells 
were transfected with the indicated GFP-tagged constructs (green) (B, top), and stimulated with SEE-
pulsed Raji B cells (blue) (B, bottom).  Representative images are shown. Bar: 3 µm.  (C) Quantitative 
analysis of GFP-tagged protein accumulation at the immune synapse (IS).  Each dot represents the 
synapse:cytosol intensity ratio for each protein after antigen presenting cell (APC) encounter.  Data 
shown as mean ± SEM (*p<0.05, **p <0.01, ***p <0.001; one-way ANOVA/Bonferroni post test; 
n ≥ 19). a.u., arbitrary units. A representative experiment is shown (n = 3). 
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during IS formation.  We compared its dynamics to those of GFP-SNX27 WT protein and 
SNX17-GFP, which lacks both the PtdInsP-binding pocket and the PDZ domain (Fig R1A).  
Whereas SNX17-GFP did not show IS localization, GFP-SNX27 RRK/E recruitment to the IS 
was similar to that in the WT protein (Fig R1B, C); this suggested that the FERM domain 
PtdInsP-binding site is not necessary for SNX27 localization to the T cell-APC contact area.  
The punctuate endosomal location of the RRK/E mutant in unstimulated Jurkat cells was 
nonetheless not well defined after APC engagement (Fig R1B).  Since SNX17-GFP showed 
impaired endosomal and IS localization (Fig R1B, C), and PDZ deletion reduces SNX27 
targeting to the ERC 271 and the IS 270, lack of the PDZ domain could explain SNX17 localization 
defects, but not those of the non-PtdInsP-binding mutant. 
To better assess differences in endosomal localization for the RRK/E mutant during IS 
formation, we measured the overlap of our GFP-tagged constructs with internalized Tf 
(rhodamine-coupled Tf, Tf-Rhod) as an ERC marker.  Videomicroscopy showed that in Jurkat 
cells, the GFP-SNX27 RRK/E colocalized with Tf-positive vesicles (Fig R2A, B).  Quantitative 
analysis nonetheless demonstrated a significant decrease in Tf-Rhod colocalization with the 
GFP-SNX27 RRK/E mutant or SNX17-GFP compared with GFP-SNX27 WT protein, in basal 
and in polarized recycling conditions (Fig R2C).  This defect was the result of reduced 
endosomal association, measured as the ratio of punctuate-to-cytosolic fluorescence (Fig R2D).  
Z-stack projections of confocal images showed the entire ERC and confirmed that after T cell 
stimulation, GFP-SNX27 maintains overlap with the polarized Tf-positive recycling organelles, 
and some labeling at the contact area (Fig R3A B, top).  The non-PtdInsP-binding mutant was 
also found at the cell-cell contact site, but did not colocalize with the Tf-positive recycling 
compartment after IS formation (Fig R3A B, bottom). 
Time-lapse imaging of Jurkat T cells cotransfected with cherry-SNX27 and GFP-SNX27 
RRK/E further confirmed similar translocation dynamics, with loss of endosomal labeling of the 
FERM mutant (Fig R3C, Video 1; see links to all videos in Appendix 3).  Whereas blocking 
FERM domain binding to PtdInsP did not grossly impair SNX27 localization to the IS, increased 
cytosolic fluorescence in GFP-SNX27(RRK/E)-expressing cells correlated with defective 
localization to the ERC.  This coincides with results from Tseng et al., who compared SNX27 
vesicle-binding abilities to those of other SNX-FERM proteins, and suggested an additional lipid-
binding site in SNX27 that was absent in both SNX17 and SNX31 326. 
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Fig R2. PtdInsP lipid interaction through the SNX27 FERM domain contributes to its 
recruitment to the endocytic recycling compartment 
Jurkat T cells were transfected with GFP-tagged constructs (green), incubated with Tf-Rhod 
(rhodamine-coupled transferrin; red) to visualize Tf-positive recycling endosomes by videomicroscopy 
(A), and stimulated with SEE-pulsed Raji B cells (blue) (B). Bar: 3 µm.  WT and PtdInsP-binding 
mutant (RRK/E) GFP-SNX27 colocalization with Tf-Rhod (C).  Measurement of the punctuate-to-
cytosolic fluorescence intensity ratio (D) suggested that this defect is the result of reduced GFP-
SNX27 RRK/E endosomal association.  (C, D) Pearsonʼs correlation coefficient and ratio values are 
represented as dot plots, with each dot representing an individual cell.  Data shown as mean ± SEM.  
*p <0.05, ***p <0.001; two-way ANOVA; n ≥ 15; a representative experiment is shown. 
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Fig R3. SNX27 recruitment to recycling endosomes is enhanced by PtdInsP 
binding to the FERM domain 
(A) Jurkat T cells were transfected with GFP-tagged constructs (green), incubated with Tf-Rhod (red) 
to visualize Tf-positive recycling endosomes, and stimulated with SEE-pulsed Raji B cells (blue).  Cells 
were methanol-fixed and imaged by confocal microscopy.  A Z-stack projection shows that, after 
synapse formation, WT GFP-SNX27 but not the PtdInsP-binding mutant colocalizes with Tf-Rhod-
positive compartments. (B) Densitometric analysis of GFP-SNX27 and Tf-Rhod distribution along the 
white lines in (A).  (C) The relative dynamics of IS recruitment of SNX27 to the IS were assessed 
directly by comparing Cherry-SNX27 with GFP-SNX27 RRK/E.  Live transfected Jurkat cells were 
imaged, SEE-pulsed APC were added, and images acquired every 15 s by time-lapse microscopy (see 
complete video in Video 1). Bars in A, C: 3 µm.  Color scale of fluorescence intensity (C, bottom). 
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As mentioned above, the FERM domain lipid-binding site showed a clear preference for bi- 
and triphosphorylated PtdIns such as PtdIns(4,5)P2 and PtdIns(3,4,5)P3.  We analyzed the 
contribution of these lipids to SNX27 recruitment to the IS by studying lipid dynamics using 
fluorescent probes for these lipids, to track their subcellular distribution in living T cells.  
PI3K-mediated generation of PtdIns(3,4,5)P3 at the PM is one of the earliest signals observed in 
IS formation 138.  Transfection of Jurkat T cells with the PtdIns(3,4,5)P3-binding AKT pleckstrin 
homology (PH) domain (DsRed-AKT-PH) allowed distinction between initial and mature stages 
of IS formation (Fig R4A, B).  We confirmed PtdIns(3,4,5)P3 accumulation at the T cell-APC 
contact area during early IS formation.  At later times, the AKT-PH domain translocated to distal 
and peripheral areas that correspond to annular PtdIns(3,4,5)P3 accumulation, which controls 
actin architecture and thus facilitates cell adhesion and polarized secretion 181.  Cotransfection 
of the PtdIns(3,4,5)P3 sensor with WT or the non-lipid-binding SNX27 showed impaired mutant 
protein colocalization with PtdIns(3,4,5)P3 during initial recruitment (Fig R4A, B).  This result 
suggests that the early SNX27 translocation to the PM is enhanced by FERM domain binding to 
lipids. 
Together with its phosphorylated product PtdIns(3,4,5)P3, PtdIns(4,5)P2 is also recognized 
as a regulator of polarized trafficking; the spatiotemporal generation and accumulation of this 
lipid is modulated precisely to activate effectors or signaling molecules (reviewed in 79).  In 
stimulated T cells, PtdIns(4,5)P2 is converted to PtdIns(3,4,5)P3 by PI3K, or is hydrolyzed by 
PLC to produce Ins(1,4,5)P3 and DAG.  As a result, PtdIns(4,5)P2 levels decrease substantially 
following APC contact, and transfection of the GFP-tagged PLC& PtdIns(4,5)P2-binding PH 
domain did not allow clear analysis of PtdIns(4,5)P2 dynamics in activated T cells (not shown). 
As the IS is a focal point not only for endocytosis, but also for exocytosis 128, we considered 
that vesicle fusion to the PM could result in SNX27 accumulation at the synapse.  To track the 
dynamics of ERC-enriched PtdIns3P, we transfected Jurkat T cells with a sensor composed of 
two tandem FYVE domains fused to a fluorescent protein (Cherry-FYVE).  When T cells were 
cotransfected with Cherry-FYVE and the SNX27 constructs, both GFP-SNX27 and the 
GFP-SNX27 RRK/E mutant showed substantial overlap with PtdIns3P-positive intracellular 
compartments in unstimulated T cells (Fig R5A).  APC-challenged T cells did not accumulate 
PtdIns3P at the synapse; instead, PtdIns3P-enriched vesicles accumulated at discrete locations 
that delimited the SNX27-positive compartment, often at two foci at the synapse periphery 
(Fig R5B).  These results suggest that SNX27 localization at the IS is not strictly dependent on 
either PtdIns3P or PtdIns(3,4,5)P3 association, but that dynamic changes in SNX27 PtdInsP 
interactions lead to segregation to distinct membrane domains. 
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Fig R4.  SNX27 accumulates transiently at discrete PtdIns(3,4,5)P3-enriched sites 
during T cell-APC contact 
Jurkat T cells were stimulated with SEE-pulsed APC (blue) after cotransfection with the 
PtdIns(3,4,5)P3-binding probe DsRed2-PH-AKT (red) and WT GFP-SNX27 (A) or the RRK/E mutant 
(B).  At initial contact, WT GFP-SNX27 overlapped clearly with the PtdIns(3,4,5)P3 probe, but not at 
later times, as PtdIns(3,4,5)P3 redistributed to peripheral IS areas.  In contrast, the RRK/E mutant 
SNX27 showed little colocalization with the PtdIns(3,4,5)P3 probe at any stage during synapse 
formation.  Arrows indicate IS location; initial contact is shown in insets; bar: 3 µm. 
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Fig R5.  SNX27 accumulates at discrete PtdIns3P-enriched sites during T cell-APC contact 
Jurkat T cells were cotransfected with the PtdIns3P-binding probe Cherry-FYVE (red) and GFP-SNX27 
or the GFP-SNX27 RRK/E mutant (both green).  (A) In resting T cells, both of the GFP-SNX27 proteins 
showed marked colocalization with PtdIns3P-postive intracellular compartments.  (B) After stimulation 
with SEE-pulsed APC (blue), intracellular PtdIns3P-postive vesicles localized to the contact area 
outside the limits of the GFP-SNX27 and GFP-SNX27 RRK/E pools at the IS. Insets show areas with 
GFP/Cherry colocalization;  bar: 3 µm. 
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1.2. PDZ domain contribution to SNX27 localization at the IS 
SNX27 accumulation at the T cell-APC contact area is impaired by deletion of the SNX27 
PDZ domain 270, which simultaneously binds to PDZ-bm-containing cargoes and to the retromer 
component VPS26 111, 308.  Mutation of L67-74A or H114A residues in SNX27 abolishes its 
interaction with VPS26 or with PDZ ligands, respectively 111 (Fig R6A).  We carried out 
co-immunoprecipitation analyses of the GFP-SNX27 WT and PDZ mutant proteins expressed in 
Jurkat T cells.  We used as a control the SNX27 PDZ-interacting protein DGK! 270, 271 and 
observed that the histidine residue at position 114 of SNX27 is essential for DGK! interaction, 
whereas impaired VPS26 interaction (L67-74A mutant) reduces DGK! recognition (Fig R6B). 
These experiments showed that VPS26 association cooperates in SNX27 binding to DGK!, as 
demonstrated for other PDZ cargoes such as GLUT1, and Kir3.3 111.  
To examine the contribution of these two PDZ subdomains to SNX27 localization at the IS, 
Jurkat cells were transfected with the GFP-SNX27 constructs and incubated with SEE-loaded 
APC to allow IS formation.  Confocal microscopy analysis showed that the WT GFP-SNX27 
Fig R6.  Cargo binding through the SNX27 PDZ domain promotes its accumulation 
at the immune synapse 
(A) SNX27 structure, with details of amino acids involved in PDZ domain interactions.  (B-D) Jurkat T 
cells were transfected with the indicated GFP-tagged constructs.  (B) GFP                      
immunoprecipitates from whole-cell lysates were analyzed by western blot.  DGK! was used as a 
control for PDZ-bm-mediated interactions.  (C, D) GFP-SNX27 (green)-transfected Jurkat T cells were 
stimulated with SEE-pulsed Raji B cells (blue) (15 min) and fixed with cold methanol. 
(C) Representative confocal images; bar: 10 µm.  (D) Quantitative analysis of WT and mutant GFP-
SNX27 accumulation at the IS.  Each dot represents the synapse/cytosol mean fluorescence intensity 
(MFI) ratio of the proteins after APC encounter.  Data shown as mean ± SEM; ***p <0.001; one-way 
ANOVA/Bonferroni post test; n ≥19.  A representative experiment is shown. 
SNX27 dynamics and function at the immune synapse  
79 
protein polarized to the IS and accumulated at the T cell-APC area.  In contrast, IS localization 
of the GFP-SNX27 PDZ mutant proteins was impaired (Fig R6C, D).  These results showed that 
a reduced recognition of PDZ ligands by SNX27, directly due to mutation of the PDZ-bm-
interacting residues (GFP-SNX27 H114A), or indirectly due to mutation of VPS26-binding 
residues (GFP-SNX27 L67-74A), prevents SNX27 accumulation at the IS. 
To determine PDZ ligand binding contribution to SNX27 localization at the IS and at the early 
endosomes we immunostained the transfected cells using PKC' as an IS marker, and EEA1 as 
an endosomal marker, and analyzed their colocalization with the GFP-SNX27 H114A mutant 
and the WT proteins.  Both proteins colocalized similarly with EEA1-positive vesicles 
(Fig R7C, D), but only the WT protein accumulated at the PKC'-positive IS area (Fig R7A,B).  
This confirmed that impaired cargo interaction mainly affects SNX27 localization to the T cell-
APC contact area.  To track the simultaneous dynamics of polarization, we cotransfected 
Cherry-SNX27 WT and GFP-SNX27 H114A.  The proteins colocalized in polarized vesicles, 
although H114A SNX27 did not accumulate at the cell-cell contact area (Fig R7E, F and Video 
2).  Our results demonstrate the type of interactions necessary for SNX27 localization at the T 
cell-APC contact area, and support previous data suggesting that PDZ binding to an as yet 
uncharacterized protein(s) is the main driver of SNX27 accumulation at the IS 270. 
1.3. Analysis of the SNX27 interactome during IS formation 
SNX27 accumulation at the T cell-APC contact area is lost in the absence of PDZ ligand 
interaction.  To establish the proteins associated with SNX27 during IS formation, we examined 
the SNX27 interactome and compared it with that of the H114A SNX27 mutant, which has 
impaired PDZ ligand binding. Conjugates of transfected Jurkat T cells and SEE-loaded APC 
were lysed, GFP-tagged proteins were immunoprecipitated, and associated proteins analyzed 
by MS (Fig R8).  Immunoprecipitates from empty GFP vector-transfected cells were used as 
controls.  A total of 186 proteins were specific to the SNX27 immunoprecipitates, with proteins 
that interacted only with WT SNX27 (30 proteins, Supplemental Table S3; see links to all 
supplemental tables in Appendix 3), the mutant form (31, Supplemental Table S4), or both (125, 
Supplemental Table S5). 
1.3.1. PDZ-independent SNX27 interactions during IS formation  
We first explored the PDZ-independent interactome (Supplemental Table S5), shared by WT 
and H114A GFP-SNX27, to determine the biological role of the identified proteins.  Analysis of 
the Gene Ontology (GO) “Biological Process” terms showed an enrichment in proteins involved 
in endosomal transport, but also in endocytosis-mediated downregulation of receptor signaling.   
The large representation of protein binders involved in metabolic process and translation 
suggests the complexity of SNX27 functions (Fig R9A, see data in Supplemental Table S6).  
The proteins linked to endosomal transport included all the main retromer and WASH complex 
members as well as some associated regulatory proteins (Fig 9B, Table R1).  Noteworthy, we 
also identified USP7, a deubiquitinating enzyme recently reported to control ubiquitin-dependent  
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Fig R7.  H114A mutation in SNX27 prevents accumulation at the immune synapse 
(A, C) Representative confocal images of GFP-SNX27 (green)-transfected Jurkat T cells stimulated 
with SEE-loaded Raji cells (blue; white asterisk), then immunostained (red) (A) for the PKC' IS marker 
or (C) for EEA1 to label the endosomal compartment; bar: 10 µm.  The WT, but not the PDZ mutant 
GFP-SNX27, localized to the PKC' positive area at the T cell-APC contact region.   (B, D) Quantitative 
analysis of WT and mutant GFP-SNX27 colocalization with (B) PKC' or (D) EEA1.  Mandersʼ overlap 
coefficient values are represented as dot plots, with each dot representing an individual cell.  Data 
shown as mean ± SEM. (ns, not significant, p>0.05; ***p <0.001; t-test; n ≥ 20; a representative 
experiment is shown).  (E, F) The relative dynamics of SNX27 recruitment to the IS was assessed 
directly by comparing Cherry-SNX27 (red) with GFP-SNX27 H114A (green) cotransfected in Jurkat T 
cells.  SEE-loaded Raji cells (blue) were added and cells imaged every 15 s by time-lapse microscopy 
(E; see complete video in Video 2). (F) A composite kymograph of SNX27 construct dynamics were 
acquired for the dashed area in (E).  Bars: 3 µm. 
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WASH activation 135.  The presence of USP7 in GFP-SNX27 immunoprecipitates suggests its 
interaction with the SNX27/WASH/retromer multimeric protein complex, and that this ubiquitin-
mediated WASH regulatory mechanism operates during IS formation. 
 
 
 
 
 
 
 
 
 
  
Protein name Interactors References 
Retromer complex   
VPS35 VPS29, VPS26, FAM21, TBC1D5, FKBP15 61, 123, 136, 145, 264, 363 
VPS29 VPS35 61, 145, 264, 363 
VPS26 VPS35, SNX27 111, 123, 145, 264, 308, 363 
WASH complex   
WASH1 FAM21, Strumpellin, SWIP, CCDC53 77, 124, 161 
FAM21 VPS35, VPS29, FKBP15, SNX27, RME-8, 
WASH 
77, 110, 124, 137, 141, 160, 185, 
308 
Strumpellin/KIAA0196 SWIP, FAM21, WASH 77, 161 
SWIP/KIAA1033 Strumpellin, WASH 77, 161 
CCDC53 WASH 77, 161 
Associated proteins   
RME-8/DNAJC13 FAM21 110 
TBC1D5 VPS35/29/26 136, 260, 287 
FKBP15/FKBP133/WAFL FAM21, VPS35/29/26 136, 137 
Table R1. PDZ-independent SNX27 interactome during IS formation 
Fig R8. Proteomic analysis of SNX27 interactome during IS formation   
Overview of the workflow used.  Jurkat T cells were transfected with the indicated GFP-tagged 
constructs.  After 24 h, cells were mixed at a 1:1 ratio with SEE-loaded Raji cells and incubated 
(15 min).  Cells were lysed and GFP immunoprecipitates were analyzed by 1D-gel-MS for protein 
identification and by western blot for validation. 
   RESULTS 
82 
 
Fig R9.  Analysis of PDZ-
independent SNX27 interactome  
 (A) Gene Ontology enrichment 
analysis using the Cytoscape plug-in 
ClueGO for biological process of the 
PDZ-independent SNX27 
interactome.  Proteins associated 
with clusters with   p <0.05 (number 
of genes mapped and P values, 
lower right).  Heavy lines indicate 
associations based on experimental 
evidence. (B) Network analysis of 
PDZ-independent SNX27 
interactome components using the 
STRING database.  Heavy lines 
indicate stronger evidence of 
association. 
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Western blot analysis of the GFP-SNX27 immunoprecipitates used for protein identification 
confirmed that WASH associates to SNX27 independently of PDZ domain integrity (Fig R10A).  
Immunofluorescence analysis of endogenous proteins during IS formation showed partial 
WASH colocalization with SNX27 at the IS (Fig R10B, C).  The primary role of WASH is to 
promote the generation of the branched actin networks necessary for endosomal and lysosomal 
integrity 76, 77, 124, 249.  Although originally considered responsible exclusively for protein 
degradation, lysosomes are dynamic organelles with secretory function in specialized cell types 
including T lymphocytes 29.  IS formation leads to rapid polarization of the Golgi and the ERC, 
and delivery of secretory lysosomes to the point of target recognition 312.  Cotransfection 
experiments with a plasmid that encodes the secretory lysosome marker GFP-CD63 confirmed 
its rapid polarization and partial localization with SNX27 (Fig R10D and Video 3).  These 
experiments show that whereas SNX27 is located exclusively in the ERC in non-activated T 
lymphocytes 271, it also localizes to the polarized secretory compartment after antigen 
recognition. 
Fig R10. Val idat ion of SNX27/WASH interact ion dur ing IS formation 
(A) GFP immunoprecipitates used for protein identification were validated in western blot. (B) 
Representative confocal images of Jurkat T cells stimulated with SEE-loaded Raji cells (blue; white 
asterisk) and immunostained for WASH (green) and for SNX27 (red).  (C) En-face (xy-z) 
reconstruction of the dashed rectangle in (B) shows protein localization at the T cell-APC contact 
region.  (D) Time-lapse microscopy was used to assess the relative dynamics of IS recruitment of 
Cherry-SNX27 (red) and GFP-CD63 (green) cotransfected in Jurkat cells.  SEE-loaded Raji cells (blue; 
white asterisk) were added and cells imaged every 15 s (see complete video in Video 3).  Pseudo-
color scale of fluorescence intensity (B, D, bottom). 
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1.3.2.  SNX27 role in WASH-mediated transport in T cells 
Proteomic data confirmed SNX27 interaction with WASH in Jurkat cells during antigen 
recognition.  Our analysis however does not detect WASH-regulated transmembrane proteins in 
T cells that include the TCR, CD28, GLUT1 and the integrin LFA-1 (lymphocyte function-
associated antigen 1) 256.  We nevertheless identified the TfR (Supplemental Table S5), which 
requires WASH for efficient recycling in HeLa cells 77.  We thus explored the effects of SNX27 
silencing on the turnover of WASH-regulated transmembrane proteins.  Western blot analysis in 
SNX27-silenced cells showed decreased TfR levels and altered GLUT1 expression, with an 
increase in a slower-migrating band.  Inhibition of protein synthesis by cycloheximide (CHX) 
treatment had no obvious effect on total protein levels in control cells, but induced loss of 
GLUT1 in SNX27-silenced cells (Fig R11A), which indicated that SNX27 promotes GLUT1 
recycling.  TfR abundance remained constant in these cells after CHX treatment (Fig R11A), 
suggesting that SNX27 regulates TfR levels, but not its recycling. 
To measure protein recycling to the PM, we 
compared the effect of CHX treatment on surface 
expression of TfR (CD71), TCR CD3 epsilon chain 
(CD3*) and LFA-1 subunit CD11a in control and 
SNX27-silenced Jurkat T cells.  Flow cytometry 
analysis showed reduced TfR levels after SNX27 
silencing, with no significant differences between 
Fig R11. Effect of SNX27 silencing on protein trafficking 
shControl and shSNX27 Jurkat T cells were treated with 10 µg/ml cycloheximide (CHX) for the times 
indicated (A) or 4 h (B).  Total or cell surface levels of the indicated proteins were measured by 
Western blot (A) or by flow cytometry (B), respectively. Geometric mean fluorescence intensity (GMFI) 
was normalized to untreated shControl cells.  Data shown as mean ± SEM (**p <0.01, ***p <0.001; 
two-way ANOVA/Bonferroni post test) from at least three independent experiments. Graphs are shown 
for a representative  experiment. 
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control and SNX27-silenced cells after CHX treatment (Fig R11B, left).  Cell surface abundance 
of CD3* was higher as a result of SNX27 silencing, with no further effect after CHX addition 
(Fig R11B, center); CD11a levels were unaffected by SNX27 silencing in basal conditions, but 
were significantly reduced by CHX treatment (Fig R11B, right).  These studies indicate that 
SNX27 silencing in T cells decreases TfR abundance and alters GLUT1 and LFA-1 recycling, 
but not that of CD3*, partially mimicking WASH loss. 
1.3.3. Identification of SNX27 PDZ cargoes during IS formation 
The SNX27 PDZ-independent interactome led us to investigate SNX27 role as an adaptor for 
WASH-mediated trafficking in T cells.  The defect of the GFP-SNX27 H114A mutant to 
accumulate at the IS nonetheless suggested important functions of SNX27 PDZ-bm-containing 
cargoes at the IS.  Proteomic results were thus analyzed to identify putative cargoes; the 
proteins present only in the GFP-SNX27 WT immunoprecipitates and not those of the H114A 
mutant form were considered (Supplemental Table S3), and their C-terminal amino acid 
sequences examined to identify a characteristic type I PDZ-bm (Table R2).  We mostly detected 
cytosolic proteins and only two multipass membrane-associated proteins, the phosphate export 
mediator XPR1 (xenotropic and polytropic murine leukemia virus receptor) 121 and Kidins220 
(kinase D-interacting substrate), which is a receptor scaffolding protein that promotes ERK 
signaling in neurons 10, and in T and B lymphocytes 78, 100.  Although XPR1 does not bear a 
canonical type I PDZ-bm, cell surface levels of both proteins decrease after SNX27 silencing in 
HeLa cells 308. 
The PDZ-dependent SNX27 interactome also showed proteins linked to the regulation of 
Entry name Protein C-terminal 
ACOT8 Acyl-coenzyme A thioesterase 8 QVSESKL 
ARHG7 Rho guanine nucleotide exchange factor 7 ($-PIX) AWDETNL 
GIT1 ARF GTPase-activating protein GIT1 ITTREKK 
GIT2 ARF GTPase-activating protein GIT2 TTKENNN 
ARHG6 Rho guanine nucleotide exchange factor 6 (#-PIX ) SKTSILP 
CENPJ Centromere protein J VLMDTEL 
CTRO Citron Rho-interacting kinase (CRIK) VWDQSSV 
DGKz Diacylglycerol kinase zeta (DGK!) EDQETAV 
KDIS Kinase D-interacting substrate of 220 kDa (KIDINS220) EERESIL 
OTUL Ubiquitin thioesterase OTULIN VCEETSL 
SHKB1 SH3KBP1-binding protein 1 KLNETSF 
ZO-2 Tight junction protein zonula occludens-2 RYRDTEL 
CGN Cingulin NLQTSSC 
XPR1 Xenotropic and polytropic retrovirus receptor 1 TDDEANT 
Table R2. PDZ-dependent SNX27 interactome during IS formation. Cargoes with consensus 
C-terminal PDZ-bm are indicated (bold) (for complete results, see Supplemental Table S3). 
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receptor endocytosis.  The acyl CoA thioesterase 8 (ACOT8) binds to the HIV-1 Nef protein and 
mediates Nef-induced downregulation of CD4 and MHC-1 193.  SH3KBP1 binding protein 1 
(SHKBP1) interacts with the 85 kDa Cbl-interacting protein (SH3KBP1/CIN85), a known 
regulator of receptor endocytosis 98 that was indeed identified in our SNX27 PDZ-independent 
interactome (Supplemental Table S5).  In addition to proteins related to receptor transport, we 
found the deubiquitinase OTULIN, which cleaves Met1-linked ubiquitin chains 89.  This post-
translational modification, known as linear ubiquitination, has recently acquired relevance in the 
regulation of immune responses 155, 293. 
SNX27 PDZ interactors in activated T cells also included spindle-associated proteins such 
as CENPJ/CPAP (centromere associated protein J), a tubulin-binding protein that is essential 
for centrosome biogenesis 318.  Although does not contain a canonical type 1 PDZ-bm, we also 
detected CRIK (citron Rho-interacting kinase), a cytokinesis-specific RhoA effector.  CRIK controls 
midbody formation by connecting contractile ring components and MT-associated proteins 19. 
In addition, we found validated SNX27 PDZ cargoes such as DGK! 270, 271, zona occludens-2 
(ZO-2) 366 and  the p21-activated kinase (PAK)-interactive exchange factor ARHGEF7, also 
known as $-PIX, as well as the other PIX/GIT complex members #-PIX (ARHGEF6) and GIT1/2 
(GPCR kinase-interacting proteins 1 and 2) 328.  For biochemical validation of our proteomics 
data, we used western blot analysis to test for two selected proteins, $-PIX and ZO-2; we used 
DGK! as control (Fig R12A).  To determine whether IS formation affects SNX27 interaction with 
DGK!, $-PIX or ZO-2, we tested for these proteins in GFP-SNX27 immunoprecipitates from 
Jurkat cells incubated with Raji B cells, alone or loaded with SEE.  Contact with SEE-loaded 
APC induces activation of TCR-mediated signals as detected by ERK phosphorylation, used as 
a control of stimulation.  The SNX27 interaction with DGK!, $-PIX and ZO-2 was independent of 
Fig R12.  Analysis and validation of SNX27 PDZ ligands during IS formation 
(A) Western blot analysis of immunoprecipitates confirmed PDZ-bm-dependent interaction of $-PIX and 
ZO-2 with GFP-SNX27 WT.  DGK! was used as a positive control.  (B) The interactions in (B) are not 
markedly regulated by T cell activation with SEE-pulsed APC. 
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antigen presentation, as binding was also observed after incubation with unloaded APC 
(Fig R12B). 
Whereas DGK! and $-PIX are known to localize to the T cell IS 120, 254 some of the 
additionally identified proteins could also contribute to the PDZ-dependent accumulation of 
SNX27 at the IS.  ZO-2 is a member of the membrane-associated guanylate kinase (MAGUK) 
family of proteins that regulate assembly of tight junctions in epithelial cells 96.  The lack of 
studies on ZO-2 expression in T lymphocytes, and the presence of its binding partner 
Cingulin 62 in SNX27 immunoprecipitates prompted us to investigate the possibility of functional 
localization of ZO-2 at the IS. 
1.3.4. Characterization of the ZO-2/SNX27 interaction during IS formation 
During IS formation molecules reorganize in supramolecular activation clusters (SMAC) 227.  At 
the central SMAC (cSMAC), TCR molecules accumulate and deliver signals following antigen 
recognition.  Adhesion molecules 
distribute at the peripheral SMAC 
(pSMAC), and promote cell-cell 
adhesion that “seals” the contact 
area and allows polarized 
exchange of information between 
the contacting cells 84.  Using PKC' 
as a cSMAC marker, we examined 
the location of endogenous ZO-2 in 
Jurkat T cells incubated with SEE-
pulsed APC.   ZO-2 was found at 
the cell-cell contact area, bordering 
the PKC' pool (Fig R13A).  
En-face reconstruction confirmed 
the peripheral localization of ZO-2 
relative to PKC' (Fig R13B).  
Comparison of ZO-2 localization 
with that of the pSMAC marker 
talin showed that these proteins 
colocalized at the margin of the 
contact area (Fig R13C).  
Reconstruction confirmed 
peripheral ZO-2 distribution, 
although colocalization with talin-
enriched areas was incomplete 
(Fig R13D). 
Fig R13.  The tight junction protein ZO-2 polarizes 
to the IS of Jurkat T cells 
(A-D) Representative confocal images of Jurkat cells 
stimulated with SEE-loaded Raji cells (blue; white asterisk), 
then immunostained for ZO-2 (green), and (A, B) for the PKC' 
IS marker (red) or (C, D) for talin (red) to label the peripheral 
IS.  En-face (xy-z) reconstructions of dashed rectangles in (A) 
and (C) are shown in (B) and (D), respectively. Pseudo-color 
scale of fluorescence intensity (A, C, bottom). Representative 
confocal images are shown; bar: 10 µm 
A B 
D C 
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To visualize ZO-2 dynamic distribution early in synapse formation, we transfected Jurkat T 
cells with a plasmid that encodes GFP-ZO-2, and incubated them with SEE-loaded APC.  
GFP-ZO-2 accumulated rapidly at the contact area, then redistributed to the pIS, as does the 
endogenous protein (Fig  R14A and Video  4).  The GFP-ZO-2 fluorescence intensity ratio at the 
T cell-APC contact site vs PM outside correlation the contact area showed increased ZO-2 
accumulation following antigen recognition (Fig R14B).  We used fluorescence recovery after 
photobleaching (FRAP) to confirm stable ZO-2 localization at the IS and measure its mobility.  
We calculated GFP-ZO-2 halftime of fluorescence recovery after photobleaching at the 
membrane, with a mean value of 3.13 s in unstimulated Jurkat cells, which increased to 6.77 s 
at the IS in conjugates with SEE-loaded APC (Fig R14C).  GFP-ZO-2 mobility thus lessens 
when the IS forms, demonstrating its stable accumulation at the IS. 
ZO proteins regulate actin distribution at cell junctions 94.  As IS formation results in rapid 
actin rearrangement, we examined the correlation between GFP-ZO-2 localization and actin 
polymerization.  The relative F-actin dynamics were tracked by transfection with a construct that 
encodes a fluorescently labeled Life-act peptide (RFP-LifeAct).  In the absence of antigen 
stimulation, Jurkat cells continuously scan APC without forming stable synapses.  GFP-ZO-2 
accumulated at membrane ruffles, which are also sites of actin rearrangement (Fig R14D, top).  
When stable IS formed, GFP-ZO-2 redistributed to and outside those areas in the pIS with 
intense actin assembly (Fig R14D, bottom).  Analysis of GFP-ZO-2 colocalization with drebrin, 
an F-actin-binding protein that regulates actin polymerization at the IS 253, further confirmed 
ZO-2 localization at actin cytoskeleton rearrangement sites (Fig R14E).  En-face reconstruction 
showed a similar organization pattern for these proteins, although GFP-ZO-2 localized in part at 
sites closer to the margin of the T cell-APC contact area (Fig R14F). 
Videomicroscopy analysis of live T cells showed that GFP-ZO-2 localization at the IS 
changed rapidly when T cells contacted a new APC (Video 5).  This dynamic relocalization of 
ZO-2 to new T cell-APC contact areas suggested rapid ZO-2 traffic from and to the synapse as 
a result of TCR triggering.  We cotransfected Jurkat cells with GFP-ZO-2 and Cherry-SNX27 to 
examine their dynamic distribution during IS formation.  Resting cells showed partial ZO-2 
localization to SNX27-positive endosomes (Fig R15A, top).  After IS formation, most SNX27 was 
found at the ERC, whereas GFP-ZO-2 redistributed to the edges of the IS (Fig R15A, bottom).  
Videomicroscopy analysis in real time allowed better visualization of SNX27 and ZO-2 dynamic 
distribution during IS formation (Fig R15B and Video !6).  ZO-1 and ZO-2 share the same 
domains, although ZO-1 lacks a PDZ-bm 222.  Similar studies in Jurkat T cells using GFP-ZO-1 
showed analogous distribution at the IS, with no consistent colocalization with Cherry-SNX27 in 
any condition (Fig R15C and Video 7).  These data confirmed SNX27/ZO-2 interaction at the 
ERC, and suggest that ZO protein localization to the synapse is not PDZ-bm-dependent.  To 
determine whether SNX27 affects ZO-2 accumulation and/or mobility at the IS, we used 
videomicroscopy and FRAP experiments.  The fluorescence intensity ratio at the T cell-APC 
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contact site vs. non-IS membrane showed increased ZO-2 accumulation at the IS in SNX27-
silenced cells (Fig R15D), in which photobleaching experiments demonstrated reduced 
GFP-ZO-2 mobility at the IS (Fig R15E).  These studies suggest that SNX27 interaction 
facilitates ZO-2 traffic from the PM, as reported in tight junctions between epithelial cells 366. 
Fig R14.  GFP-ZO-2 dynamic distribut ion during immune synapse formation 
Dynamics of IS recruitment of GFP-ZO-2 alone (A, green; see Video 4) or relative to actin 
polymerization marked by RFP-LifeAct (D, red; see Video 5) were assessed by videomicroscopy. 
Transfected Jurkat cells were imaged every 15 s after the addition of unloaded (top) or SEE-loaded 
(bottom) Raji cells (blue; white asterisk).  (B) Quantitative analysis of GFP-ZO-2 accumulation at the T 
cell-APC contact area.  Each dot represents the ZO 2 synapse/cytosol MFI ratio after APC encounter. 
Data shown as mean ± SEM (***p <0.001; unpaired t-test; n ≥20); a representative experiment is 
shown. (C) FRAP (fluorescence recovery after photobleaching) curves of GFP-ZO-2 normalized 
fluorescence intensity over a 60-s period after photobleaching.  Transfected Jurkat cells were in basal 
conditions (black line) or stimulated with SEE-loaded APC (grey line). Curves were fitted by one-phase 
association exponential equations (see Methods). Data shown as mean ± SEM; ***p <0.001; two-way 
ANOVA; n ≥19. (E-F) GFP-ZO-2 (green)-transfected Jurkat T cells stimulated with SEE-loaded Raji 
cells (blue; white asterisk) were immunostained for the F-actin-binding protein drebrin (red).  (F) En-
face (y-z) reconstruction of dashed rectangle in (E). (A, D) Representative confocal images are shown; 
bar: 10 µm; pseudo-color scale of fluorescence intensity.   
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All together, our results suggest the participation of SNX27 in the regulation of the 
intracellular transport of cytoskeleton-associated proteins involved in cell-cell contacts 
formation.  Defective traffic of some of these proteins such as LFA-1 results in decreased ability 
to form T cell-APC conjugates 246.  SNX27-silenced Jurkat cells showed no major synapse 
Fig R15.  SNX27 colocalizes with GFP-ZO-2 and affects its mobility at the 
T cell-APC contact area 
(A-C) Jurkat T cells were transfected with the indicated constructs and stimulated with SEE-loaded Raji 
cells (blue, asterisk).  Videomicroscopy was used for direct assessment of the dynamics of GFP-ZO-2 
(A, B) or GFP-ZO-1 (C) (green) localization relative to Cherry-SNX27 (red) polarization to the IS.  Cells 
were imaged every 15 s.  Representative confocal images are shown in (A, C); bar: 10 µm (complete 
videos for A, B) in Video 6 and for (C) in Video 7).  (D, E) shControl or shSNX27 Jurkat T cells 
expressing GFP-ZO-2 were stimulated with SEE-loaded APC.  (D) Quantitative analysis of GFP-ZO-2 
accumulation at the T cell-APC contact area.  Each dot represents the ZO-2 synapse/cytosol MFI ratio 
after APC encounter.  Data shown as mean ± SEM; *p <0.05; unpaired t-test; n ≥20; a representative 
experiment is shown.  (E) FRAP curves of GFP-ZO-2 normalized fluorescence intensity over a 60-s 
period after photobleaching. shControl (black line) or shSNX27 (grey line) curves were fitted by one-
phase association exponential equations (see Methods).  Data shown as mean ± SEM; ***p <0.001; 
two-way ANOVA; n ≥19. Pseudo-color scale of fluorescence intensity (A, C, bottom). 
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formation defect, indicated by PKC' localization to the IS (Fig R16A) and the similar number of 
conjugates formed after incubation with SEE-loaded APC (Fig R16B, right) compared to 
controls.  SNX27-silenced cells nonetheless showed increased antigen-independent conjugate 
formation (Fig R16B, left), suggesting a regulatory mechanism of adhesion mediated by SNX27 
independently of TCR signaling. 
 
 
 
Fig R16.  Effect of SNX27 silencing on conjugate formation capacity in Jurkat cells 
(A) shControl and shSNX27 Jurkat T cells were stimulated with SEE-pulsed APC (blue; white asterisk; 
15 min) and immunostained for the PKC' marker for immune synapse formation (red). Representative 
confocal images are shown; bar: 10 µm.  (B) T cell-APC conjugate formation was calculated using flow 
cytometry (see Experimental Procedures) after T cell stimulation with unpulsed (left) or SEE-pulsed 
(right) APC for the indicated times.  Data shown as mean ± SEM (*p<0.05, **p<0.01; two-way 
ANOVA/Bonferroni post test; n=4). 
   RESULTS 
92 
2. SNX27 REGULATION OF LIPID SIGNALING 
The study of SNX27 dynamics and its interactome at the IS suggested broad functions for 
SNX27 in T cell intracellular protein trafficking, with various PDZ cargoes identified as 
cytoskeletal-associated proteins and endocytosis regulators.  We also detected SNX27 binding 
to the lipid signaling modulator DGK!, which limits activation of the DAG/Ras/ERK pathway after 
T cell antigen recognition 120.  Our group reported that SNX27 silencing leads to enhanced ERK 
activation after stimulation with antigen-loaded APC 270, which suggested that DGK! and SNX27 
act in the same pathway.  These data concur with the increasing evidence for the participation 
of intracellular trafficking pathways in the spatiotemporal control of signaling cascades 
(reviewed in 24, 64, 247).  We decided to examine the possible regulatory mechanisms of 
DGK!/SNX27 interaction, and to further study of the role of this interaction in the control of 
DGK! functions. 
2.1. Analysis of the SNX27/DGK! PDZ-dependent interaction 
The canonical mechanism of PDZ domain interaction involves recognition of cargo proteins 
through their C-terminal PDZ-bm.  Type 1 motifs have the sequence [Ser/Thr]-x-( (( = any 
hydrophobic residue), such as that of DGK! (T-A-V).  Whereas the C-terminal triplet is essential 
for binding, specificity is often enhanced by upstream sequences 132, 354.  Dr. Brett Collinsʼs 
group (Institute for Molecular Bioscience, University of Queensland, Australia) defined the 
sequence requirements for PDZ-bm binding to SNX27, and showed that there are high- and 
low-affinity ligands based on the positions of negatively charged acidic side chains upstream of 
the C-terminal PDZ-bm.  High-affinity cargoes require acidic residues located at -3 and -5 
positions that are able to clamp a conserved arginine (Arg58) on the SNX27 surface.  Some 
low-affinity cargoes bear amino acids susceptible to phosphorylation that could mimic the acidic 
side chains necessary for SNX27 high-affinity binding, thus constituting a post-translational 
regulatory mechanism for PDZ binding (60 see Appendix 4.4).  These data indicated that DGK! 
C-terminus, with the E-D-Q-E-T-A-V sequence, is a high-affinity ligand of SNX27. 
To confirm the importance of the electrostatic clamp in DGK!, we collaborated with Collins to 
test the ability of DGK! PDZ-bm mutants (Fig R17A) to co-immunoprecipitate SNX27 in Jurkat T 
cells.  While WT GFP-DGK! precipitated SNX27, constructs modified in their DGK! PDZ triplet 
did not ()ETAV, T927A) (Fig R17B).  Mutation of the -3 side chain (E926A) or -3 and -5 side 
chains (D924A/E926A) abolished the interaction with SNX27, whereas alteration of the -5 side 
chain only (D924A) reduced but did not abolish binding, which indicated that the -5 acidic side 
chain has an important but auxiliary role to the essential -3 residue. 
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DGK! acidic residues at positions -3, -5 and -6 are not subject to the post-translational 
regulatory mechanism.  Phosphorylation at the -2 residue is nonetheless another regulatory 
mechanism for PDZ interactions (114, 362, reviewed in 169, 184).  We thus tested SNX27 binding to 
the GFP-DGK! protein with a phosphomimetic mutation at the -2 position (T927D) (Fig R17B).  
The interaction was barely detected, which confirmed that Thr-2 phosphorylation provides a 
regulatory switch that prevents SNX27 binding to cargo, presumably by causing a steric clash 
with the SNX27 His114 side chain.  To explore the biological relevance of this negative 
regulatory mechanism, we retrieved experimental data from several web-based bioinformatics 
resources such as Phosphosite 146.  While phosphoproteomic studies found DGK! 
phosphorylated in many residues after various stimuli, there are thus far no reports of PDZ-bm 
Thr-2 phosphorylation (Phosphosite, Acc. nº Q13574).  These data are in agreement with our 
immunoprecipitation studies showing a constitutive DGK!/SNX27 association after T cell 
encounter with loaded or unloaded APC (Fig R12B).  
2.2. SNX27 contribution to DGK! stability 
Our data indicated that DGK! is a high-affinity constitutive cargo of SNX27.  The best-known 
function of SNX27 interaction with its cargoes is to facilitate their retrieval from the lysosomal 
Fig R17.  Analysis of the SNX27/DGK! PDZ-dependent interaction 
(A) DGK! structure including MARCKS (myristoylated alanine-rich C-kinase substrate) and ankyrin 
(Ank) repeat sequences.  Amino acids of the DGK! PDZ-binding motif (PDZ-bm) and the mutants 
generated are detailed (right); possible phosphorylation sites (pink) and positively charged amino acids 
(blue) are colored.  (B) GFP-DGK! WT and PDZ-bm mutant constructs expressed in Jurkat T cells 
were analyzed for binding to SNX27 by GFP immunoprecipitation and western blot with the indicated 
antibodies.  A representative experiment is shown (n = 3). 
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degradation pathway 308.  We thus examined DGK! stability in SNX27-silenced Jurkat cells; as a 
control, we monitored the abundance of the transmembrane proteins GLUT1 and Kidins220, 
both known SNX27 PDZ cargoes 308.  As previously shown for GLUT1 (Fig R11A), SNX27 
silencing in these cells resulted in high levels of both transmembrane cargoes, and protein 
synthesis inhibition by CHX treatment acutely decreased protein abundance, which was partially 
rescued after proteasome inhibitor (MG-132) treatment (Fig R18A).  These results suggested 
that in Jurkat cells, protein recycling defects elicit a compensatory feedback mechanism to 
promote protein synthesis.  In contrast, DGK! did not behave as a classical SNX27 PDZ cargo.  
SNX27-silenced Jurkat cells showed approximately a 20% reduction in DGK! levels in untreated 
cells (Fig R18B), and protein synthesis inhibition alone or combined with proteasome inhibition 
resulted in modest variations in DGK! protein abundance.  These data suggested that an 
indirect mechanism decreases DGK! stability in the absence of SNX27. 
In neurons, proteolytic degradation downregulates DGK! levels in excitotoxic conditions, 
when DGK! translocates from the nucleus to cytosol 244.  Subcellular DGK! localization is 
controlled by a nuclear localization signal (NLS) that overlaps the myristoylated alanine-rich 
C-kinase substrate (MARCKS) domain (see DGK! structure in Fig R17A) 35; serines within the 
NLS can be phosphorylated by PKC# 204, 323.  To determine whether PKC-mediated 
phosphorylation regulates the decrease in DGK! abundance observed after SNX27 silencing, 
we treated Jurkat T cells with the classic PKC-selective inhibitor Gö6976 (Gö).  We monitored 
DGK! protein abundance by western blot, and used an antibody that recognizes 
phosphorylation of PKC substrates to confirm PKC inhibition.  While DGK! levels remained 
Fig  R18.   SNX27 s i lenc ing t r iggers  PKC act iva t ion  and subsequent  DGK !  
degrada tion in basal condit ions  
(A-D) shControl and shSNX27 Jurkat T cells were treated with the indicated inhibitors (10 µg/ml 
cycloheximide (CHX); 5µM MG-132; 100nM Gö) for 6 h.  Total or cell surface levels of the indicated 
proteins were measured by western blot. Blots are shown from a representative experiment. 
(B) Quantification of DGK! (top) long (L) and (bottom) short (S) splicing isoforms levels 72-96 h after 
shRNA transfection. Data shown as mean ± SEM from at least three independent experiments. Graphs 
are shown for a representative  experiment. 
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constant in shRNA control cells following Gö treatment, they were rescued in SNX27-silenced 
cells (Fig R18C).  Accordingly, we observed that in untreated cells the phospho-PKC substrate 
antibody signal was higher in SNX27-silenced cells than in controls (Fig R18D).  These data 
indicated that PKC-mediated regulation of DGK! protein levels also occurs in T cells, and that 
SNX27 silencing triggers PKC activation and subsequent DGK! degradation in basal conditions. 
2.3. Analysis of DAG signaling in SNX27-silenced activated T cells 
DGK!-MARCKS phosphorylation by PKC# not only regulates DGK! localization and stability, but 
also its activity 203, 204, 323, and DGK! limits PKC# activity by attenuating local DAG accumulation.  
This is a mutual regulatory mechanism in which DGK! phosphorylation following PKC activation 
leads to disruption of PKC/DGK! association 203.  The spatial organization of this signaling 
complex allows to precisely modulate local DAG signaling.  Our results suggested that SNX27 
contributes to sustain this complex, as silencing SNX27 in Jurkat T cells increases PKC activity 
in basal conditions.  Our laboratory previously showed that SNX27 silencing mimicked that of 
DGK!, and resulted in enhanced ERK activation after T cell triggering by antigen-loaded 
APC 270, which suggested that SNX27 also controls DGK!-dependent negative regulation of the 
PKC/Ras/ERK pathway after stimulation. 
DAG generation downstream of TCR triggering promotes Ras/ERK activation and AP-1 
transcription! 86.  The activation of this pathway can be monitored by measuring surface 
abundance of CD69, a C-type lectin that is transcriptionally upregulated shortly after TCR 
stimulation 280.  To test whether SNX27 silencing leads to enhanced, functional Ras/ERK 
activation, we measured CD69 surface abundance after incubation of Jurkat T cells with agonist 
antibodies.  We used soluble anti-CD3 for TCR triggering alone, or in combination with soluble 
anti-CD28 for costimulation.  Whereas unstimulated Jurkat T cells expressed low CD69 levels, 
CD3 stimulation resulted in a large cell population with high surface CD69 levels (CD69hi) that 
increased following CD28 costimulation.  In SNX27-silenced cells, the number of CD69hi cells 
was significantly higher than in controls (Fig R19A,B), which concurs with findings in DGK!-
depleted cells 365.  CD3 and CD3/CD28 costimulation also led to an increase in the geometric 
mean fluorescence intensity (GMFI) of the CD69hi population, with SNX27-silenced cells 
showing a significantly higher value after T cell stimulation (Fig R19A-C).  To confirm that CD69 
upregulation in SNX27-silenced cells was caused by hyperactivation of the Ras/ERK/AP-1 
pathway, we measured the promoter activity of the AP-1-binding site in the CD69 promoter 45.  
AP-1 activity after CD3 stimulation was higher in SNX27-silenced compared to control cells, and 
CD28 markedly augmented this difference (Fig R19D), which correlated well with the effect 
observed on CD69 induction. 
In DGK!-silenced activated Jurkat T cells, the absence of the mutual DGK!/PKC# regulation 
leads to PKC#-dependent Ras hyperactivation 119.  To dissect PKC and ERK signaling input to 
CD69 transcriptional upregulation, cells were pretreated with pharmacological inhibitors before 
stimulation; we used Gö for classic PKC inhibition, and the MEK (MAPK/ERK kinase) inhibitor 
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PD98059 for ERK pathway blockade.  Gö treatment reduced AP-1 activity following anti-CD3 
stimulation in test and control cells.  SNX27-silenced cells nonetheless showed higher promoter 
activity than controls, which suggested additional gain of function effects on AP-1 regulated 
transcription.  After PD treatment, AP-1 activity levels decreased to similar extent in SNX27-
silenced cells and controls (Fig R19D), which indicated that the additional gain of AP-1 activity 
in SNX27-silenced cells was probably related to direct DAG-dependent RasGRP1/Ras 
hyperactivation.  Our results thus demonstrated that CD3 stimulation after SNX27 silencing 
results in Ras/ERK pathway hyperactivation that is partially PKC#-dependent.  AP-1 promoter 
activity in CD3/CD28-stimulated cells was also sensitive to PKC and MEK inhibition, but 
enhanced AP-1 activity was still observed in SNX27-silenced cells compared to controls, which 
implied a contribution by additional signaling pathways (Fig R19D).  
PKC' is the main PKC isoform that acts downstream of CD28 to amplify early TCR signaling 
pathways 274.  PKC' activation not only promotes ERK-dependent AP-1 transcription, but also 
activates the NF-%B-mediated transcription program (reviewed in 157).  Recent results from our 
laboratory indeed suggest a role for DGK! in the control of PKC'/PDK-1/NF-%B activation 
downstream of CD3/CD28 stimulation (Avila-Flores et al., unpublished data).  Analyses of the 
promoter activity of the NF-%B binding site in the CD69 promoter 197 showed that signaling in this 
Fig R19.  Stimulation of SNX27-silenced Jurkat cells results in Ras/ERK/AP-1 
and NF-%B pathway hyperactivation 
shRNA-transfected Jurkat T cells were stimulated (6h) with soluble anti-CD3 alone or with anti-CD28 
for costimulation.  Where indicated, cells were pretreated with Gö6976 or PD98059 for classic PKC or 
MEK inhibition, respectively. (A-C) Cells were stained for CD69 surface marker and, using flow 
cytometry, CD69hi cells were gated, and (B) the percentage and (C) geometric mean fluorescence 
intensity (GMFI) of CD69hi cells were calculated. (A) Representative flow cytometry plots with CD69hi 
gate shown. (B, C) Data shown as mean ± SEM (ns, not significant, p>0.05; *p<0.05; **p<0.01; 
***p<0.001; paired t-test; n = 4).  (D-E) Luciferase assays were performed to calculate (D) AP-1 or (E) 
NF-%B promoter activity. (D) Data shown as mean ± SEM (n = 2).  (E) Data shown as mean, a 
representative experiment is shown (n = 3).  RLU, relative luciferase units (see Methods). 
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pathway is also augmented in SNX27-silenced cells, and that PKC# activity contributes only 
partially to NF-%B promoter activity (Fig R19E).  Further studies are required to determine 
whether PKC' hyperactivation promotes NF-%B activity after SNX27 silencing. 
2.4. Analysis of TCR signaling in SNX27-silenced T cells 
Our results demonstrated that stimulation of SNX27-silenced Jurkat T cells results in 
Ras/ERK/AP-1 and NF-%B pathway hyperactivation and suggest that enhanced activation of 
DAG-regulated signals mediates this effect.  We performed a detailed biochemical analysis to 
examine the activation of well-characterized signaling molecules that participate in the 
transmission of TCR activation signals and could contribute to an enhanced T cell response. 
PKC activation was monitored using an anti-phospho-PKC substrates antibody; SNX27-
silenced cells showed increased phosphorylation of PKC substrates compared to controls 
(Fig R20A).  PKC activation promotes phosphorylation and degradation of the NF-%B inhibitor 
I%B, which releases NF-%B into the nucleus, where it activates its target genes 213.  In 
accordance with the enhanced NF-%B promoter activity, SNX27 silencing led to increased I%B 
degradation compared to controls (Fig R20B).  We also analyzed PKD activation, which is a 
dual, direct and PKC-mediated DAG effector that is phosphorylated on its PKC-regulated 
residue (Ser744/748) in response to TCR stimulation (reviewed in 214).  CD3/CD28 stimulation 
triggered transitory PKD phosphorylation, which was enhanced and sustained in SNX27-
silenced cells (Fig R20B).  These data thus supported the hypothesis that PKC-mediated 
functions downstream of CD28 costimulation are enhanced after SNX27 silencing. 
SNX27-silenced cells showed increased Ras/ERK pathway activation, measured as CD69 
Fig R20. Effect of SNX27 silencing on DAG-dependent signaling after 
CD3/CD28 costimulation 
shControl and shSNX27 Jurkat T cells were stimulated with soluble anti-CD3 and anti-CD28 for 
costimulation for the times indicated.  Western blot analysis of cell lysates showed (A) phosphorylation 
of PKC substrates (p-PKC subs) and (B) phospho- and total protein abundance of the indicated 
proteins. Phospho-ERK signals were normalized to total ERK abundance, and results for each time 
point were also normalized to  unstimulated cells to calculate fold induction.  Blots and graphs are for a 
representative  experiment. 
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induction and AP-1 activity.  When we monitored ERK phosphorylation directly, however, we 
found unpredicted lower ERK phosphorylation in unstimulated SNX27-silenced Jurkat cells than 
in controls.  Although these data require further study, when ERK phosphorylation after TCR 
triggering was quantified and normalized to unstimulated cells, SNX27-silenced cells showed 
the predicted marked increase in ERK phosphorylation (Fig R20B), which coincides with our 
earlier findings. 
CD28 engagement also activates PI3K, and subsequent PtdIns(3,4,5)P3 production allows 
PDK-1 and AKT recruitment and activation, which in turn assists activation of the metabolic 
regulator mTOR and its substrates, including the S6 kinase (S6K) (59 reviewed in 33, 338).  
Analysis of mTOR activation by determining S6K phosphorylation at the Thr389 residue, 
showed reduced activation in SNX27-silenced cells (Fig R20B).  This implied that in contrast to 
the enhanced activation of PKC- and ERK-regulated signals, SNX27 silencing decreases 
mTORC1 activation downstream of CD3/CD28 triggering. 
2.5. Analysis of DGK! function in SNX27-silenced T cells 
Our results showed that SNX27 silencing in T cells was reminiscent of that of DGK!, and led to 
enhanced activation of DAG-effectors like PKC and RasGRP as well as a subsequent increase 
in AP-1/CD69 upregulation and NF-%B transcriptional activity (sections 2.3 and 2.4).  We also 
found that although SNX27 silencing partially decreased DGK! abundance due to PKC 
hyperactivation, DGK! expression was not completely abolished (section 2.2).  To examine 
whether the residual DGK! is able to control these pathways when SNX27 expression is 
reduced, we analyzed CD69 upregulation and NF-%B promoter activity in cells expressing 
shRNA sequences against SNX27 and DGK! (Fig R21A). The combined downmodulation of the 
two proteins did not have an additive effect, as CD69 induction did not increase substantially 
compared to silencing of SNX27 or DGK! individually.  When PKC and ERK contributions were 
assessed using Gö and PD inhibitors, we obtained similar results in SNX27-, DGK!-, and 
SNX27/DGK!-silenced cells (Fig R21B, C).  Induction of NF-%B promoter activity after 
costimulation was also similar in SNX27- and in DGK!-silenced cells, although double shRNA-
silenced cells appeared to be resistant to Gö treatment (Fig R21D). 
Our results demonstrate that SNX27 participates in DAG lipid signaling through DGK! 
interaction in both basal and stimulation conditions, and suggest that the effects after SNX27 
silencing are due mainly to a combination of decreased abundance, activity, and/or 
mislocalization of DGK!, which are all causally related.  Further experiments are needed to 
address this hypothesis. 
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Fig R21.  SNX27 participates in DAG lipid signaling through DGK! interaction 
(A) Total abundance of the indicated proteins in shRNA-transfected Jurkat T cells were analyzed by 
western blot.  (B-D) shRNA-transfected cells were stimulated (6h) with soluble anti-CD3 alone or with 
anti-CD28 for costimulation.  Where indicated, cells were pretreated with Gö6976 or PD98059 for 
classic PKC or MEK inhibition, respectively. (B, C) Cells were stained for CD69 surface marker and, 
using flow cytometry, the CD69hi population were gated, and the geometric mean fluorescence intensity 
(GMFI) of CD69hi cells were calculated. (B) Data shown as mean ± SEM (n = 2).  (C) Representative 
flow cytometry plots with CD69hi gate shown. (D) Luciferase assays were performed to calculate NF-%B 
promoter activity. Data shown as mean, a representative experiment is shown (n = 2).  RLU, relative 
luciferase units (see Methods). 
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3. EFFECT OF SNX27 DEFICIENCY ON PRIMARY T CELL FUNCTION 
Our studies in Jurkat T cells indicate that SNX27/DGK! interaction regulates DGK!-dependent 
DAG metabolism downstream of TCR triggering and costimulation.  DGK!-deficient primary 
T cells are hyperresponsive to TCR stimulation 365, which suggests that DGK! limits the DAG 
signaling threshold for activation.  SNX27 depletion in primary T cells could thus mimic that of 
DGK! to promote DAG-regulated functions.  The defective function of additional SNX27 
interactors could nonetheless also affect T cell activation.  To determine whether SNX27 plays a 
role in naïve T cell activation, we characterized primary T cell development and function in 
SNX27 KO mice (Snx27−/−).  Snx27−/− mice were originally reported to die at 4 weeks post-
partum due to postnatal growth defects 40.  Optimization of housing and feeding conditions by Dr 
G Kinna (in Dr. B Collinsʼs and Dr. R Teasdaleʼs groups) nonetheless allowed us to analyze 
mice from 6 to 12 weeks old.  Crossing Snx27+/− heterozygotes on C57BL/6 and 129SV mixed 
backgrounds 40 generated F1 hybrid background Snx27+/+ and Snx27−/− mice and enabled 
paired analysis of littermates. 
3.1. T cell development analysis 
Committed lymphoid progenitor cells arise in the bone marrow and migrate to the thymus.  
Thymocytes differentiate into mature T lymphocytes after the processes of death by neglect, 
negative and positive selection, and lineage-specific development (reviewed in 115).  T 
lymphocytes are then borne in the blood to the peripheral lymphoid tissues in the spleen and 
lymph node organs (reviewed in 199).  We analyzed total cellularity of the thymus, spleen and 
lymph nodes (LN) in Snx27−/− mice and observed a significant decrease in spleen cellularity 
compared to littermate controls (Fig R22A); this decrease correlated with a smaller organ 
(Fig R22B).  This was consistent with previous reports showing that Snx27 deletion in mice 
Fig  R22 .  Snx27− /−   m ice show reduced sp leen ce l lu la r i t y !(A) WT and Snx27−/− littermate-matched pairs of mice were sacrificed and total cellularity was 
recorded of the thymus, spleen and lymph nodes following erythrocyte lysis.  Data shown as mean ± 
SEM (*p<0.05; paired t-test; n = 7).  (B) Spleens from a littermate pair are shown.  Bar: 1 cm. 
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results in smaller animals with reduced organ size 40, 51.  Thymus and LN cellularity were 
nonetheless unaltered in Snx27−/− mice (Fig R22A). 
T cell development and maturation takes place in the thymus; thymocyte populations at 
different stages are identified by cell surface marker expression.  Early committed T cells lack 
expression of the TCR and of the CD4 and CD8 coreceptors, and are termed double negative 
thymocytes (DN; CD4-CD8-).  DN thymocytes can be subdivided into four differentiation stages 
defined by CD44 and CD25 expression (DN1, CD44+CD25−; DN2, CD44+CD25+; DN3, 
CD44−CD25+; DN4, CD44−CD25−) 122.  Throughout these stages, cells undergo $-selection, a 
process that involves apoptosis of thymocytes that do not express a productive pre-TCR.  
Selected thymocytes proliferate extensively during DN3-DN4 stages and mature into double 
positive thymocytes (DP; CD4+CD8+) that replace their pre-TCR to yield a complete #$TCR.  
Subsequent positive and negative selection determines thymocyte commitment to the CD4 or 
CD8 lineages (reviewed in 115) (Fig R23A). 
Using flow cytometry, we analyzed cell surface expression of CD4, CD8, CD44 and CD25 
markers in thymocytes and calculated the percentage of cells found at each stage of T cell 
development.  The analysis of thymocyte distribution in DN stages showed a decrease in the 
DN1 population and an increase in DN4 cells in Snx27−/− mice, both significant compared to WT 
controls (Fig R23B).  The DN4 stage is defined by cells negative for CD44 (the hyaluronic acid 
receptor) and CD25 (the interleukin-2 (IL-2) receptor # chain).  Both of these receptors are 
prone to recycling 91, 142, so an enlarged CD44−CD25− population could be the result of defective 
CD44 or CD25 protein trafficking.  We thus analyzed the percentage of this population in other 
developmental stages, and found that the number of CD44−CD25− cells gated in CD4+, CD8+ 
and DP thymocytes was within the normal ranges (not shown).  These data suggest that there 
is no general CD44 or CD25 protein trafficking defect in Snx27−/− thymocytes.  We also 
determined that the larger DN4 population in Snx27−/− mice was not a result of elevated TCR"& 
expression, as the DN population included a similar percentage of TCR"&+ cells in WT and 
Snx27−/− mice (Fig R23C).  As accumulation of previously selected mature thymocytes that 
downregulated expression of CD4 and CD8 coreceptors might also explain our data, we 
analyzed DN thymocytes for maturation indicators such as smaller cell size and/or TCR#$ 
expression.  While DN4 Snx27−/− thymocytes showed a tendency towards smaller cell size 
(Fig R23D), the percentage of TCR#$+ DN cells was similar to WT thymocytes (Fig R23C).  
Although additional studies are needed, our results suggest enhanced proliferation of Snx27−/− 
thymocytes at the DN4 stage during development.  Analysis of DP and CD4+ or CD8+ single 
positive (SP) thymocyte populations showed no significant differences, although we observed a 
slight tendency towards increased numbers of SP cells in Snx27−/− thymocytes (Fig R23E). 
Mature T lymphocytes exit the thymus and migrate to peripheral lymphoid sites in the spleen 
and LN, where mature B cells also reside (reviewed in 182, 199).  We quantified the percentages of 
lymphocyte populations in cell suspensions from WT and Snx27−/− spleen and LN as above; 
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Fig  R23 .  Ana lys is  of T ce l l  development  in WT and Snx27− /−  m ice 
(A) Stages in T cell development (see text for details). (B-E) Thymocytes from WT and Snx27−/− 
littermate pairs were stained for the indicated cell surface markers and analyzed by flow cytometry. (B-
D) Double negative thymocytes (DN,CD4−CD8−) were gated and (B) cell percentage and (D) size in the 
four developmental stages was calculated (DN1, CD44+CD25−; DN2, CD44+CD25+; DN3, 
CD44−CD25+; DN4, CD44−CD25−); (C) percentage of cells expressing TCR#$ or TCR"& was also 
calculated.  (E) The percentage of total double-positive (DP, CD4+CD8+) and single positive (SP, 
CD4+CD8− or CD4−CD8+) thymocytes was calculated. (B, E) Representative flow cytometry plots are 
shown (left). Data shown as mean ± SEM [*p<0.05; paired t-test; (B-D) n = 3 (E) n = 7] (right). a.u., 
arbitrary units. 
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Fig R24.  Snx27−/− mice show normal T cell populations in peripheral lymphoid tissue 
(A-D) Splenocytes and (E-H) lymph node (LN) cells from WT and Snx27−/− littermate pairs were stained 
for the indicated cell surface markers and analyzed by flow cytometry.  (A, B, E, F) The percentage of 
B220+ and TCR#$+ cells was calculated. (C, D, G, H) TCR#$+ cells were gated and the percentages of 
CD4+ and CD8+ cells were calculated. (A, C, E, G) Data shown as mean ± SEM [*p<0.05; paired t-test; 
(A, C) n = 7 (E, G) n = 4]. (B, D F, H) Representative flow cytometry plots are shown. !
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B cells were detected by surface expression of B220, an isoform of the tyrosine phosphatase 
CD45 expressed at all B lymphocyte stages.    
Compared to WT controls, there were no gross differences in the number of Snx27−/− 
TCR#$+ cells in spleen or LN (Fig R24A, B, E, F) or in the percentages of CD4+ and CD8+ cells 
gated in TCR#$+ (Fig R24C, D, G, H).  Analysis of the B220+ cell population in LN nonetheless 
showed increased numbers in Snx27−/− mice (Fig R24E); further studies are needed to confirm 
these data. 
3.2. T cell activation analysis 
Snx27 deletion in mice did not markedly alter T cell development.  The normal cellularity of 
Snx27−/− mouse thymus contrasted with a substantial decrease in spleen.  Snx27−/− mice 
nonetheless maintained peripheral T cell populations similar to WT littermates, which allowed us 
to compare the activation of spleen T cells from WT and Snx27−/− mice.  To trigger T cell 
activation in vitro, we stimulated splenocytes for 48 h with agonistic antibodies; we used plate-
bound anti-CD3 for TCR triggering alone, or combined with soluble anti-CD28 for costimulation.  
Using flow cytometry, we measured cell surface expression of several activation markers in 
CD4+ or CD8+ cells, as well as their proliferation and growth. 
3.2.1. Induction of T cell activation markers 
TCR triggering and costimulation in SNX27-silenced Jurkat T cells resulted in hyperactivation of 
DAG/PKC/Ras-dependent pathways, as shown by the increase in the number of cells that 
upregulated CD69, as well as in enhanced CD69 expression per cell.  We thus analyzed CD69 
upregulation in WT and Snx27−/− activated T cells.  At 48 h after stimulation with anti-CD3 
antibody, the percentage of CD69+ cells was higher in Snx27−/− CD4+ and CD8+ cells compared 
to those in WT mice (Fig R25A-D).  This is reminiscent of the larger proportion of CD69+ T cells 
observed after anti-CD3 stimulation of DGK!−/− mouse T cells 365, and suggests that SNX27 
limits the Ras signaling threshold for activation in primary mouse T cells.  The GMFI of the 
CD69+ cells was nonetheless similar in WT and Snx27−/− cells (Fig R25E, F), resembling that 
described for ERK phosphorylation in DGK!−/− mice 268.  
Whereas CD69 upregulation is a very sensitive, transient measure of antigen recognition, 
CD44 expression is also induced after antigen recognition, and remains high on all antigen-
experienced cells 34.  We thus analyzed Snx27−/− T cell activation by measuring CD44 
upregulation in CD4+ and CD8+ cells.  Naïve CD4+ T cells express low levels of CD44 34; 
Snx27−/− CD4+ splenocytes showed normal amounts of surface CD44, as indicated by CD44 
GMFI in basal conditions (Fig R26A, B).  TCR activation nonetheless resulted in a marked 
reduction in CD44 levels in Snx27−/− CD4+ T cells, which was significant compared to controls 
after CD3/CD28 costimulation (Fig R26B).  Naïve CD8+ T cells do not express CD44, and we 
could thus distinguish the proportion of responsive T cells.  As shown in CD69 analysis 
(Fig R25), a larger proportion of Snx27−/− T cells responded to anti-CD3 stimulation compared to 
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controls (Fig R26C, D) confirming that SNX27 limits the threshold for responsive cells.  CD44 
GMFI was nonetheless reduced in Snx27−/− activated CD8+ T cells (Fig R26); this suggests a 
general defect in Snx27−/− T cells in achieving high CD44 levels, which is aggravated by 
CD3/CD28 costimulation.  
!
3.2.2. Induction of T cell growth and proliferation 
Snx27−/− mice showed a larger population of responsive T cells, whereas low cell surface CD44 
abundance suggested a Snx27−/− T cell impairment in achieving a full activation phenotype.  
During naïve T cell activation, quiescent lymphocytes enter the cell cycle.  Full activation of 
primary T cells not only elicits proliferation signals, but also triggers metabolic reprogramming to 
Fig R25.  Analysis of CD69 induction in Snx27! /! splenocytes  
(A-F) Splenocytes from WT and Snx27−/− littermate pairs were stimulated (48 h) with plate-bound anti-
CD3 alone or with soluble anti-CD28 for costimulation, and stained for the indicated cell surface 
markers.  Using flow cytometry, (A, B, E) CD4+ or (C, D, F) CD8+ cells were gated, and (B, E) the 
percentage and (E, F) geometric mean fluorescence intensity (GMFI) of CD69+ cells were calculated. 
(B, D, E, F) Data shown as mean ± SEM (ns, not significant, p>0.05; *p<0.05; paired t-test; n = 4).  (A, 
C) Representative flow cytometry plots are shown. 
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support cell growth.  Binding of costimulatory molecules activates PI3K and the metabolic 
regulator mTOR (reviewed in 33, 338).  As recently reported, mTOR activity downstream of TCR 
triggering is indicated by cell size 259.  When we monitored T cell size by flow cytometry using 
forward scatter (FSC), we observed naïve cell growth after CD3 stimulation, with a larger 
number of cells that increased in size in response to CD28 costimulation (Fig R27A, E). 
Abundance of cell surface CD44 in naïve T cells is also an mTOR activity reporter 147, as 
described in cancer cells 67.  The putative correlation between mTOR activity and CD44 
expression following T cell activation has nonetheless not yet been addressed.  We thus 
examined cell surface CD44 abundance relative to cell size, a known mTOR activation marker 
in T cells.  We calculated the CD44 GMFI of cells from four distinctly sized populations [from the 
smallest FSC MFI population (“size 1”; S1) to the largest (“size 4”; S4) (Fig R27 A, E)], and used 
cell surface TCR$ expression as a control.  Our results showed that while TCR$ GMFI remained 
constant independently of cell size, CD44 GMFI was directly proportional to FSC MFI in CD4+ 
and CD8+ cells after CD3 or CD3/CD28 stimulation (FigR27C, D).  These data suggest mTOR-
dependent control of CD44 upregulation after T cell activation, and that the Snx27−/− T cell 
defect in achieving high CD44 levels could be a result of poor mTOR activation and cell growth. 
Fig R26.  Analysis of CD44 induction in Snx27! /! splenocytes  
Splenocytes from WT and Snx27−/− littermate pairs were stimulated (48 h) with plate-bound anti-CD3 
alone or with soluble anti-CD28 and stained for the indicated cell surface markers.  Using flow 
cytometry, (A, B) CD4+ or (C, D) CD8+ cells were gated, and the CD44 GMFI was calculated. 
(B, D) Data shown as mean ± SEM (ns, not significant, p>0.05; *p<0.05; paired t-test; n = 4). 
(A, C) Representative flow cytometry plots are shown.  a.u., arbitrary units. 
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To determine whether SNX27 deficiency affects cell growth, we measured cell size in WT 
and Snx27−/− mouse T cells.  Snx27−/− cell size was normal in basal conditions (Fig R28B, E), 
but was smaller than WT controls after CD3 or CD3/CD28 stimulation; differences were 
significant for CD4+ cells, and for CD8+ cells only following CD3/CD28 stimulation (Fig R28B, E).  
When we calculated cell distribution among distinctly sized populations (gates shown in 
Fig R28 A, D), we observed that CD3-stimulated T cells were found mostly in the smaller S1 
and S2 populations, with no gross differences between WT and Snx27−/− T cells.  Following 
Fig R27.  Correlation between cell size and CD44 expression in activated T cells  
Splenocytes from WT mice were stimulated (48 h) with plate-bound anti-CD3 alone or with soluble anti-
CD28 and stained for the indicated cell surface markers.  Using flow cytometry, (A-C) CD4+ or (D-F) 
CD8+ cells were gated and the MFI of CD44 (black) and TCR$ (blue) were calculated in cells from the 
four distinctly sized populations (S1, S2, S3, S4; gates shown in A, E).  (C, D) Data shown as mean ± 
SEM (n = 2). (B, F) Representative flow cytometry plots are shown.  a.u., arbitrary units. 
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CD28 costimulation, the percentage of WT T cells in the larger sized populations S3 and S4 
increased, whereas the percentage of S3 and S4 populations in CD4+ and CD8+ Snx27−/− cells 
remained low (Fig R28 C, F).  This growth defect was independent of Ras activation, as most 
Snx27−/− cells upregulated CD69 after TCR triggering.  The lower CD44 abundance observed in 
Snx27−/− T cells could be explained by this growth defect, as our previous analyses showed that 
S3 and S4 populations are those with the highest CD44 levels (Fig R27). 
T cell growth following stimulation is linked to subsequent proliferation; the expression of 
T cell activation markers including CD44 increases further after cell division 97.  To determine 
Fig R28. Snx27−/−  splenocytes showed reduced growth after activation 
(A-F) Splenocytes from WT and Snx27−/− littermate pairs were stimulated (48 h) with plate-bound anti-
CD3 alone or with soluble anti-CD28 for costimulation, and cell size was calculated using flow 
cytometry. (A-C) CD4+ or (D-F) CD8+ cells were gated, and (B, E) MFI of the forward scatter (FSC) 
was calculated, as well as (C, G) the percentage of cells in four distinctly sized populations (S1, S2, S3, 
S4; gates shown in A, D). (B, C, E, F) Data shown as mean ± SEM (ns, not significant, p>0.05; 
*p<0.05; **p<0.01; paired t-test; n = 4). (A, D) Representative flow cytometry plots are shown.  
a.u., arbitrary units.!
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whether SNX27 depletion in T cells also affects proliferative responses, we monitored cell 
proliferation by flow cytometry.  Before stimulation, WT and Snx27−/− splenocytes were stained 
with CellTrace, and at 48 h after stimulation, generations of proliferating cells were identified by 
dye dilution.  Proliferation of anti-CD3 antibody-treated Snx27−/− CD4+ and CD8+ T cells was 
normal (Fig R29).  CD28 costimulation further promoted division in WT and Snx27−/− cells, 
although analysis of flow cytometry plots indicated a low proportion of cells with a higher division 
rate in Snx27−/− splenocytes (Fig R29).  To determine whether Snx27−/− cells have an intrinsic 
defect that prevents a high division index, we turned to less physiological but more potent 
proliferative stimuli.  We used phorbol 12-myristate 13-acetate (PMA, 0.1 µg/ml) and ionomycin 
(Io, 1nM) for pharmacological TCR stimulation, or the T cell mitogen concanavalin A (ConA), a 
lectin that crosslinks glycosylated surface receptors including the TCR.  These treatments 
indeed resulted in a more productive response; cell proliferation and CD44 abundance 
increased (not shown).  Snx27−/− T cells maintained low surface CD44 abundance compared to 
controls (not shown), whereas the number of WT and Snx27−/− splenocyte divisions was similar 
(Fig R29).  Overall, our data showed no gross Snx27−/− T cell proliferation defects, and suggest 
impaired capacity for full mTOR activation as a cause of reduced CD44 expression after 
activation. 
 
Fig R29.  Dye dilution analysis of T cell division  
Splenocytes from WT and Snx27−/− littermate pairs were labeled with CellTrace and stimulated (48 h) 
with plate-bound anti-CD3 alone or with soluble anti-CD28 for costimulation, with concanavalin 
A  (ConA, 5 µg/ml) or phorbol 12-myristate 13-acetate (PMA, 0.1 µg/ml) and ionomycin (Io, 1 nM).  
Cells were then stained for CD4 and CD8 surface markers and analyzed by flow cytometry. (A, B) 
CD4+ or (C, D) CD8+ cells were gated, and representative flow cytometry plots of Cell Trace intensity 
were analyzed.  Data shown are representative of three experiments.!
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3.2.3. mTOR activation in T cells 
mTOR activation and metabolic reprogramming in T cells leads to enhanced expression of 
nutrient receptors and transporters, including TfR! and GLUT1, to allow rapid growth (109, 364, 
reviewed in 33, 338).  To confirm decreased mTOR activation in Snx27−/− cells, we analyzed 
surface expression of these receptors after T cell stimulation.  Available anti-GLUT1 antibodies 
react poorly with GLUT1 extracellular domains, and data on cell surface GLUT1 abundance 
were thus inconclusive (not shown).  Analysis of surface TfR abundance on activated T cells 
was possible using a fluorescently labeled anti-CD71 antibody. CD71 expression increased 
after anti-CD3 stimulation in WT T cells, with a further increase after anti-CD28 costimulation 
(Fig R30).  Snx27−/− T cells also upregulated CD71, although it was less abundant than in WT 
controls; differences were substantial after CD28 costimulation (Fig R30). 
Our flow cytometry data strongly suggested impaired mTOR activation in SNX27-depleted T 
cells.  In a biochemical analysis, we directly assessed mTOR activation in splenocytes after 
TCR triggering and costimulation elicited by ConA treatment.  To examine early signaling up to 
1 h post-activation, we analyzed rps6 (ribosomal protein S6) phosphorylation at Ser235/6, which 
is downstream of the mTORC1/S6K pathway; we also tested mTORC2-dependent AKT 
phosphorylation at Ser473, as well as ERK phosphorylation as a control for Ras/ERK pathway 
Fig R30.  Analysis of CD71 induction in Snx27! /! splenocytes  
Splenocytes from WT and Snx27−/− littermate pairs were stimulated (48 h) with plate-bound anti-CD3 
alone or with soluble anti-CD28 for costimulation, and stained for the indicated cell surface markers.  
Using flow cytometry, (A, B) CD4+ or (C, D) CD8+ cells were gated, and the CD71 GMFI was 
calculated. (B, D) Data shown as mean ± SEM (ns, not significant, p>0.05; paired t-test; n = 4). 
(A, C) Representative flow cytometry plots are shown. 
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activation.  Whereas ERK phosphorylation proceeded normally in Snx27−/− splenocytes, rps6 
phosphorylation was delayed (Fig R31).  AKT Ser473 phosphorylation was also reduced in 
Snx27−/− splenocytes at later times, which indicated alterations in mTORC2 pathway 
downstream of TCR triggering.  These data indicate that impaired mTOR activation is 
concomitant with the inability of SNX27-depleted T cells to grow normally or to express high 
CD44 and TfR levels.  
 
 
 
 
 
 
 
 
 
3.2.4. Analysis of surface levels of putative SNX27 cargoes 
SNX27-depleted T cells responded to activation by CD3/CD28 costimulation, and proliferated 
with no gross defects, whereas they did not grow normally in response to stimulation.  Weak 
mTOR pathway activation due to altered TCR-mediated signaling or metabolic defects could 
explain the smaller cell size.  Indeed, SNX27 is known mainly for its implication the PDZ-
dependent trafficking of nutrient receptors and transporters such as GLUT1 308.  The NPxY-
binding capacity of the SNX-FERM proteins, including SNX27, could also mediate recycling of 
proteins important for T cell function such as LFA-1 and the TCR complex protein CD3*.  WASH 
KO primary T cells have low levels of cell surface LFA-1 in basal conditions and of TCR$ after 
activation 256, and our data in Jurkat cells indicated that SNX27 silencing affects LFA-1 stability.  
To determine whether SNX27 depletion alters cell surface abundance of these two proteins in 
primary T cells in basal or stimulation conditions, we monitored the signal of fluorescently 
labeled anti-CD11a and -CD3* antibodies by flow cytometry. 
In contrast to WASH-depleted T cells, Snx27−/− cells showed normal CD11a levels in basal 
conditions compared to controls (Fig R32).  After TCR triggering, cell surface CD11a was low in 
Snx27−/− T cells, which was significant compared to controls after CD3/CD28 costimulation 
(Fig R32B,D).  When we analyzed CD3* expression in the same conditions, we found no 
defects in Snx27−/− T cells; the activation-dependent downmodulation of CD3* was indeed less 
pronounced in Snx27−/− T cells and led to a small increase in cell surface CD3* that was 
Fig R31.  Snx27!/! 
splenocytes show reduced 
mTOR activation   
Splenocytes from a WT and 
Snx27−/− littermate pair were 
stimulated with ConA for the 
indicated times.  AKT, rpsS6 
and ERK phosphorylation and 
total abundance were 
evaluated by western blot in 
total cell lysates.  Tubulin was 
used as a loading control. A 
representative experiment is 
shown.!
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significant in activated CD8+ T cells (Fig R33).  Similar analysis of these two proteins in 
unstimulated SNX27-silenced Jurkat cells showed significant differences in LFA-1 levels after 
protein synthesis inhibition, whereas cell surface CD3* abundance remained normal or higher 
than controls in all conditions (Fig R11B in section 3.2).  These results suggest that whereas 
SNX27 is not necessary for TCR recycling, it participates in maintaining cell surface LFA-1 
levels. 
!!
Fig R32.  Analysis of LFA-1 (CD11a subunit) abundance in Snx27−/− splenocytes  
Splenocytes from WT and Snx27−/− littermate pairs were stimulated (48 h) with plate-bound anti-CD3 
alone or with soluble anti-CD28, and stained for the indicated cell surface markers.  Using flow 
cytometry, (A, B) CD4+ or (C, D) CD8+ cells were gated, and the CD11a GMFI was calculated.  
(B, D) Data shown as mean ± SEM (ns, not significant, p>0.05; *p<0.05; **p<0.01; paired t-test; n = 4). 
(A, C) Representative flow cytometry plots are shown. 
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Fig R33.  Analysis of CD3* cell surface abundance in Snx27!/! splenocytes  
Splenocytes from WT and Snx27−/− littermate pairs were stimulated (48 h) with plate-bound anti-CD3 
alone or with soluble anti-CD28, and stained for the indicated cell surface markers.  Using flow 
cytometry, (A, B) CD4+ or (C, D) CD8+ cells were gated, and the CD3* GMFI was calculated. 
(B, D) Data shown as mean ± SEM (ns, not significant, p>0.05; *p<0.05; **p<0.01; paired t-test; n = 4). 
(A, C) Representative flow cytometry plots are shown.!
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4. SNX27 ROLE DURING INVASION 
Proteomic and subcellular localization studies demonstrated SNX27/WASH interaction in T 
cells.  We showed partial colocalization of SNX27 with WASH and CD63, which suggested 
SNX27 participation in WASH-mediated polarized secretion after antigen recognition, and 
requires further study.  In cancer cells, WASH also colocalizes with CD63-positive late 
endosomes 360, and controls actin assembly to facilitate integrin and metalloproteinase secretion 
228, 360.  The putative participation of SNX27 in WASH-regulated tumor cell polarized trafficking 
and exocytosis, however, has not yet been explored. 
The MDA-MB-231 human invasive breast adenocarcinoma cell line is used as a model to 
study invadopodia formation and MT1-MMP! delivery to these structures.  When MDA-MB-231 
cells are cultured on cross-linked gelatin as a matrix, the majority of intracellular MT1-MMP is 
located at late endosomes 307, where the WASH/exocyst complex assist in MMP trafficking and 
exocytosis to the invadopodial PM 228.  To determine whether SNX27 participates in these 
processes, we first examined SNX27 dynamics relative to actin polymerization in MDA-MB-231 
cells plated on cross-linked gelatin.  Live-cell imaging after cotransfection of the F-actin probe 
RFP-LifeAct with GFP-SNX27 showed that SNX27-positive endosomes moved rapidly and 
accumulated at actin cytoskeleton remodeling areas (Video 8, yellow arrows).  In spreading 
cells, these endosomes localized at stable ring-shaped punctuate structures, some of which 
showed tubules that were reminiscent of linear invadopodia 163 (Video 8, blue arrows). 
To determine whether the observed structures were MT1-MMP PM delivery sites 228, 
Cherry-SNX27 (Ch-SNX27)-transfected cells were immunostained for WASH and MT1-MMP 
endogenous proteins, and F-actin was labeled with fluorescent phalloidin.  Densitometric 
analyses of protein distribution showed that Ch-SNX27 colocalized with WASH at MT1-MMP-
positive F-actin-rich structures (Fig R34A-C), which was confirmed by quantitative colocalization 
analyses (Fig R34C).  Immunostaining of the endogenous SNX27 and WASH proteins in cells 
transfected with the MT1-MMPmCherry (MT1-MMPCh) construct further confirmed 
colocalization of both proteins in MT1-MMPCh-positive endosomes.  The amount of SNX27 
accumulated at these sites inversely correlated with the size of the MT1-MMP-positive area 
(Fig R34D), which concurs with WASH localization at invadopodia during early stages of their 
formation 228.  Z projections and orthogonal views reconstructed from confocal images of the 
MT1-MMP-enriched sites showed that, while SNX27 localized at the top region of the MT1-MMP 
endosomes, WASH was closer to the region adjacent to the PM (Fig R34E).  Although total 
internal reflection fluorescence (TIRF) and super-resolution microscopy are required to confirm 
these data, our results suggested that SNX27 is an adaptor for cargoes that participate in early 
stages of invadopodium formation. 
To further explore the role of SNX27 during invadopodium formation, we established stable 
MDA-MB-231-derived cell lines that expressed shRNA against the previously validated SNX27 
mRNA sequence (shSNX27 cells) or a non-targeting one (shCtrl cells) in a doxycycline (Dox)-
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dependent manner.  After 72-96 h Dox treatment, SNX27 protein abundance in shCtrl cells 
remained constant, while it was reduced to 40% in shSNX27 cells (Fig R35A,B).  
WASH complex components stability depends on the expression of core subunits including 
Strumpellin, FAM21 or SWIP 77, 161.  Protein abundance of WASH1 and Strumpellin in Dox-
treated shSNX27 cells was normal (Fig R35B), which indicated that in MDA-MB-231 cells, 
SNX27 might be a WASH complex adaptor, but it is not a core component.  MT1-MMP levels in 
Dox-treated shSNX27 cells were also unchanged, suggesting that SNX27 is not needed for 
MT1-MMP recycling in MDA-MB-231 cells (Fig R35B).  We nonetheless analyzed MT1-MMP-
positive endosomes morphology in these cells plated on cross-linked gelatin.  In control 
shSNX27 cells (no Dox addition), MT1-MMP accumulated at small vesicles associated to well 
Fig R34. SNX27 colocalizes with WASH on MT1-MMP-positive endosomes in invasive cells 
MDA-MB-231 cells were transfected with the indicated Cherry-tagged constructs, plated on cross-
linked gelatin, stained with antibodies for the indicated proteins and, where indicated, also for F-actin 
using phalloidin. (A, B, D) Representative confocal images are shown; bar: 10µm.  Densitometric 
analyses of protein distribution along the white line are shown on RGB profiles on the right.  
(C) Quantitative analysis of Cherry-SNX27 colocalization with WASH and MT1-MMP. Mandersʼ overlap 
coefficient values for each cell were calculated and represented as box plots.  (E) Z-projection of the 
cell shown in D (left), orthogonal views of the boxed regions (right) were generated using Image J. 
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organized WASH-positive puncta (Fig R35C, top).  In Dox-treated cells, however, we observed 
large MT1-MMP-positive aggregations inside and outside WASH-delimited endosomes 
(Fig R35C, bottom), which suggested that SNX27 participates in MT1-MMP PM delivery 
regulation.  Quantitative analyses of the MT1-MMP-positive area per cell showed an increased 
area in Dox-treated shSNX27 cells (Fig R35D), which correlated with the alterations in MT1-
MMP-positive endosomes morphology. 
Our studies in 2D invadopodia-forming cells allowed us to examine SNX27 dynamics and 
localization at these invasive protrusions.  Nonetheless, cells in tumors invade into 3D 
extracellular matrices (ECM).  To study SNX27 role during cell invasion in matrix we used 
circular invasion assays (CIA; see Material and Methods section), which closely mimic 3D 
invasion while allowing live-cell and immunofluorescence microscopy analyses.  Imaging of 
GFP-SNX27-transfected live cells during invasion into matrigel showed that GFP-SNX27 
Fig R35. SNX27 silencing alters MT1-MMP morphology at WASH-positive endosomes 
For SNX27 silencing, MDA-MB-231 cells stably expressing the pLKO-Tet-on-shSNX27 construct were 
treated with 1 mg/ml doxycycline (Dox) for 72-96 h to induce shRNA expression. (A, B) Protein 
abundance of SNX27 and the indicated proteins in cell lysates was analyzed by western blot using the 
corresponding antibodies. (A) Quantification showed SNX27 silencing after 72h of Dox treatment (n=2). 
No differences in SNX27 levels were detected in Dox-treated control cells (shCtrl). (C, D) Cells were 
plated on cross-linked gelatin, stained with antibodies for the indicated proteins, and imaged using a 
confocal microscope; bar: 10µm. Insets show WASH/MT1-MMP-positive endosomes. (D) MT1-MMP-
positive area per cell was calculated using ImageJ. Each dot represents an individual cell, data shown 
as mean ± SEM (t-test,***P<0.001).. 
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clustered in small puncta near the tips of invading pseudopods (Video 9, yellow arrows).  
SNX27-positive vesicles also moved throughout the cell body or were organized in ring-shaped 
punctuate structures similar to those observed in 2D invadopodia assays (Video 9, blue arrows).  
Immunostaining of endogenous SNX27 in non-transfected untreated shSNX27 cells confirmed 
its accumulation at the F-actin-enriched tips of invasive protrusions, where it colocalized with 
endogenous WASH protein (Fig R36A top, yellow arrows).  Anti-MT1-MMP antibody detected 
poorly the MMP in Matrigel-embedded cells, so its location could not be examined in these 
assays.  Our data nonetheless suggested functional accumulation of SNX27 at the tips of 
invading pseudopods. 
In agreement with previous data, SNX27 knockdown after Dox treatment did not prevent 
WASH location at endosomes or its localization to invading pseudopods (Fig R36A bottom, 
yellow arrows).  Quantification of the area invaded in CIA nonetheless showed a tendency 
towards reduced invasion of Dox-treated cells compared to untreated controls (Fig R36B).  
During CIA, cells invade in a protease-dependent manner and assemble focal adhesions and 
invadopodia similar to those of Matrigel-embedded cells 359.  To confirm the effect of SNX27 
silencing on tumor cell invasion into the ECM, we analyzed MDA-MB-231 cells ability to invade 
into 3D Matrigel matrices using inverted invasion assays (see Methods).  Dox-treated or 
untreated shSNX27 cells were allowed to invade into Matrigel for 96 h.  We calculated the 
relative invasion area, and showed that it was reduced after SNX27 knockdown (Fig R36C-D).  
Our data suggested that SNX27 assists WASH functions promoting tumor cell invasion.  SNX27 
controlled MT1MMP1-positive endosomes morphology, but it did not regulate MT1-MMP protein 
abundance, indicating that other putative SNX27 cargoes must participate in PM MT1-MMP 
delivery. 
Clustered and aggregated MT1-MMP-positive endosomes are also found in MDA-MB-231 
cells after silencing of WASH-associated exocyst complex components 228.  
PIP5K-dependent PtdIns(4,5)P2 production regulates exocyst complex assembly as well as its 
function promoting integrin trafficking in MDA-MB-231 cells 322.  The PIP5K isoform $ bears a 
PDZ-bm 211, and thus we hypothesized that its binding to SNX27 could control local 
PtdIns(4,5)P2 production and assist exocyst function.  In collaboration with our colleague 
Dr. Rosa Ana Lacalle from Dr. Santos Mañesʼs group (Centro Nacional de Biotecnología-CSIC, 
Madrid) we tested the ability of SNX27 to bind PIP5K$.  We used a splice variant of the PIP5K" 
isoform (PIP5K"i2) as a non-PDZ-binding control.  Co-immunoprecipitation analyses of 
Myc-tagged SNX27 and FLAG-tagged PIP5K expressed in HEK293T cells (see Fig R37A) did 
not detect Myc-SNX27 interaction with PIP5K$ (data not shown).  Instead, we observed an 
unpredicted SNX27/PIP5K"i2 association (Fig R37B).  PIP5K"i2 was nonetheless absent in 
immunoprecipitates of a Myc-SNX27 that lacks the FERM domain (SNX27-NT) (Fig R37B), 
which indicates that SNX27 FERM domain is essential for SNX27/PIP5K"i2 binding.  These 
results were confirmed by testing the interaction between in vitro-translated full-length SNX27 
   RESULTS 
118 
(FL) or SNX27-NT proteins and FLAG-PIP5K"i2 immunoprecipitated from HEK293T lysates 
(Fig R37C).  Moreover, GST pull-down assays indicated direct physical interaction between 
GST-SNX27 and PIP5K"i2 purified proteins (Fig R37D). 
PIP5K"i2 (also termed PIP5K"661) compared to other variants has an extended C-terminal 
region essential for talin interaction (Fig R37B); talin-FERM domain binds PIP5K"i2 through the 
same binding site that mediates its NPxY-dependent association with $-integrins (reviewed 
in 330).  We thus hypothesized that the molecular mechanism for PIP5K"i2 association with 
SNX27 FERM domain could be analogous to that with talin-FERM domain.  We tested the ability 
of a SNX27 mutant with impaired NPxY-binding (Myc-SNX27 WA) to co-immunoprecipitate with 
PIP5K"i2.  SNX27 WA mutation however did not prevent PIP5K"i2 binding (Fig R37E).  
Moreover, SNX27 also co-immunoprecipitated with the PIP5K" isoform splice variant 1 
(PIP5K"i1) that lacks the talin-binding site (Fig R37F).  These data suggested an alternative 
mechanism for SNX27/PIP5K"i2 interaction. 
Fig R36. SNX27 silencing affects the invasive capacity of MDA-MB-231 cells 
(A,B) Matrigel circular invassion assays (CIA) were performed (see Methods). Untreated and Dox-
treated shSNX27 MDA-MB-231 cells were allowed to invade for 12 h, (A) fixed, and stained for SNX27 
and WASH by immunofluorescence. F-actin was detected using fluorescent phalloidin. Insets show 
SNX27/WASH-positive endosomes localized at actin-puncta within invading pseudopods. Images are 
from a representative experiment; bar: 10µm.  (B) Total invaded area was calculated using ImageJ. 
Results from three independent experiments are shown on the dot plot. (C-D) Matrigel inverted 
invasion assays were performed (see Methods). (C) Untreated and Dox-treated shSNX27 MDA-MB-
231 cells were allowed to invade for 96 h, and serial optical sections were captured at 15-µm intervals. 
Relative invasion was calculated using ImageJ considering cells that invaded 45µm or more. (D) Each 
dot represents repeated values obtained within an experiment. Results from three independent 
experiments in duplicate are shown. 
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PIP5K# interaction with $-arrestin is dependent on PtdIns(4,5)P2/PtdIns(3,4,5)P3 recognition 
through a PtdIns-binding pocket (Arg234, Arg238, and Lys252; RRK residues) 238 analogous to 
that located at the SNX27 FERM domain 118.  To examine whether SNX27/PIP5K"i2 interaction 
is PtdIns-binding dependent, we used the SNX27 RRK/E mutant in our co-immunoprecipitation 
analyses.  RRK/E mutation in SNX27 did not prevent PIP5K"i2 interaction; indeed, SNX17, 
Fig  R37 . SNX27 d irect ly  binds PIP5K "  th rough FERM domain  
(A) Scheme of proteins used, domains and interaction sites are shown (tags not shown)  (B,E-G) Myc-, 
FLAG- or GFP-tagged proteins expressed in HEK293 cells were tested for binding by 
co-immunoprecipitation.  Results were analyzed by western blot. (C) SNX27 and SNX27-NT proteins 
were in vitro-translated using the TNT system and tested for co-immunoprecipitation with FLAG-
PIPK"i2 in a HEK293 cell lysate.  (D) Physical interaction between the two proteins was confirmed by 
GST-pull down assay using GST-SNX27 and purified PIPK"i2. (H) Summary of the results of 
immunoprecipitation and pull-down assays. 
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which lacks the PtdIns-binding pocket, also interacted with PIP5K"i2 (Fig R37G).  Our results 
indicate a unique SNX FERM association to PIP5K" that is different from that described for other 
proteins structurally similar to SNX27, which will require further studies for its characterization.  
This previously unreported association could be important to control endosomal PtdIns(4,5)P2 
production and couple lipid signaling to intracellular protein trafficking and exocytosis. 
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VI. DISCUSSION 
1. ROLE OF SNX27 IN T CELLS 
1.1. SNX27 at the immune synapse 
1.1.1. FERM domain lipid binding contributes to SNX27 localization 
The PtdIns3P-binding PX domain promotes SNX endosomal membrane recruitment (reviewed 
in 319).  SNX27, SNX17 and SNX31 bear a FERM-like domain that interacts with cargoes 
containing NPxY/NPxxY motifs 116.  Coordinated binding to phosphoinositides and cargo 
enhances membrane attachment of many trafficking proteins through the process termed 
coincidence detection (reviewed in 42).  Ghai et al. showed that the contribution of NPxY/NPxxY 
interactions to endosomal localization is nonetheless different for SNX17 and SNX27.  Whereas 
mutation of the residue that mediates this type of interaction in SNX17 (W321A) profoundly 
affects its endosomal localization, the analogous mutation in SNX27 (W475A) has no impact on 
SNX27 localization to vesicles in epithelial-like cells 116.  In accordance, our results in Jurkat T 
cells showed that, like the WT protein, GFP-SNX27 W475A localized to the ERC and to the T 
cell-APC contact area, which indicates that binding to the NPxY/NPxxY motif affects neither 
ERC nor IS recruitment of SNX27. 
Ghai et al. suggested that the lower sensitivity of SNX27 membrane recruitment to 
NPxY/NxxY cargo engagement can be explained in part by membrane localization enhanced 
via PDZ domain interaction with cargoes 116.  The low endosomal association of SNX17 shown 
here, and the limited vesicle localization of a mutant SNX27 protein lacking the PDZ domain 
reported previously 270, 271 support this hypothesis.  In addition to PDZ-based interactions, 
PtdIns-binding sites alternative to that at the PX domain can also explain the enhanced 
membrane affinity of SNX27.  In collaboration with Ghai et al., we defined a PtdIns-binding site 
at the SNX27 FERM domain that was absent in SNX17 and SNX31 118.  This PtdInsP-binding 
pocket is adjacent to the NPxY/NxxY cargo recognition site 118, which might allosterically 
regulate FERM domain binding to cargo and to PtdInsP. 
Localization analyses in HeLa cells suggested that the FERM-located PtdIns-binding site is 
not necessary for SNX27 accumulation at the ERC (see 118 in Appendix 4.1).  This coincides 
with results from Tseng et al. in the same cell type; they compared SNX27 vesicle-binding ability 
to that of SNX17 and SNX31, and suggested an additional lipid-binding site in SNX27 that was 
apparent only in cells treated with the PI3K inhibitor wortmannin, or when the PX domain was 
mutated 326.  In contrast to the modest effect in untreated HeLa cells, endosomal localization of 
the SNX27 FERM non-PtdIns-binding mutant was markedly altered in Jurkat cells; poor vesicle 
association was evident in basal conditions, and this phenotype was more pronounced in Jurkat 
cells challenged by superantigen-loaded APC.  This suggests the need for lipid binding through 
the FERM domain for correct SNX27 localization during polarized vesicle traffic.  The reduced 
SNX17 vesicle localization in unstimulated Jurkat cells, and its notably enhanced cytosolic 
localization after stimulation with APC also concur with this hypothesis.  The combined results 
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from both of these cell models leads us to conclude that the additional lipid anchor in SNX27 
assists its continuity at the ERC when ERC lipid composition is altered by inhibitor treatment or 
after transition to an activated state. 
Using fluorescent-tagged lipid binding domains, we were able to examine SNX27 partitioning 
between different membrane domains in APC-stimulated T cells in greater detail.  The initial IS 
recruitment of WT GFP-SNX27 correlated with transient IS location of a PtdIns(3,4,5)P3-binding 
probe (Fig D1A); however, the SNX27 FERM mutant did not colocalize with the lipid-binding 
probe at this stage.  To determine whether this initial PM accumulation of the WT GFP-SNX27 
originates directly from vesicles or if it is driven by PM lateral movement will require further 
study.  At the mature IS, when the PtdIns(3,4,5)P3-binding probe localized to peripheral IS, both 
WT and the FERM mutant SNX27 accumulated normally at the central IS (Fig D1A).  These data 
are in agreement with our current and previous studies showing that PM localization of SNX27 
during IS formation is PDZ domain-dependent 270.  The reduced retrieval of the FERM mutant 
protein into endosomal compartments after IS maturation nonetheless suggests that recognition 
of bi- and triphosphorylated PtdIns derivatives aids SNX27 transport back to the ERC (see 
model in Fig D1B). The contribution of this additional lipid-binding site to SNX27 localization 
thus correlates with its preference for lipid derivatives known to be involved in endocytosis 118. 
1.1.2. PDZ ligand binding mediates SNX27 accumulation at the immune synapse 
SNX27 does not accumulate at the IS after deletion of its PDZ domain 270, which binds 
simultaneously to PDZ-bm-containing cargoes and to the retromer component VPS26 111, 308.  
Distinct point mutants prevent SNX27 binding to the retromer or to PDZ-bm; impaired 
SNX27/retromer association nonetheless affects PDZ ligand binding 111, and the precise 
contribution of retromer binding to SNX27 IS localization thus could not be determined in these 
experimental conditions.  Our protein localization studies allowed us to demonstrate that SNX27 
IS accumulation is mediated through its association to PDZ-bm, as the non-PDZ-bm-binding 
mutant (H114A) did not accumulate at the T cell-APC contact area.  The mutant protein 
overlapped at the ERC with EEA1, and also with the WT protein when cotransfected; the IS 
localization defect was thus not a result of mutant protein mislocalization to a different 
endosome subset, but of a lack of interaction with PDZ ligands. 
To identify the SNX27 interactome during IS formation, we performed a proteomic analysis to 
compare proteins associated to the WT SNX27 and to the point mutant with impaired 
PDZ-cargo recognition (H114A).  This strategy allowed discrimination between PDZ-dependent 
and -independent SNX27 interactomes.  Although it was not anticipated, we detected proteins 
specifically associated with the mutant form; further studies are needed to determine whether 
mutation of the PDZ ligand-binding site in SNX27 directly promotes binding to alternative 
cargoes or is a result of defective mutant localization to the IS. 
Analysis of the PDZ-dependent SNX27 interactome identified several proteins with a 
canonical type I PDZ-bm.  Structural studies by Clairfeuille et al. recently defined PDZ-bm 
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subcategories based on amino acid sequences upstream of the PDZ-bm, and predicted their 
binding affinity to the SNX27 PDZ domain; an acidic residue at the -3 position is essential for 
association, whereas acidic residues in -5/6 positions enhance interaction affinity.  
Phosphorylated residues can substitute for acidic amino acids and act as a regulatory switch for 
SNX27 binding to ligands (60 see Appendix 4.4).   Most proteins in our PDZ-dependent 
interactome analysis bear an acidic residue at the -3 position (see Table R2), and some have 
acidic residues in -5/6 positions.  None of the proteins identified have Ser or Thr in -5/6 
positions, which indicates that they are not subject to PDZ-bm regulatory switching.  Our 
biochemical analyses validated the PDZ-mediated interaction of SNX27 with DGK!, $-PIX and 
ZO-2, and showed that these interactions occur in resting cells or cells challenged with SEE-
Fig D1.  SNX27 and phosphoinositide 
lipid dynamics during immune synapse 
formation!
(A) Scheme of lipid dynamics and SNX27 
partitioning during IS formation.  In basal 
conditions, SNX27 localizes to the 
PtdIns3P-enriched ERC.  Initial contact of 
the Jurkat T cell with antigen-loaded APC 
triggers SNX27 accumulation at the T cell-
APC contact area simultaneously with 
PtdIns(3,4,5)P3 generation from 
PtdIns(4,5)P2.  Formation of a mature 
supramolecular adhesion complex (SMAC) 
comprises lipid segregation to central, 
peripheral and distal SMAC, maintaining 
focal points of adhesion and 
endo/exocytosis by recruitment of lipid-
binding proteins.  (B) Summary of our 
models for SNX27 FERM and PDZ mutant 
behavior during IS formation.  The structure 
of the GFP-tagged constructs used and their 
partitioning (green) is shown.  For further 
details, see text. 
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loaded APC, findings that coincide with the strong constitutive association to SNX27 predicted 
by Clairfeuille et al. 60.  These data suggest that the PDZ-dependent IS localization of SNX27 is 
not mediated by binding to specific cargoes only in stimulation conditions.  Alternatively, IS 
recruitment of cargoes constitutively bound to SNX27 could drive SNX27 IS localization.  Our 
identification of ZO-2 as an IS component, and the translocation of DGK! and $-PIX to the 
synapse 120, 254 support this hypothesis. SNX27 interaction with Kidins220, which is constitutively 
associated with the TCR 78, and with CENPJ, which forms part of the centrosome that moves to 
and contacts the PM at the IS 311, could also contribute to PDZ-dependent IS localization. 
1.1.3. SNX27 controls ZO-2 dynamic redistribution at the immune synapse 
The strict organization of the IS resembles the ordered regulation of cytosolic proteins in the 
vicinity of transmembrane proteins in polarized epithelial cells.  Several cell polarity proteins 
indeed localize to the IS 201.  The ZO proteins act as scaffolds to facilitate interaction between 
transmembrane proteins and cytoskeletal components, and are reported to be important in 
epithelial cell-cell junctions 94.  Identification of ZO-2 as a SNX27 partner in T lymphocytes was 
therefore not predicted.  The presence of cingulin, a ZO-2 interactor in tight junctions, indicated 
a conserved role for ZO-2 at the IS.  Cingulin is a RhoA signaling regulator that links ZO-2 to the 
actomyosin cytoskeleton 62 and indeed, our immunofluorescence analyses showed ZO-2 at the 
peripheral/distal SMAC, the site of actin retrograde flow and actomyosin contraction during IS 
formation 355. 
Gap junctions (GJ) mediate direct transfer of small molecules between adjacent cells; ions, 
metabolites, and second messengers such as Ca2+ and InsP3 as well as siRNA are permeable 
to GJ (reviewed in 74, 90).  This type of junction is observed at the peripheral SMAC 88, 219, where 
the GJ channel-forming protein connexin 43 (Cx43) mediates bidirectional communication 
between APC and T cells in murine and human systems 219.  Cx43-associated proteins include 
ZO-2 and ZO-1 299 as well as drebrin, which maintains functional Cx43-containing GJ in 
epithelial cells and astrocytes 37.  A very recent report describes the formation of these 
supramolecular complexes through non-overlapping binding sites for drebrin and ZO-1 in 
Cx43 6.  In Jurkat T cells, ZO-1 (data not shown), ZO-2 and drebrin colocalized at the IS (see 
model in Fig D2), but Cx43 expression was not detected (not shown).  Although Cx43 is the 
most ubiquitous Cx, 21 Cx genes have been found in humans, with Cx30 and Cx32 also 
expressed in T cells (reviewed in 237).  Cx30 and Cx32 indeed associate with ZO-2 during 
mammary epithelial cell differentiation (316, reviewed in 74).  Further studies are thus needed to 
assess the details of ZO-2 participation in T cell GJ formation.  
To detect antigens, T lymphocytes scan cell surfaces continuously; this results in the 
formation/disruption of cell-cell contacts that culminate in stable, polarized synapses. We 
showed that during sequential contact with APC, ZO-2 rapidly relocalized from one cell-cell 
contact area to a new one, which correlated with localized actin rearrangement.  SNX27 and 
ZO-2 colocalized at endosomal compartments, and FRAP studies demonstrated that SNX27 
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silencing decreases ZO-2 mobility at the synapse.  These studies suggest that SNX27-mediated 
interaction facilitates dynamic ZO-2 traffic to and from cell-cell contacts (see model in Fig D2), 
consistent with the reported function of SNX27 366.  Our observations not only coincide with ZO 
function in epithelial cells, but also in neuronal dendrites.  ZO proteins control the accumulation 
of adhesive components at filopodia to stabilize the transient interactions between dendrites 172. 
ZO localization to regulate dendritic filopodial dynamics is reminiscent of our videomicroscopy 
observations, and further suggests that ZO proteins could be important in stabilizing cell-cell 
connections in T cells.  Our study thus indicates conservation in the pathways that delimit 
polarized structures in both nervous and epithelial systems during IS formation. 
1.2. SNX27 as an adaptor for WASH-mediated trafficking 
WASH mediates actin polymerization on vesicles involved in recycling and exocytosis 77, 124, 249.  
During IS formation, the T cell-APC contact zone becomes a focal area for endo- and 
exocytosis 29.  WASH-positive endosomes polarize to the IS 124, where we showed partial 
colocalization of SNX27 with WASH and CD63, which suggests SNX27 participation in WASH-
mediated polarized secretion after antigen recognition.  Whereas the WASH role in T cell 
protein secretion has not been studied, its function in protein recycling has been addressed; 
WASH KO in mouse CD4 T cells leads to low cell surface levels of LFA-1 in basal conditions, 
and of TCR and GLUT1 after activation 256. 
SNX27 is widely accepted as an adaptor for WASH-mediated trafficking of PDZ-bm-
containing cargo including GLUT1 308.  In agreement, Jurkat T cells showed decreased GLUT1 
Fig  D2.   Model  for  SNX27 role in  p rotein transport  a t the  immune synapse    
In T cells, SNX27 acts as an adaptor for WASH-mediated transport mainly for PDZ cargoes, some of 
which are recruited to the immune synapse (IS) and promote SNX27 accumulation at this site.  These 
include the cell-cell adhesion and communication protein ZO-2, which localizes to actin rearrangement 
sites where it is subject to SNX27-mediated trafficking.  ZO-2 colocalizes with the F-actin-binding 
protein that regulates actin polymerization at the IS.  The complex formed by ZO proteins and drebrin 
bound to the gap junction (GJ) channel-forming proteins termed connexins could mediate bidirectional 
communication between antigen-presenting cells (APC) and T cells. 
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stability after SNX27 silencing.  Although the LFA-1 integrin and the TCR do not have a 
PDZ-bm, the cytoplasmic tails of subunits in both protein complexes have amino acid 
sequences that potentially bind the SNX FERM domain.  The LFA-1 integrin $2 subunit, also 
termed CD18, bears an NPxF motif (reviewed in 317), and the TCR complex protein CD3* has 
the NPxY consensus sequence.  Nevertheless, neither SNX27 silencing in Jurkat T cells, nor its 
depletion in primary mouse T cells decreased CD3* cell surface abundance in any conditions, 
which suggests that the WASH functions that stabilize the TCR at the PM do not require SNX27 
interaction.  Recent data identified SNX17 as a regulator of TCR and LFA-1 traffic in activated 
T lymphocytes 246.  SNX17 silencing in Jurkat and human primary T cells decreases surface 
TCR#$ levels 246, indicating that SNX17 and SNX27 functions are not redundant, and SNX17 
has a prominent role controlling TCR#$ recycling. 
LFA-1 trafficking in Jurkat cells is affected by SNX17 and SNX27 knockdown.  Nonetheless, 
we showed that SNX27 silencing lowered LFA-1 abundance only after inhibition of protein 
synthesis, whereas Osborne et al. found reduced LFA-1 levels in untreated, unstimulated 
SNX17-silenced cells 246.  This coincides with results in other cell types, in which SNX27 
depletion has a mild effect on integrin recycling, at difference from the clear integrin-protective 
function of SNX17 and SNX31 309, 326.  LFA-1 is essential for T cell-APC conjugate formation 230, 
and SNX17 knockdown results in fewer conjugates than in controls 246.  SNX27 silencing did not 
alter conjugate formation, which further supports the prominent role of SNX17 in LFA-1 
trafficking.  The alteration of TCR levels on the SNX17-silenced cell surface could nonetheless 
explain the defects reported in antigen-dependent conjugate formation 246. 
In primary T cells, our results and those of Osborne et al. showed that SNX17 or SNX27 
depletion affects LFA-1 levels, mainly after T cell activation.  SNX27 binds preferentially to 
NPxY phosphorylated at Y0 116, and binding of various proteins to integrin $ tails is regulated by 
phosphorylation (reviewed by 186).  While this regulatory mechanism could operate for SNX27 
binding to $ integrins, the NPxF of $2 integrins is a non-phosphorylatable motif; activation-
induced phosphorylation of the binding motif thus does not explain the stimulation-dependent 
decrease in LFA-1 surface abundance in Snx27−/− T cells.  A recent study of docking protein 1 
(Dok1) binding to CD18 showed that NPxF adjacent phosphorylation sites (Ser745 and Ser756) 
regulate Dok1/CD18 association 130.  Phorbol esters and CD3 ligation induce CD18 
phosphorylation on these Ser residues by activating PKC isoforms # and + 92.  This 
phosphorylation-based regulatory mechanism could thus operate after T cell activation, leading 
to conformational changes in the LFA-1 heterodimer that promote SNX-FERM/NPxF motif 
interaction for SNX17- or SNX27-mediated integrin recycling. 
Based on current knowledge, we suggest that SNX27 is specialized and directs PDZ 
cargoes to the WASH/retromer pathway, while the other SNX-FERM proteins make a larger 
contribution to NPxY-containing cargo traffic to this transport pathway.  This might be explained 
by the structural differences of SNX FERM domains (detailed in section 1.1), and concurs with 
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unaltered dynamics of the non-NPxY-binding mutant GFP-SNX27 W475A during IS formation.  
As SNX17 does not interact with the WASH/retromer transport machinery, however, it must use 
an indirect mechanism to stabilize integrins and TCR components. 
Studies in HeLa cells indicate that TfR recycling needs WASH function 77, but not that of 
SNX27 308.  We identified the TfR in the PDZ-independent SNX27 interactome, and showed that 
SNX27 silencing results in a marked decrease in total and cell surface TfR levels in Jurkat cells.  
At difference from the SNX27 PDZ partner GLUT1, TfR abundance was not further reduced 
after protein synthesis inhibition.  These data coincide with the HeLa cells studies and indicate 
that, in T lymphocytes, SNX27 controls TfR expression via a mechanism that differs from that of 
the conventional recycling pathway of PDZ cargoes.  Our analysis of Snx27−/− primary mouse T 
cells, which showed decreased TfR expression after TCR triggering, helped to explain Jurkat 
data and will be discussed (section 1.3.2). 
1.3. SNX27 modulates lipid and metabolic signaling pathways 
SNX27 PDZ and FERM-like domains are known scaffolds for signaling complexes.  The RA 
domain in the SNX27 FERM-like domain associates with H-Ras 117 and K-Ras 196.  The SNX27 
PDZ domain binds CASP, which regulates signaling through the Arf family of small 
GTPases 209, as well as Kidins220 308, a scaffold that promotes ERK signaling 10, 78, 100.  Our 
proteomic analysis confirmed SNX27 PDZ association to additional scaffolds and signaling 
complexes such as ZO-2! 366 and the PIX/GIT complex 328.  Furthermore, our laboratory 
identified SNX27 PDZ domain association to DGK! and suggested that SNX27 also participates 
in DAG-dependent signaling pathways 270, 271. 
1.3.1. DGK!/SNX27 association regulates DAG signaling in T cells 
SNX27-mediated regulation of PKC activity 
DGK! has a central role in the control of DAG signaling after T cell activation (reviewed in! 220), 
and we demonstrated that this contribution is strictly dependent on SNX27 interaction.  SNX27 
showed strong constitutive interaction with DGK!, and SNX27 silencing affected DGK! protein 
stability in Jurkat cells.  The SNX27 contribution to DGK! stability nonetheless differed from its 
function in stabilizing transmembrane PDZ cargoes such as GLUT1 and Kidins220, which use 
SNX27-mediated transport to recycle after internalization 308.  In T cells, SNX27 silencing potentiates 
DGK! degradation in a PKC-dependent manner, similar to that described in neurons 244. 
DGK! and PKC#  are subject to reciprocal regulation; DGK!-mediated DAG consumption 
limits PKC# function, whereas PKC#-dependent DGK! phosphorylation at the MARCKS domain 
disrupts PKC#/DGK! association 203, 204, 323.  At neuronal synapses, the PDZ-containing scaffold 
protein PSD-95 (postsynaptic density protein 95) enables this regulatory mechanism in basal 
conditions 183.  In neuromuscular junctions, the PDZ proteins syntrophins facilitate PKC-
dependent localization of DGK! to junctions 1.  In T cells, where reciprocal PKC#/DGK! 
modulation also occurs 119, SNX27 acts an endosomal scaffold for DGK! to control basal PKC 
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activity.  Disruption of SNX27/DGK! association leads to PKC hyperactivation and subsequent 
DGK!-MARCKS domain phosphorylation and degradation (Fig D3, left). 
Analysis of DGK! in endogenous SNX27 and GFP-SNX27 immunoprecipitates showed both 
long and short alternative splicing DGK! isoforms, which concurs with their common C-terminal 
domain 81.  Decreased DGK! protein abundance after SNX27 silencing was nonetheless more 
apparent for the long isoform, which has an extended N-terminal region that bears several Akt 
phosphorylation consensus sequences (R-X-R-X-X-S/T).  Whether the two DGK! isoforms have 
distinct regulatory mechanisms and functions in the immune system remains to be determined.  
Based on experimental data in the Phosphosite repository 146 (Phosphosite, acc. nº Q13574), 
these sites can be phosphorylated in Jurkat cells.  These post-translational modifications could 
also contribute to the protein stability changes observed after SNX27 silencing. 
The reciprocal PKC/DGK! regulatory mechanism is PKC#-specific 203, 204, 323.  PKC# bears a 
C-terminal PDZ-bm 306 that, although it is not predicted to bind SNX27 (60 see Appendix 4.4), is 
needed for the abovementioned PSD-95 scaffolding functions 183.  We thus hypothesized that 
the effects of SNX27 silencing on DAG signaling pathways are PKC#-dependent.  In agreement, 
after inhibition of classic PKC, TCR-triggered AP-1 promoter activity and CD69 upregulation in 
SXN27-silenced cells were similar to controls. 
Novel PKC, including PKC', are also regulated by the DAG produced after TCR triggering 80.  
PKC' is the main PKC isoform that operates downstream of CD28 (reviewed in 157) and 
interacts with PDK-1 to promote NF-%B activation 250.  Data from our laboratory showed that 
DGK! silencing enhanced PKC' membrane stability and promoted PDK-1 scaffolding functions; 
DGK! therefore not only limits DAG signaling, but also its crosstalk with PtdIns(3,4,5)P3 
pathways downstream of TCR triggering and costimulation (Avila-Flores et al., unpublished 
data).  When SNX27-silenced cells were co-stimulated, the enhanced NF-%B and AP-1 promoter 
activity and high CD69 expression were reduced only in part by inhibition of classical PKC, 
suggesting the participation of additional DAG effectors.  Further studies are needed to 
determine whether enhanced PKC' activity mediates the effects observed in SNX27-silenced 
cells after CD3/CD28 costimulation. 
We found a minor fraction of DGK! associated with endogenous SNX27 (data not shown), 
and SNX27 silencing led to only a 20% decrease in DGK! total protein abundance.  The 
hyperactive phenotype of SNX27-silenced cells nonetheless mimicked that of DGK!-silenced 
cells, which suggests that the DGK! fraction that remains after SNX27 silencing does not control 
DAG-dependent pathways.  Although additional studies are needed to assess this question, 
PKC-mediated DGK! phosphorylation and inactivation would explain these data in agreement 
with the model proposed by Luo et al.! 203, 204. SNX27 silencing might also lead to DGK! 
mislocalization to subcellular compartments where it is not functional.  Fractionation 
experiments or immunofluorescence analyses with antibodies that detect endogenous DGK! 
would be needed to determine its subcellular localization in the absence of SNX27. 
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The effects of silencing SNX27 and DGK! on CD69 upregulation and NF-%B activity were not 
enhanced in double-silenced T cells, which supports the hypothesis that SNX27 controls DAG 
signaling through DGK! interaction.  SNX27 nonetheless has other putative PDZ cargoes also 
related to DAG and PtdIns(3,4,5)P3 signaling pathways such as the PH domain and leucine-rich 
repeat protein phosphatase (PHLPP).  PHLPP suppresses lipid second messenger signaling 
directly by dephosphorylating and inactivating Akt, PKC, and S6K at their hydrophobic 
phosphorylation motifs (reviewed in 240).  The role of PHLPP in immune cells has only been 
addressed in regulatory T cells, where it limits Akt activity 251.  PHLPP1 and PHLPP2 PDZ 
ligands bind SNX27 in vitro (60 see Appendix 4.4), and SNX27/PHLPP interaction was observed 
in proteomics analyses 304.  Although PHLPP2 was not identified in our interactome analysis, 
preliminary data from our laboratory confirmed PDZ-dependent SNX27/PHLPP2 association in 
Jurkat T cells (not shown).  Further studies are needed to determine whether this interaction 
contributes to signaling downstream of TCR triggering and CD28 costimulation. 
SNX27-mediated regulation of RasGRP 
DAG generation after TCR triggering controls the Ras/ERK/AP-1 pathway by promoting PKC 
activity 119, 274 and also through direct RasGRP1 binding 86.  Inhibition of classic PKC in SXN27-
silenced cells reduced in part AP-1 transcription, whereas MEK inhibition decreased AP-1 
activity to a similar level in both SNX27-silenced and control cells.  These data suggest that 
SNX27 silencing leads to TCR-triggered hyperactivation of the Ras/ERK/AP-1 pathway both 
through direct and PKC-mediated RasGRP1 regulation.  This coincides with data in DGK!-
silenced T cells 119, 274, and correlates with studies in non-T cells that reported DGK! interaction 
Fig D3.   Model  for  SNX27 role as a scaf fo ld fo r  l ip id  s igna l ing   
In T cells, SNX27 is an endosomal PDZ scaffold for DGK!-mediated control of DAG effectors 
activation.  SNX27 allows DGK!/PKC# reciprocal regulation, and thus SNX27 silencing leads to PKC 
hyperactivation and subsequent DGK!-MARCKS domain phosphorylation and degradation.  SNX27 
silencing in (right) stimulated T cells leads to both PKC and RasGRP1/ERK pathways hyperactivation; 
in contrast, SNX27 silencing in (left) basal conditions prevents DGK!-mediated PKC modulation while it 
promotes DGK! stabilization in the RasGRP1 signaling complex. 
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not only with PKC# 203, but also with RasGRP1 324.  This dual role of DGK! and the 
hypothesized function for SNX27 as a constitutive scaffold for DGK!, concur with a model where 
SNX27 silencing would eliminate the DGK!-mediated restriction for DAG access to PKC and 
RasGRP1.  Increasing evidence indeed supports the relevance of the spatial control of Ras 
activation (reviewed in 164). 
Biochemical analyses confirmed that fold induction of ERK phosphorylation after CD3- (data 
not shown) and CD3/CD28-triggering relative to unstimulated cells was higher in SNX27-
silenced cells than in controls.  Nonetheless, basal ERK activation, at difference of that 
observed upon DGK! silencing 119, was lower in SNX27-silenced cells compared to controls.  
Basal Ras activity in unstimulated T cells, referred to as constitutive or tonic signaling, is the 
consequence of RasGRP1 activity; RasGRP1 facilitates SOS (son of sevenless)/RasGTP 
priming that is further activated upon TCR triggering in a tyrosine kinase-dependent manner 275.  
As DGK! also acts as a negative regulator of basal RasGRP1/ERK activation 275, our data 
suggest a role for SNX27 coupling tonic PKC and Ras activation in endosomes.  On the one 
hand, SNX27 could scaffold DGK! association with PKC and not with RasGRP in basal 
conditions; SNX27 silencing would thus prevent DGK!-mediated PKC signaling modulation, 
while promoting DGK! stabilization in the RasGRP signaling complex (Fig D3, right).  On the 
other hand, SNX27 scaffolding functions for Ras proteins 117, 196 might contribute to PKC/Ras 
signal transduction in unstimulated T cells. 
Both hypotheses could explain low constitutive ERK activation after SNX27 dowmodulation; 
however, there are results inconsistent with a putative low basal RasGRP1 activation.  Several 
studies indicate that DAG/RasGRP1 tonic signals control TCR expression 212, 274, and we found 
significant upregulation of TCR surface abundance in SNX27-silenced Jurkat cells compared to 
controls.  Moreover, constitutive RasGRP1 activity controls mTOR-dependent CD44 expression, 
and Rasgrp1−/− mice show low CD44 levels in DP and SP thymocytes 67; in contrast, although 
we showed low CD44 induction linked to defective mTOR triggering in activated Snx27−/− T 
cells (see section 1.3.2), Snx27−/− thymocytes had normal CD44 surface abundance.  Further 
studies are thus needed to confirm whether SNX27 downmodulation or depletion results in low 
RasGRP1 activation as well as to elucidate the molecular details that facilitate SNX27 control of 
the Ras/ERK axis under different stimulation conditions.  
1.3.2. SNX27 silencing or depletion in T cells affects mTOR activation 
mTOR is a major regulator of T cell metabolism whose activation promotes high expression of 
nutrient receptors and transporters to support cell growth (reviewed in 33, 338).  In this study we 
demonstrated SNX27 contribution to full mTOR activation in T cells.  TfR upregulation in 
Snx27−/− activated T cells was reduced compared to controls, and our results in Jurkat T cells 
suggested that this was not due to defective TfR recycling.  Snx27−/− activated T cells and 
SNX27-silenced Jurkat cells (data not shown) were smaller than controls, and biochemical 
analyses of both SNX27-silenced Jurkat and primary Snx27−/− activated T cells confirmed 
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defective mTOR activation following TCR/CD28 costimulation.  Furthermore, we found that T 
cell size after TCR triggering and costimulation not only correlates with mTOR activity 259, but 
also with CD44 cell surface abundance, which is an mTOR activity reporter in naïve T cells 147.  
In accordance, we showed low surface levels of CD44 in Snx27−/− activated T cells.  CD44 
levels were not monitored in Jurkat T cells due to lack of expression of this protein. 
mTOR is a nutrient sensor activated by amino acids and glucose, and also by lipids 
necessary for membrane biosynthesis during cell growth.  PA is a central metabolite for 
membrane phospholipids synthesis and participates in mTOR signaling (12, 324, 357, reviewed 
in 107).  Data in T cells lacking DGK# and DGK!, however, suggest an inhibitory role for DGK 
activity on mTOR signaling 126 (Avila-Flores et al., unpublished data).  Our data indicate that, 
contrary to DGK silencing, abnormal control of DAG/PA production as a result of DGK! 
malfunction or mislocalization in SNX27-silenced and -depleted T cells could lead to impaired 
mTOR activation. 
SNX27 binding to other cargoes could nonetheless explain the defects in TCR-mediated 
mTOR activation.  Amino acid and glucose uptake contribute to mTOR activation in T 
lymphocytes (reviewed in 258).  On the one hand, GLUT1 is the major glucose transporter in T 
cells (reviewed in 248), where its deficiency impairs sustained mTORC1 signaling and efficient 
upregulation of TfR and CD98 expression 208.  On the other hand, TCR triggering induces 
leucine uptake via a System L amino-acid transporter that is composed of CD98 and SLC1A5 
(also termed ASCT2) 298, which is needed for mTORC1 activation in naïve T cells after 
TCR/CD28 costimulation 235.  SNX27 regulated GLUT1 levels in Jurkat T cells and, although we 
did not monitor CD98 cell surface expression, SLC1A5 also bears a PDZ-bm at the C-terminus 
and is a putative SNX27 cargo 308.  These data indicate that SNX27-mediated trafficking of 
GLUT1 facilitates mTOR signaling in T lymphocytes, and suggest that SNX27-dependent 
regulation of the amino acid transporter levels, directly through SLC1A5 recycling, or indirectly 
by the control of GLUT1 levels, could also contribute to mTOR activation after TCR triggering. 
Irrespective of the identity of cargoes involved, our studies strongly indicate defective mTOR 
activation after SNX27 downmodulation or depletion.  Additional data supporting this hypothesis 
come from studies in mice; low or null expression of the proteins that participate in the mTOR 
signaling pathway results in small animals with reduced organ size (reviewed in 353), and 
Snx27−/− mice are indeed smaller than controls 40, 51.  Nevertheless, while we observed 
decreased spleen cellularity in Snx27−/− animals compared to controls, thymus and lymph 
node (LN) cellularity were unaltered. Normal thymus and LN cellularity concur with no gross 
defects in T cell development; however, if we considered their relative size to that of the animal, 
their cellularity would be proportionally higher in Snx27−/− mice than in controls.  LN cellularity 
data could be variable due to the laborious process for their extraction from small mice.  Further 
analyses are required to rule out Snx27−/− mice alterations in LN cellularity determinants such as 
lymphocyte homing (reviewed in 337).  Thymic size and thymopoiesis capacity are determined by 
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thymic niche availability and by T cell progenitor dosage, which depends on cell proliferation 
and apoptosis during development and thymic involution (reviewed in 129).  Although additional 
studies are needed, the increase in Snx27−/− DN4 progenitors suggests enhanced thymocyte 
proliferation at the DN4 stage, which could contribute to maintain a normal-sized thymus. 
Defects in cell growth seem to counteract cell proliferation; cell growth and cell cycle 
progression are nonetheless distinct processes in mammalian cells 101.  In T lymphocytes, 
mTOR promotes cell cycle progression but is not strictly necessary for proliferation (reviewed 
in 56).  Snx27−/− cells, with a clear defect in cell growth, were indeed able to proliferate normally.  
SNX27 binding to cargoes with diverse functions might account for the opposed effects of 
SNX27 depletion on T cell activation; while downregulation of mTOR signaling-related cargoes 
explains growth defects, proliferation and CD69 expression data concur with a defective DGK! 
function 365.  These effects might compensate for each other and, depending of each cell type 
demands, become more apparent in primary mouse T cells or Jurkat cells.  Whereas small cell 
size was observed in primary cells only after activation, when they have high metabolic 
demands, it was reproduced in the human leukemic cell line Jurkat (data not shown).  This 
correlates with the elevated basal activation of PI3K-dependent pathways in Jurkat cells, which 
lack the PtdIns(3,4,5)P3 phosphatase PTEN (phosphatase and tensin homolog) 290 and whose 
growth is also PI3K/Akt axis-dependent 349.  Cell growth defects in this cell line did not impair 
the positive outcome of DAG signaling hyperactivation after TCR triggering; however, severe 
growth limitations in Snx27−/− T cells could result in alterations in T cell differentiation and 
expansion of effector populations and must be preventing further effects on CD69 upregulation 
and cell proliferation. 
2. ROLE OF SNX27 IN CANCER CELL INVASION 
The WASH and exocyst complexes have an important role during tumor cell invasion; they 
coordinate to allow the formation of late endosomes-to-PM connections that facilitate focal 
delivery of invasion-related proteins to the ECM 228.  WASH-dependent actin polymerization 
generates the forces required to form these endosomal membrane extensions 76, 77, 125, while the 
exocyst assists membrane tethering and promotes vesicle fusion through SNARE complex 
regulation (reviewed in 140).  In MDA-MB-231 cells, the WASH/exocyst association regulates 
MT1-MMP exocytosis at invadopodia 228.  Our studies, carried out in these cells during invasion 
into 2D and 3D matrices, indicated a dynamic localization of SNX27 at these structures that 
correlated with actin cytoskeleton rearrangements.  We demonstrated consistent colocalization 
of SNX27 with WASH at MT1-MMP-positive endosomes, which showed altered morphology 
after SNX27 silencing.  These data, and the tendency of SNX27-silenced cells towards reduced 
invasion in 2D and 3D assays, suggest the participation of SNX27 in the regulation of WASH-
dependent transport during cancer cell invasion. 
SNX27 acts as a WASH adaptor for PDZ-binding cargoes including the GLUT1 and the 
monocarboxylate transporter (MCT1) 308, which have been associated with cancer cell 
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invasion 105, 158.  Nevertheless, most reports on SNX27 PDZ cargoes in cancer cells indicate 
their contribution to cell growth and chemoresistance; MRP4 139 is an ATP-binding cassette 
(ABC) transporter that promotes tumor drug resistance 102, and alterations in GLUT1, MCT1 or 
SLC1A5 expression are linked to the metabolic reprogramming in tumors that supports cell 
growth (reviewed in 27, 133).  The so termed “Warburg effect” and “glutamine addition” in tumor 
cells are indeed proved targets for cancer treatment (for more information see 27, 52, 133).  SNX27 
downmodulation in highly metastatic cells, like in primary activated T cells, could thus affect 
metabolic signaling pathways activation and interfere with cell growth, which provides a reason 
for further studies.  
Metabolic defects can contribute to reduce tumor cell invasion 134.  Aggressive tumor cell 
lines like MDA-MB-231 are nonetheless resistant to metabolic signaling pathways inhibition 194, 
which suggests that alterations in other signaling or trafficking pathways reduce the invasion of 
SNX27-silenced cells.  We found morphological changes in WASH/MT1-MMP-positive 
structures after SNX27 silencing, indicating its participation in MT1-MMP trafficking.  This 
concurs with results from Steinberg et al. in HeLa cells; they found MT1-MMP in SNX27 
interactome, and showed increased MT1-MMP surface abundance in SNX27-silenced cells, 
which they proposed was caused by unbalanced sorting processes 308.  SNX27 PDZ is not 
predicted to bind MT1-MMP C-terminus (RSLLDKV) (60; see Appendix 4.4), and thus it is 
unlikely that SNX27 acts as a direct adaptor for MT1-MMP/WASH complex association.  
Alternatively, SNX27 might bind to regulatory proteins that control WASH-mediated MT1-MMP 
transport during invasion. 
WASH-associated machinery not only facilitates MT1-MMP delivery to invadopodia, the 
exocyst is presented as a regulatory complex that restricts and prevents excessive diffusion of 
MT1-MMP to ensure its efficient focal delivery; direct interaction between WASH and the 
exocyst components Exo84 and Sec3 negatively controls WASH functions 228.  Our finding that 
SNX27 interacts with PIP5K", a known exocyst regulator 322, suggests a role for SNX27 
facilitating lipid-mediated control of the WASH/exocyst complex.  As the PA produced by DGK! 
regulates PIP5K activity 205, the respective binding of PIP5K and DGK! to SNX27 FERM and 
PDZ domains would add another level of complexity to this regulatory mechanism (Fig D4).  
Nevertheless, we cannot rule out the contribution of other PDZ interactions, some components 
of the exocyst complex including the Exo70 and the WASH-interacting subunit Exo84 were 
detected in SNX27 interactome analyses and bear a PDZ-bm predicted to bind SNX27 (60, 308). 
Additional experiments are required to confirm the formation of these multiprotein complexes 
in invasive tumor cells and to define their molecular details.  We nonetheless hypothesize that 
SNX27 scaffolding functions ensure a correct activation of exocyst and WASH complexes 
through the modulation of endosomal lipid composition.  This model is in agreement with our 
results and those from Steinberg et al. 308 that suggest that SNX27 silencing leads to 
unbalanced MT1-MMP trafficking, but does not impair MT1-MMP delivery. 
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The assays used in this study examine the MMP-dependent invasion capacity of MDA-
MB-231 cells 359.  WASH-dependent integrin recycling contributes to enhance this capacity 360, 
and exocyst regulation by PIP5K controls integrin recycling in this cell type 322.  SNX27 and 
WASH colocalized in #5 integrin-positive endosomes adjacent to focal adhesions when MDA-
MB-231 cells were plated on fibronectin, with a localization pattern similar to that shown in MT1-
MMP-positive structures (data not shown).  Although additional studies are needed, SNX27 
could thus participate in the formation of this type of structures irrespectively of vesicle content, 
which varies depending on cell requirements during a particular physiological process. 
3. SNX27: A HUB FOR ENDOSOMAL SIGNALING AND PROTEIN TRANSPORT 
IN POLARIZED CELLS 
In this study, we aimed to determine the role of SNX27 in two polarized cell models, activated 
T cells and invasive tumor cells.  Our data suggest that whereas the well-known function of 
SNX27 in the recycling of nutrient receptors and transporters is crucial for primary T cell growth, 
there is a major contribution of SNX27 role as a cytoskeleton regulator and lipid signaling 
scaffold during IS and invadopodia formation.  We hypothesize that SNX27 acts as an 
endosomal hub to assist local lipid modulation in both cell models.  In T cells, where DAG-
regulated pathways are crucial to delimit cell functions (reviewed in 220), SNX27 controls DAG 
signals through DGK! binding.  In cancer cells, where PA production regulates membrane 
remodeling 176, 205, 352, SNX27 binding to DGK! and PIP5K could contribute to the formation of 
invasive structures.  Both at the IS and at the invadopodium, lipid modulation is linked to 
cytoskeletal remodeling (reviewed in 345).  DGK! could couple lipid signaling to actin 
reorganization through PIP5K activity modulation 272, and through Rac1 and RhoA regulation 2, 9. 
DGK! and PIP5K expression augment in several types of metastatic cancer 39, 315.  Although 
SNX27 expression has not been studied, its chromosome localization (1q21.3) in humans is 
frequently amplified in different types of invasive cancer (reviewed in 55, 229).  This coincides with 
data from bioinformatics resources such as the cBioPortal for Cancer Genomics 49, 113 (see 
Appendix 1).  Other genes within 1q21 amplicon have been associated with poor prognosis 207, 
361, enhanced SNX27 expression could contribute to promote oncogenic traits in tumor cells. 
Fig D4.   Model  for  SNX27 role 
as a sca ffo ld for  l ip id  s ignal ing 
in  invas ive cel ls  
The WASH-associated exocyst complex 
(EXO) regulates MT1-MMP focal delivery to 
invadopodia. PIP5K" regulates exocyst 
function through PtdIns(4,5)P2 (PIP2) 
production. SNX27 interacts with PIP5K" 
and with DGK!, which generates the 
phosphatidic acid (PA) that regulates 
PIP5K activity.  Respective binding of 
PIP5K and DGK! to SNX27 FERM and 
PDZ domains suggests a lipid-based 
regulatory mechanism to control protein 
trafficking to invadopodia. 
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In contrast to SNX27 amplification in cancer cells, diminished expression and/or mutation of 
SNX27 and its interactors are linked to neurodegenerative diseases (Table D1).  Emerging 
evidence indicates that sufferers of a neurodegenerative disorder have reduced incidence for 
most cancers 152.  Our studies in tumor cells thus help to illustrate how the alteration of a 
molecular pathway linked to neurodegenerative diseases could exert a protective role against 
cancer development. 
Our proteomic study in T cells identified SNX27 interactors linked to neurological diseases 
(Table D1), which suggests close analogy between neurological function and immune system 
regulation.  Moreover, the hypothesized scaffolding role of SNX27 for local lipid signaling 
modulation in T cells is reminiscent of that reported for other PDZ-containing proteins in 
neurons; DGK! localizes to neuronal synapses through direct interaction with PSD-95, and 
regulates dendritic spine maintenance by promoting DAG-to-PA conversion downstream of 
NMDAR activation (for more information see 170, 183, 288).  These receptors are known SNX27 
cargoes 40, 342, and thus the molecular organization of these proteins in SNX27-positive 
endosomes could be similar to that found at the synaptic PM.  Studies of SNX27 at the neuronal 
synapse have been mainly focused on SNX27 role in the recycling of PDZ-interacting receptors 
40, 150, 162, 196, 342.  Our data indicate that SNX27 could integrate sorting events with lipid signaling 
to control signal transduction of these receptors.  Furthermore, NMDAR trafficking and surface 
abundance is controlled by PKC activation 54, which suggest participation of SNX27 in this 
feedback mechanism that ensures receptor availability at the cell surface.  In addition to 
NMDAR signal transduction, DGK! modulation of the DAG/PKC pathway is involved in GPCR 
signal transduction 72, 239, 241, 281, and thus DGK! deregulation in Snx27−/− mice might account for 
some of the observed effects in PTHR signaling hyperactivation 51. 
This study broadens our knowledge of the SNX27 function in T lymphocytes and invasive 
tumor cells, and suggests that our findings on SNX27-mediated coordination of lipid signaling 
with polarized vesicular trafficking and cytoskeletal dynamics could be extrapolated to other 
models of intense polarized trafficking. 
Protein names Neurological disorders References 
SNX27 Down syndrome, Alzheimer disease, myoclonic epilepsy 70, 341, 342 
VPS26 Alzheimer disease 301 
VPS35 Alzheimer disease, Parkinson disease 200, 301, 335 
SWIP Intellectual disability 276 
RME-8 Parkinson disease 334 
Strumpellin Hereditary spastic paraplegia 329 
USP7 Intellectual disability and autism spectrum disorder 135 
CENPJ Primary microcephaly, Seckel syndrome 31, 218 
XPR1 Primary familial brain calcification 187 
Kidins220 Alzheimer disease 198 
Table D1. Proteins found in SNX27 interactome associated with neurological disorders 
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VII. CONCLUSIONS 
1. The SNX27 FERM domain recognizes membrane phosphoinositides.  FERM domain 
lipid recognition mediates early SNX27 translocation to the immune synapse (IS) and enhances 
its recruitment to the endocytic recycling compartment during IS formation, but is nonetheless 
dispensable for SNX27 recruitment to the mature IS of Jurkat T cells. 
2. PDZ ligand recognition is necessary for SNX27 accumulation at the IS, which suggests 
that cargoes recruited to the IS could contribute to this localization.  Proteomic analysis of PDZ-
interacting cargoes identified the cell-cell junction protein ZO-2 as a SNX27 partner during IS 
formation.  ZO-2 localizes to the actin cytoskeleton rearrangement sites at the peripheral IS of 
Jurkat T cells, where its dynamics are regulated by SNX27/ZO-2 interaction. 
3. The constitutive interaction of DGK! with SNX27 facilitates DGK!-dependent regulation 
of DAG-based signals both in basal and stimulating conditions.  SXN27 silencing reduced DGK! 
protein levels as a result of PKC activation in basal conditions; after TCR triggering, enhanced 
activation of classical PKC promoted Ras/ERK/AP-1 hyperactivation.  Co-stimulation further 
augmented Ras/ERK/AP-1 signals and enhanced NF-%B activation in SNX27-silenced cells, 
which suggests participation of additional DAG effectors. 
4. Snx27 deletion in mice does not grossly alter T cell development.  Activation-induced 
CD69 expression was normal in Snx27−/− primary mouse T cells and their proliferation was not 
substantially altered.  Snx27−/− T cells nonetheless showed growth defects and lower CD44 
surface abundance compared to controls.  This correlated with a decrease in CD71 levels and 
in mTOR activation after TCR triggering, which was also apparent in SNX27-silenced Jurkat T 
cells. 
5. SNX27 interacts with the retromer/WASH complex in Jurkat T cells.  WASH localizes to 
CD63-positive endosomes and colocalizes with endosomal SNX27 at the IS.  SNX27 acts in 
part as an adaptor for WASH-mediated transport in T cells; it is essential for the recycling of its 
PDZ cargo GLUT1, and participates in maintaining cell surface LFA-1 levels in Jurkat cells and 
in activated mouse T cells.  SNX27 is not necessary for TCR recycling. 
6. In MDA-MB-231 invasive breast cancer cells, SNX27 colocalized with WASH- and 
MT1-MMP-positive endosomes located at invadopodia; when these cells invaded 3D matrices, 
SNX27 localized at the front of the invading pseudopods.  SNX27 downmodulation in 
MDA-MB-231 cells altered MT1-MMP accumulation at invadopodia and its depletion reduced 
invasive cell migration.  The previously unreported SNX27 association to PIP5K", a 
PtdIns(4,5)P2-synthesizing enzyme that modulates exocyst function and promotes cancer cell 
migration, could contribute to the effects observed on cell invasion. ! !
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VII. CONCLUSIONES 
1. El dominio FERM de SNX27 reconoce fosfoinositidos de membrana.  Dicho 
reconocimiento facilita la translocación inicial de SNX27 a la sinapsis inmune (SI) y promueve 
su localización en el compartimento endocítico durante la formación de la SI.  Sin embargo, es 
dispensable para su reclutamiento a la sinapsis madura de células Jurkat. 
2. El reconocimiento de cargos de PDZ es necesario para la acumulación de SNX27 en la 
SI, lo que sugiere el reclutamiento de dichos cargos.  Empleando un análisis proteómico 
identificamos cargos que emplean o no el dominio PDZ para unir SNX27 durante la formación 
de la SI.  Entre ellos cabe destacar la proteína de las uniones intercelulares ZO-2, cuya 
asociación con SNX27 le permite regular sus dinámicas de localización en la SI. 
3. La interacción constitutiva DGK!/SNX27 facilita la regulación de las señales de DAG 
dependientes de DGK!.  El silenciamiento de SNX27 en condiciones basales reduce los niveles 
de proteína DGK! por la activación de PKC; tras la estimulación del TCR, la activación 
aumentada de PKC clásicas resulta en la hiperactivación de la ruta de Ras/ERK/AP-1; la 
coestimulación promueve un aumento aún mayor de la señalización de esta ruta así como de la 
de NF-%B, lo que sugiere la participación de otros efectores del DAG. 
4. La deleción de Snx27 en ratones no afecta notablemente al desarrollo de células T.  
Tras la activación de las células T primarias Snx27−/− la expresión de CD69 es normal y su 
proliferación no está alterada sustancialmente.  Sin embargo, dichas células comparadas con 
los controles, muestran defectos en crecimiento y bajos niveles de CD44 en superficie.  Esto 
correlaciona con una baja expresión de CD71 y una menor activación de mTOR tras la 
estimulación, lo cual también se observó en células Jurkat silenciadas para SNX27. 
5. SNX27 interacciona con el complejo retrómero/WASH en células Jurkat.  WASH se 
localiza en endosomas positivos para CD63 y colocaliza con la fracción endosomal de SNX27 
en la SI.  SNX27 funciona en parte como un adaptador para el transporte mediado por WASH 
en células T; es esencial para el reciclaje de cargos de PDZ como GLUT1, y participa en 
mantener LFA-1 en superficie tanto en células Jurkat como en células T primarias de ratón 
activadas.  SNX27 no es necesaria para el reciclaje del TCR. 
6. En la línea celular de cáncer de mama invasivo MDA-MB-231, SNX27 colocaliza con 
endosomas positivos para WASH y MT1-MMP en los invadopodios; durante la invasión en 
matrices 3D, SNX27 localiza al frente de los pseudópodos invasivos.  El silenciamiento de 
SNX27 en MDA-MB-231 altera la acumulación de MT1-MMP en los invadopodios y reduce la 
capacidad migratoria invasiva de estas células.  La asociación previamente no reportada de 
SNX27 a PIP5K", una enzima lipídica que modula la función del exocisto y promueve la 
migración de las células tumorales, podría contribuir a los efectos observados en la invasión 
celular. 
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3. Links to videos and supplemental tables 
Video 1 related to Figure R3: Relative dynamics of IS recruitment of GFP-SNX27 and the 
RRK/E mutant 
https://www.dropbox.com/s/rdc4bfc7q8x9tfk/video1.mov?dl=0 
Video 2 related to Figure R7: Relative dynamics of IS recruitment of GFP-SNX27 and the PDZ 
mutant 
https://www.dropbox.com/s/xwgeege3m4tlotn/video2.mov?dl=0 
Video 3 related to Figure R10: Relative dynamics of IS recruitment of Cherry-SNX27 and 
GFP-CD63  
https://www.dropbox.com/s/xapnkqxthnta8vt/video3.mov?dl=0 
Video 4 related to Figure R14: Dynamics of IS recruitment of GFP-ZO-2 
https://www.dropbox.com/s/pnnnevpwyjgo23q/video4.mov?dl=0 
 Video 5 related to Figure R14: Dynamics of IS recruitment of GFP-ZO2 relative to actin 
polymerization 
https://www.dropbox.com/s/u22t54zsx4m7cu2/video5.mov?dl=0 
Video 6 related to Figure R15: Relative dynamics of IS recruitment of GFP-ZO-2 and Cherry-
SNX27  
https://www.dropbox.com/s/s1ce8s8cbqucyls/video6.mov?dl=0 
Video 7 related to Figure R15: Relative dynamics of IS recruitment of GFP-ZO-1 and Cherry-
SNX27 
https://www.dropbox.com/s/m28k7hps09ids9r/video7.mov?dl=0 
Video 8 related to Results section 4: Dynamics of GFP-SNX27 relative to actin 
polymerization in invadopodia-forming MDA-MB-231 cells 
https://www.dropbox.com/s/lg4q78kvusf65qd/Video8.avi?dl=0 
Video 9 related to Results section 4: Dynamics of GFP-SNX27 in MDA-MB-231 cells 
invading during CIA assay 
https://www.dropbox.com/s/rbvm5vuv8xc21qo/Video9.avi?dl=0 
Supplemental Tables S1-S6 related to Figure R8 
Sheet1: Table S1. Complete report of identified proteins in all samples 
Sheet2: Table S2. Identified proteins in GFP control samples 
Sheet3: Table S3. Identified proteins in GFP-SNX27 WT samples 
Sheet4: Table S4. Identified proteins in GFP-SNX27 H114A 
Sheet5: Table S5. Identified proteins in both GFP-SNX27 WT and H114A samples 
Sheet6: Table S6. Gene Ontology (GO) enrichment analysis of PDZ-independent SNX27 
interactors 
https://www.dropbox.com/s/bba6n7kg80c1b8x/Supplemental%20Tables%20S1-S6.xlsx?dl=0 
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4.3. Torres-Ayuso et al, 2015325!
4.4. Clairfeuille et al, 2016 60!
